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Abstract 
The ease of use and versatility of the Baculovirus Expression Vector System (BEVS) has made it 
one of the most widely used platforms for recombinant protein production. In the last ten years, 
the system has even gained commercial acceptance for the production human biologics such as 
for the production of human papillomavirus vaccine (Cervarix®) and influenza vaccine 
(FluBlok®). The work presented in this thesis aims to further the utility of this system in 
coexpressing multiple proteins within a single cell, with the final goal of setting up designed and 
tightly controlled gene expression schemes within insect cells. 
In this work we explore the effect of using different Autographa californica multicapsid 
nucleopolyhedrovirus (AcMNPV) promoters to control the timing and expression of multiple 
proteins within insect cells. We do this first in a simple two fluorescent protein system where 
protein and RNA expression levels of these two proteins are tracked over time and complex 
interaction effects are evaluated. Some of these promoter combinations are then used in a more 
complex and industrially relevant influenza VLP production system, in which effects such as 
significant post translation modification, protein trafficking to the cell membrane, insertion of 
protein into the membrane, and VLP budding from the surface are present. These studies 
coexpress two influenza proteins – the Hemagglutinin (HA) and Matrix 1 (M1) proteins 
genetically fused to eGFP and DsRed2 fluorescent proteins to easily track influenza protein 
localization and expression levels within insect cells, and to track influenza virus-like particles in 
culture supernatant. Lastly, we examine the effect of coexpressing superoxide dismutase as a 
helper protein to extend the lifespan of insect cells post-baculovirus infection.  
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Chapter 1 : Introduction 
 
The baculovirus expression vector system (BEVS) has grown to be one of the most widely used 
protein production systems. The system uses one or more baculoviruses to introduce one or more 
genes of interest into insect cells where the recombinant protein(s) of interest is (are) expressed. 
The popularity of the system stems from factors such as the ability to grow insect cells in high 
density suspension cultures, the mammalian-like post translational modification capability of 
insect cells, the capability of the baculovirus genome to accept multiple large insertions, and the 
high protein yields obtained using the system. In addition, the limited host range in which these 
viruses can replicate provides a very high level of biosafety for the production of therapeutics for 
human use, as compared to mammalian cell culture.  
While superior in many ways as a protein production system to mammalian cell culture, 
there are some limitation of the BEVS. In its most widespread implementation, the proteins of 
interest are produced only in the very-late phase of the baculovirus infection cycle through the 
use of two very strong promoters: the polh and p10 promoters. Though these promoters drive the 
production of very large amounts of protein, they are active at a time when the cell is dying and 
cellular transcription and translation has largely shut down, and as a consequence, cellular post-
translation and secretory mechanisms are perturbed (Jarvis and Summers, 1989). In addition, the 
presence of viral and cellular proteases can cause the degradation of susceptible protein products 
(Ikonomou et al., 2003). Much work has been done to circumvent these problems such as 
producing proteins earlier during the infection cycle and the introduction of protease inhibitors 
(Ikonomou et al., 2003), though these methods are not commonly used in practice. 
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The BEVS is especially suited to the simultaneous expression of multiple proteins within 
a single insect cell, due to factors such as the large capacity for insertion into the baculovirus 
genome and ability to manipulate expression levels by controlling the amount of baculovirus 
added. This is useful in the production of multi-subunit proteins, as well as in the co-production 
of helper proteins such as chaperones, which can help in increasing the production of 
recombinant proteins of interest. While much work has been done in this respect, the 
simultaneous production of multiple proteins can still be optimized in several ways. The theme 
of the work presented in this thesis deals with controlling co-expression of multiple proteins 
within insect cells.  
The driving hypothesis behind this work is that promoter control can be used to control 
the timing and level of protein expression in an insect cell coexpression system. In addition, it 
was hypothesized that the simultaneous high level production of two proteins in an insect cell 
can result in the protein coding genes “competing” for cellular resources; a reduction of this 
competition effect can be achieved by temporally separating the expression of these genes. This 
control can be achieved using promoters to control levels of protein expression within a cell. We 
also aimed to better understand the dynamics involved in the production of multiple foreign 
proteins within insect cells in the BEVS system.  
The thesis starts with this general introduction to the work, followed by a review of 
relevant literature presented in Chapter 2. Following this, the various projects are presented in 
the form of individual chapters. 
The first project was a collaborative effort with Altamash Jauhar, who was a Masters of 
Applied Sciences student in the lab of Dr. Aucoin. In this, a simple system was first implemented 
where two fluorescent proteins, a green fluorescing eGFP and a red fluorescing DsRed2, were 
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co-expressed within a single cell. These proteins were expressed under different promoter 
combinations, and the resulting fluorescence was closely monitored by flow cytometry. This 
study revealed that different promoter combinations resulted in extremely well defined ratios of 
the two fluorescent proteins being expressed over time. In addition, this work demonstrated that 
clear competition effects are present when producing multiple proteins simultaneously within 
insect cells. This study was especially important as it allowed for the examination of the protein 
production process of two very simple proteins that did not have to undergo extensive post-
translational modifications or cellular trafficking. The results of this study have been published 
in a journal article in the journal Biotechnology and Bioengineering, and this is presented in 
Chapter 3 of this thesis. This study achieved the goals set out in the hypothesis statement in a 
simple system. 
One limitation of the first study was that it was not clear if the phenomenon of 
competition occurred at the transcription or translation steps. In order to resolve this, a second 
study conducted with Altamash Jauhar examined the ratios eGFP and DsRed2 RNA transcripts 
being produced over time from the different constructs co-expressing the two fluorescent 
proteins. This was done by semi-quantitative Real Time PCR. While this study suffered from a 
lot of noise in the data, some trends could be inferred, indicating that competition was present at 
the RNA transcription phase. The results of this study are presented in Chapter 4. 
The third study sought to examine these effects in a more complex and relevant protein 
system.  To this end, the production of influenza VLPs by the co-expression of influenza 
hemagglutinin (HA) and matrix 1 (M1) proteins in insect cells was examined. The examination 
of previous studies such as that by Thompson et al (2015) convinced us that a modified system 
was essential to reduce the amount of effort needed to reliably detect the production of influenza 
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proteins within insect cells and to examine their incorporation into VLPs. This was done by 
genetically modifying the HA and M1 genes to incorporate eGFP and DsRed2 genes, 
respectively, into sites that have been shown to be amenable to insertions (such that the functions 
of the HA and M1 proteins are minimally affected). The expression of these modified proteins 
within insect cells allowed for the clear visualization of protein production within cells by 
microscopy and its quantification by flow cytometry. In addition, the produced virus-like 
particles could be detected via flow cytometry due to their fluorescence. The work on production 
of fluorescent influenza proteins and their incorporation into VLPs is detailed in an article 
submitted to the Journal of Biotechnology and presented in Chapter 6. The subsequent 
manipulation of influenza protein expression levels is described in Chapter 7. This study was 
similar to that conducted in Chapter 3 in that it established the utility of promoter combinations 
to control the timing and level of production of coexpressed proteins in insect cells, albeit in a 
more complex system. It also addressed the stated objective of the work, to examine effects of 
competition in coexpressing complex proteins within insect cells. 
The fourth and final study details the use of co-expression in BEVS to attempt to extend 
the lifespan of baculovirus infected insect cells through the co-expression of a copper-zinc 
superoxide dismutase (Cu/Zn SOD), along with a gene of interest (in this case RFP). It was 
thought expression of superoxide dismutase could relieve oxidative stress on the cell and help 
maintain the viability of the culture for a longer period of time. This study, presented in Chapter 
8, was conducted with the help of an NSERC URA student Jenna Collier and showed that the 
expression of Cu/Zn SOD did not induce protective effects in infected Sf9 insect cells. 
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Chapter 2 : Literature Review 
 
2.1. Baculoviruses 
Baculoviruses are enveloped DNA viruses that have very narrow host specificity within 
arthropod invertebrates (Miller & Lu, 1997). They can be divided into the 
nucleopolyhedroviruses (NPVs), which can form occlusion bodies composed of one or more 
virions encapsulated in a polyhedrin protein matrix, and the granuloviruses (GV), which can 
form occlusion bodies containing a single virion encased in a granulin protein matrix (Funk et 
al., 1997). Baculoviruses can exist in one of two states during their life cycle: the occluded form, 
which are responsible for transmission between hosts, or the budded form, which are responsible 
for transmission within a host. Baculoviruses are large viruses nearly 300 nm in length and 50 
nm in diameter, with a circular supercoiled double stranded DNA genome that is between 80 – 
180 kb in size encoding between 90 – 180 genes (Rohrmann, 2011). The Autographa californica 
multiple nucleopolyhedrovirus (AcMNPV) was one of the first to be extensively studied and 
used for purposes such as biological pest control and for protein production. 
2.2. The baculovirus replication cycle and gene expression 
Within insect cell culture, baculovirus transmission is mainly mediated by absorptive 
endocytosis (Blissard and Wenz, 1992; Volkman and Goldsmith, 1985), with subsequent release 
of the nucleocapsid into the cytoplasm by fusion of the baculovirus membrane to the endosome 
membrane. The latter is mediated by the gp64 baculovirus surface glycoprotein (Blissard and 
Wenz, 1992). The nucleocapsids then migrate to nuclear pores and seem to enter the nucleus 
through these pores (Ohkawa et al., 2010). The viral genome is believed to be released by 
6 
 
destabilization of the capsid caused by phosphorylation of the core protein p6.9 (Funk and 
Consigli, 1993). The released viral genome is then used for viral RNA synthesis and 
multiplication of viral DNA. An overview of the baculovirus life cycle is presented in Figure 2-1  
 
Figure 2-1: Baculovirus life cycle and gene expression 
The baculovirus infection cycle is temporally divided into three phases: the early phase, 
the late phase, and the very-late phase of infection. The expression of baculovirus early phase 
genes occurs from about 30 minutes (Chisholm and Henner, 1988) to about 6 hours post 
infection (Kelly et al., 2007) and is divided into two sub-phases, with the delayed early phase 
genes requiring the expression of immediate early genes. Genes in this phase are transcribed 
using host RNA polymerase II (Grula et al., 1981) and largely code for transcriptional activators 
and enhancers. These include genes coding for products like the Immediate Early trans-
regulators (IE0, IE1 and IE2). Of these, IE1 is one of the most important and is involved in early 
gene regulation and DNA replication. The onset of baculovirus DNA replication occurs at the 
same time as the beginning of late gene transcription (Rohrmann, 2011) and is discussed later in 
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this review. The onset of baculovirus budding occurs at the end of baculovirus DNA replication, 
which corresponds to the end of the late phase of the infectious cycle (Rohrmann, 2011). The 
transcription of late and very-late phase genes is associated with the activity of a virally encoded 
multisubunit RNA polymerase (Fuchs et al., 1983; Guarino et al., 1998). The transcription of late 
phase genes begins at about 6 hours post infection and continues till the expression of very-late 
phase genes at about 20 hours post infection (Kelly et al., 2007). The polyhedrin and p10 genes 
are two genes that are expressed at very high levels during the very-late phase of infection 
(Smith et al., 1983b) and are involved in the formation of occlusion bodies. 
The origin of baculovirus DNA replication is not clearly known, with some reports 
indicating that the homologous regions (hrs) are the sites of DNA replication initiation (Kool et 
al., 1993), with others suggesting that initiation can occur at other regions (Habib and Hasnain, 
2000; Lee and Krell, 1992). The replication is thought to occur either by a rolling circle 
mechanism (Oppenheimer & Volkman, 1997) or by recombination (Okano et al., 2007) and 
requires the action of several baculovirus gene products. In addition to the DNA polymerase and 
helicase proteins encoded by the baculovirus dnapol and helicase (p143) genes, the gene 
products of the ie1, late expression factor (lef)-1, lef-2, lef-3, lef-7, and ie-n genes are necessary 
for efficient baculovirus DNA replication (A. Lu & Miller, 1995). It has also been suggested that 
host proteins also play a role in this process (Rohrmann, 2011). 
Baculovirus infection of insect cells causes the arrest of the cell cycle at the G2/M phase 
(Braunagel et al., 1998). In addition, it also causes a decrease in host transcription during the late 
phase of infection (Nobiron et al., 2003) and an almost universal shut-off of host protein 
translation from about 6 hours post-infection (Carstens et al., 1979). Another important 
characteristic of baculovirus infection of insect cells is the production of anti-apoptotic factors, 
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which counteract the natural infection-induced apoptosis response. The p35 gene product is 
produced during the early and late phases of baculovirus infection and blocks the apoptotic 
response, in addition to having a role in baculovirus gene expression (Hershberger et al., 1994). 
The p35 gene product is also capable of inhibiting apoptosis in a wide range of cell types (Clem, 
1997). Another class of genes called the inhibitor of apoptosis (iap) genes, common in viruses 
and eukaryotes, also exist in baculoviruses (Rohrmann, 2011). It is thought that both P35 and 
IAP inhibitors function by blocking the activity of caspases in infected insect cells (Bump et al., 
1995; Rohrmann, 2011). The baculovirus replication cycle and its molecular biology have been 
extensively reviewed elsewhere (Miller, 1997; Rohrmann, 2011) 
2.3. Control of baculovirus gene expression 
Baculovirus early promoters are transcribed by the host RNA polymerase II and so, the control 
elements found in early promoter expression are similar to those of insect cells. It has been 
shown that the TATA box element, which is a common site for assembly of the RNA 
polymerase pre-initiation complex in eukaryotes (Karp, 1996), is important for the activity of 
most baculovirus early promoters like that of the gp64 gene (Blissard and Rohrmann, 1991; 
Blissard et al., 1992) and ie1 (Pullen and Friesen, 1995a) early promoters. This activity is 
through the binding of the TATA-binding protein (TBP), which allows for the assembly of the 
RNA polymerase II complex (Karp, 1996). An additional control fragment is the CAGT 
consensus fragment, which is thought to be involved in positioning the RNA start site 
(Rohrmann, 2011) and can also function as activators of transcription, with many promoters 
containing a TATA box also containing a CAGT motif (Friesen, 1997; Rohrmann, 2011). In 
addition to these, and other less common elements, downstream activating regions (DARs) such 
as (A/T)CACNG present in the 5‟ untranslated region of transcripts, can also be important for the 
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activity of some promoters such as the ie1 (Pullen and Friesen, 1995b) and gp64 (Kogan et al., 
1995) promoters, and may work to stabilize the RNA polymerase complex interaction with the 
upstream CAGT sequence (Friesen, 1997). Several early baculovirus promoters also use 
upstream activating regions (UARs) such as GATA and CACGTG (Kogan et al., 1995) which 
are located before the TATA box motif and that work by binding host transcription factors, 
which in turn activate downstream early promoters as in the case of promoters such as the gp64 
(Kogan and Blissard, 1994) and pe38 (Krappa et al., 1992) promoters. These UARs may be 
found significantly upstream of the promoter as in the case of the ie1 promoter where the UARs 
can be found several hundred base pairs in front of the transcriptional start site (Pullen and 
Friesen, 1995b). The activity of early promoters can also be greatly enhanced by their proximity 
to baculovirus homologous regions or hrs, eight of which are found in the baculovirus genome 
(Ayres et al., 1994). They consist of 60 – 70 bp repeats containing imperfect 28bp palindromes. 
These have been shown to increase transcription of cis-linked early promoters (Guarino et al., 
1986; Nissen and Friesen, 1989), probably by recruiting host transcription factors. Their activity 
seems to be limited yearly promoter recruiting of RNA polymerase II (Rodems and Friesen, 
1993), which is drastically increased by the action of the baculovirus IE1 trans-activating protein 
(Guarino et al., 1986; Nissen and Friesen, 1989; Rodems and Friesen, 1995) which either binds 
to the hr 28bp palindromes as a dimer (Rodems and Friesen, 1995), or stabilizes host factor 
interactions with the hr region (Friesen, 1997). This interaction works to increase transcription of 
cis-linked genes either by direct interaction with the polymerase complex, or by altering DNA or 
chromatin conformation, which could increase transcription from the linked promoter (Friesen, 
1997).  
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IE1can also transactivate genes in the absence of hr regions, though at much reduced 
levels, and there is some preliminary evidence suggesting that this non-hr dependent mechanism 
may require the presence of host factors (Murges et al., 1997). Other important transactivators of 
early gene expression include the immediate early regulators IE0, IE2 and PE38. Comprehensive 
reviews of baculovirus early gene expression have been published elsewhere (Friesen, 1997; 
Rohrmann, 2011). 
Baculovirus late and very-late gene expression occurs after the onset of DNA replication 
and requires the presence of a baculovirus RNA polymerase (Fuchs et al., 1983; Guarino et al., 
1998). This polymerase is one of the simplest eukaryotic DNA-dependent RNA polymerases 
known and consists of two copies of the baculovirus encoded polypeptides p47, LEF-4, LEF-8 
and LEF-9 (Guarino et al., 1998). The most important element present in late and very-late 
promoters is the (A/G/T)TAAG motif (Lu and Miller, 1997; Rohrmann, 2011). This element, 
along with the ~12 - 18bp flanking regions were found to drive downstream protein expression at 
nearly wild-type levels for the gp64 promoter (Garrity et al., 1997) and to a somewhat reduced 
extent for the vp39 promoter (Morris and Miller, 1994). The mechanism of action of this motif is 
unclear but has been speculated to involve binding of transcription factors (Morris and Miller, 
1994). In addition, promoters which are active during both the early and late phases of infection, 
such as the gp64 promoter, contain a hybrid TATAAG element, which may act as an activator 
for both early and late transcription (Blissard and Rohrmann, 1991; Rohrmann, 2011). Very-late 
promoters are also controlled by the TAAG sequence, but differ in that the TAAG motif and 
short flanking regions are not sufficient for high level promoter activity (Morris & Miller, 1994), 
which indicates that the regions surrounding the TAAG motif have a significant impact on 
promoter activity, possibly by modulating the binding of different transcription factors (Morris 
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and Miller, 1994). It has been found that 18 baculovirus genes, including various LEFs, the 
proteins in the DNA polymerase complex, and IE1 and IE2 are necessary for optimal expression 
from several late and very-late promoters (Lu and Miller, 1997). An additional regulator element 
in very-late promoters is the “burst sequence” which is present between the TAAG motif and the 
translation initiation codon and which is needed for the very high levels of expression at the 
very-late phase of the infectious cycle (Ooi et al., 1989). There is evidence that this sequence 
activates transcription by binding to the very late factor 1 (VLF-1) protein (Mistretta and 
Guarino, 2005; Yang and Miller, 1999), which only activates very-late baculovirus genes. The 
activity of late promoters is not increased by the inclusion of the polh burst sequence 
downstream of late promoters (Morris and Miller, 1994) or by the activity of VLF-1 (Todd et al., 
1996). This indicates that additional sequences, found only in baculovirus late promoters are 
necessary to recruit VLF-1 or other factors, to the burst sequence. In addition, polh promoter 
activity is modulated by factors in insect cells, which may vary between different cell lines, and 
even between individual cells within a culture (Cheng et al, 2013). An excellent review of 
baculovirus gene expression in the late and very late phases of infection has been published 
elsewhere (Lu and Miller, 1997). 
There is not much data regarding translational control of baculovirus mRNAs, with 
several late genes containing mini-cistrons, which may serve to regulate gene expression (Chang 
and Blissard, 1997). It is assumed that the other aspects of translation of mRNA to protein in 
baculovirus infected insect cells are similar to those found generally in eukaryotes (Karp, 1996; 
Lu and Miller, 1997).  
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2.4. The utility of baculovirus and BEVS 
The narrow host range and high biosafety of baculoviruses has resulted in them being used in a 
wide range of practical applications such as highly selective insecticides, as gene therapy 
vectors, for screening applications using baculovirus surface display and, most importantly, as 
vectors for protein production in insect and mammalian cells, and in insect larvae. 
The BEV system has become one of the most widely used systems for protein production 
(Kost et al., 2005). This stems from its large protein production capacity, which can be compared 
to prokaryotic systems (Jarvis, 1997), and the inherent biosafety and eukaryotic protein 
processing capabilities of insect cells. In addition, the ability of multiple baculoviruses to infect 
the same cell, which coupled the large gene packaging capacity of the baculovirus, makes this 
system well suited to the production of multiprotein complexes. In addition, the ability of insect 
cells to be grown in suspension culture and their high tolerance to osmolarity and by-product 
concentrations (Ikonomou et al., 2003) allow for easier maintenance of these cultures, as 
compared to mammalian cells. 
The BEV system makes use of baculoviruses as gene delivery vehicles into permissible 
insect cell lines or larvae (Kost et al., 2005). This is done by inserting one or more genes of 
interest, using transfer plasmids, into the baculovirus genome under the control of a baculovirus 
or insect cell promoter and at a site that will not interfere with baculovirus replication. These 
have traditionally been sites coding for non-essential genes such as the polh gene (Smith et al., 
1983a), and more recently, the chiA and vcath protease genes (Fitzgerald et al., 2006). 
Furthermore, the gene of interest is most often placed under the control of the very strong 
baculovirus polh or p10 promoters (Smith et al., 1983b), which results in very high expression 
levels of the gene of interest. However, the use of other promoters to express genes at earlier 
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times during the infection cycle has been explored, and is discussed in greater detail in section 
2.8. 
2.5. Limitations of BEVS 
The BEVS is limited in its protein production capability in several ways: the lack of completely 
mammalian-like post translational modifications, the breakdown of secretory pathways in the 
very-late phase of the infectious cycle, the high amount of proteolysis in the expression system, 
and issues with baculovirus vector instability. While these issues may not be significant for all 
proteins, it does reduce the general utility of this system. In addition, the BEVS is a transient 
system requiring the use of baculoviruses, a process which is more complicated than using 
continuously producing cell lines. A further problem with this system is the presence of 
baculovirus in the supernatant at the end of a product run, which can complicate product 
recovery. 
2.5.1 Post-translational modifications 
While BEVS is capable of producing proteins with eukaryotic post-translational modifications 
such as glycosylation and proteolytic processing such as the cleavage of signal peptides, the 
pathways and end-products are not identical to those obtained from cell lines from higher 
organisms. A further complicating factor is the shutdown of host protein synthesis pathways, 
which can further affect the post-translational modification capability of the host. The problem is 
exacerbated by the large amount of protein produced by traditional polh promoter vectors, where 
high expression can overwhelm the host cell‟s weakened protein modification machinery.  
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2.5.1.1 Glycosylation 
Glycosylation is an important factor for the biological activity of many human therapeutic 
proteins, and is therefore an important consideration in choosing a cell culture platform for 
therapeutic production. Glycosylation in insect cells differs from that of mammalian cells in the 
sugar structure pattern appended to the proteins. In particular, insect cells elongate trimmed N-
glycan precursors with mannose residues to produce high-mannose structures (Jarvis and Finn, 
1995; Kulakosky et al., 1998), though this may be product specific and not a general trend 
(Davidson et al., 1990; Davidson and Castellino, 1991). Insect cell lines such as Ea4 (Ogonah et 
al., 1996) and DpNI (Palomares et al., 2003) have been shown to be capable of more complex 
glycosylation than cell lines such as Sf9. Modified glycosylation patterns in insect cells have 
been obtained by the introduction of glycosyltransferases such as galactosyltransferases and 
sialyltransferases. A good example of this strategy is the generation of a cell line incorporating 
five glycosyltransferases, as well as two enzymes involved in sialic acid synthesis. This allowed 
for the efficient sialylation and mammalian-like glycosylation of glutathione-S-transferase 
(Aumiller et al., 2003). In addition, the production of glycoproteins earlier during the infectious 
cycle has been explored to avoid the reduction in post-translational modifications during the 
very-late phase of infection.  
2.5.1.2 Secretion 
The secretory pathway in insect cells is significantly perturbed during the very-late phase of 
infection and can be overwhelmed by large amounts of recombinant protein produced during this 
phase. As a result, secreted and membrane bound proteins of interest are often produced in an 
insoluble form (Ailor and Betenbaugh, 1999). One strategy to overcome this limitation involves 
the expression of chaperones such as heat shock protein 70 (Hsp70) (Ailor and Betenbaugh, 
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1998), calreticulin (Kato et al., 2005) and binding immunoglobin protein (BiP) (Hsu and 
Betenbaugh, 1997), which have been shown to increase solubility and secretion of proteins of 
interest in insect cells. The use of chaperones to improve foreign protein production has been 
reviewed extensively elsewhere (Ailor and Betenbaugh, 1999; Sokolenko et al., 2012). 
Production of these secreted and membrane bound proteins at earlier times during the infection 
cycle, using earlier promoters, has also been studied to improve correct localization of the 
proteins of interest (Grabherr et al., 1997; Higgins et al., 2003; Lawrie et al., 1995). In addition, 
cell lines such as the Trichoplusia ni derived cell lines BTI-TN-5B1-4 High Five (Hi5) and BTI-
Tnao38 cells allow for much greater secretion of proteins out of  the cells (Wilde et al., 2014). 
2.5.2 Proteolysis 
The production of cysteine proteases (Gotoh et al., 2001) during the baculovirus infection cycle 
can affect the quality and quantity of recombinant protein when using the BEVS. These 
proteases are produced both by the cell, as a stress response or during cell lysis, and by the 
baculovirus, to facilitate baculovirus release from the cell. Baculovirus proteases such as the v-
cath protease from the vcath gene (Slack et al., 1995b), or chitinase from the chiA gene (Hawtin 
et al., 1995) are produced, along with cellular proteases, during the very-late phase of the 
baculovirus infection cycle. Strategies have been developed to counter the issue of proteases 
including deleting the baculovirus vcath and chiA protease genes (Fitzgerald et al., 2006; 
Monsma and Scott, 1997), and the use of protease inhibitor cocktails (Gotoh et al., 2001), which 
increase product yield and stability. Proteolysis in the baculovirus system and methods to reduce 
its effect on protein production has been reviewed elsewhere (Gotoh et al., 2002; Ikonomou et 
al., 2003). 
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2.5.3 Baculovirus vector instability 
One of the issues with the BEVS is baculovirus instability, where the gene expression cassette 
containing the gene(s) of interest is deleted (Carstens, 1982).  Defective interfering (DI) viruses 
with up to 43% of their genome deleted can accumulate upon repeated passaging of baculovirus 
in cell culture (Kool et al., 1991; Pijlman et al., 2001). This genome deletion is accompanied by 
the enrichment of a non-essential non-hr origin of replication (ori) within the baculovirus 
genome (Kool et al., 1993; Lee and Krell, 1992). Recent research has shown that deletions 
within the non-hr ori region can reduce these gene deletion events (Pijlman et al., 2003); 
however, this stability does not extend to the retention of inserted foreign gene sequences into 
the genome. Stable foreign gene integration is dependent on the site of insertion of foreign genes. 
The formation of DI viruses may require an intermediate step where transposon sites accumulate 
in some regions of the baculovirus genome (Carstens, 1987). Formation of DI viruses can be 
delayed by the modification of some of these sites within the fp25k gene (Giri et al., 2012). 
Interestingly, the accumulation of mutations within the fp25k gene is also thought to be 
responsible for the few polyhedra (FP) phenotype of baculovirus (Jarvis et al., 1992; Cheng et 
al., 2013; Harrison et al., 1996). The integration of a hr1 region in the opposite orientation into 
the foreign gene expression cassette in the Bac-to-Bac system, improves baculovirus vector 
stability, as well as foreign gene expression (Pijlman et al., 2003). To improve the BEVS, 
Vijayachandran et al. (2012) has set out to create a rationally designed minimal genome 
baculovirus to remove sources of baculovirus genome instability and generate a small stable 
baculovirus vector for large scale protein production. 
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2.6. Multiple protein production within a single cell 
The ability of the BEVS to enable the expression of multiple foreign genes concurrently makes 
this system well suited to the production of complex proteins such as antibodies (Song et al., 
2010; zu Putlitz et al., 1990) and virus-like particles (Betenbaugh et al., 1995; Crawford et al., 
1994; French and Roy, 1990). In addition, the production of some proteins may be enhanced by 
helper functions of other proteins, such as chaperones, which can be co-expressed in the insect 
cell system (Ailor and Betenbaugh, 1998; Hsu and Betenbaugh, 1997; Kato et al., 2005). The 
expression of multiple foreign genes in a single cell in the BEVS can be done either: by infecting 
a culture with multiple viruses, each carrying one foreign gene (co-infection); by using a single 
virus carrying multiple foreign genes (co-expression); or a combination of the two. Each system 
has unique advantages and disadvantages. The use of a co-infection system allows for easy 
manipulation of expression levels of various genes by controlling the multiplicity of infection 
(MOI) as well as by controlling time of infection (TOI) of different viruses, by which temporal 
separation of the expression of various genes can be achieved. However, the production of 
complex proteins requires that each cell be infected with at least one of each type of virus. This 
is complicated by the fact that virus infection in cell culture is known to behave as a Poisson 
process (Licari and Bailey, 1992), with some cells being infected by multiple viruses, some with 
only one, and some cells not being infected at all. This is especially disadvantageous in multi-
subunit protein production with multiple viruses, where the infection of a cell with one virus and 
not the other leads to a non-productive infection event from the perspective of the assembly of 
the complex protein of interest. 
The use of a polycistronic virus encoding for multiple genes is made possible by the large 
capacity of the baculovirus genome for accepting foreign gene insertions. The use of one virus to 
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introduce all necessary genes removes the problems associated with the co-infection process. 
The benefits of co-expression over co-infection have been shown repeatedly, with the use of 
polycistronic vectors consistently producing higher yields of final product (Pushko et al., 2005; 
Roldao et al., 2006; Shanks and Lomonossoff, 2000; Vieira et al., 2005). In addition, the 
introduction of multiple genes using a single vector reduces the overall MOI in the culture, 
which could reduce stress on the infected cell and could lead to increased cell longevity (Roldao 
et al., 2006). However, the manipulation of gene ratios and timing of expression can only be 
conducted by the manipulation of promoters and other regulatory elements driving the 
expression of the different genes, and this makes co-expression unsuitable for exploratory 
purposes. Therefore, co-infection is suitable when determining the levels of individual genes 
needed to make a suitable product efficiently, while co-expression is more suited for when this 
exploratory work is completed and large scale production is desired. However, there is a dearth 
of information regarding the strength and expression profiles of promoters active in insect cells, 
which complicates the task promoter selection for co-expression. 
Tailoring the expression levels of different component proteins produced in the BEVS 
system can be important for several reasons. The first is to modulate levels of component 
proteins in multi-subunit proteins, as has been demonstrated in the production of VLPs. 
Parvoviruses are one such example, where the levels of component proteins can affect the 
composition of the final product (Tsao et al., 1996). However, even in cases where VLP 
compositions are unaffected by the expression levels of component proteins, the proteins that are 
expressed over-abundantly are wasted, leading to unnecessary depletion of cellular resources 
(Sokolenko et al., 2012). Tailoring expression levels is also important in cases where levels of 
helper genes need to be carefully managed to be helpful to the production of the protein of 
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interest. One of the earliest references to this idea was to tailor helper chaperone production in a 
dual protein expression BEVS (Ailor and Betenbaugh, 1998). 
There have been several vector designs that allow the construction of baculovirus that 
carry multiple genes. These include commercial vectors such as pOET5 from Oxford Expression 
Technologies
TM
, which uses homologous recombination to insert foreign genes into the 
flashbac
TM
 family of baculovirus genomes. It should be noted that the flashbac
TM
 family of 
baculovirus genomes contain several deletions of proteases and non-essential genes. A similar 
system is the pFastBac™ Dual vector from Thermo Fisher Scientific Inc, which uses a 
transposition based Bac-to-Bac® system to generate recombinant baculoviruses. A further 
extension of these systems is the MultiBac
TM
 system from Geneva Biotech, where multiple genes 
can be introduced to two sites within a baculovirus genome with the chiA and vcath protease 
genes deleted, through Tn7 transposition and Cre-LoxP recombination (Fitzgerald et al., 2006; 
Fitzgerald et al., 2007b). This has used to express up to 6 genes from a single baculovirus 
(Fitzgerald et al., 2006). More recently, genes for up to seven proteins have been added in a 
single baculovirus vector (Kanai et al., 2013) by inserting each gene into different loci of the 
genome. There is still greater potential for the vector as 8 sites, other than the polh locus, are 
amenable to insertion of foreign sequences (Noad et al., 2009). 
2.7. Competition among co-expressed genes 
There is evidence in the literature pointing to competition effects when expressing multiple 
proteins in the BEVS. The deletion of genes downstream of the very strong very-late promoter 
p10 has been linked to improved transcription (Chaabihi et al., 1993) and translation (Hitchman 
et al., 2010) of genes driven by the polh promoter. It has been speculated that this may be due to 
limitation in supply of host or virally encoded transcription factors necessary for the activity of 
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the polh promoter, and for which the p10 promoter is able to compete for more successfully (Lu 
and Miller, 1997). Although the expression of the chaperone calnexin causes an increase in 
production of a protein of interest (Kato et al., 2005; Tate et al., 1999); the expression of 
calnexin along with another chaperone such as calreticulin or immunoglobulin heavy chain 
binding protein (BiP) causes a decrease in expression of the protein of interest. The latter has 
been speculated to be due to overloaded cellular protein synthesis machinery caused by the 
simultaneous high level expression of three genes under the control of the strong polh promoter 
(Kato et al., 2005). Further evidence comes from research in a system producing AAV virus 
using three baculoviruses (BacCap, producing the AAV capsid proteins; BacRep, producing 
AAV replication proteins necessary for AAV genome replication and encapsidation; and 
BacITRGFP, which supplies the AAV genome for packaging), in which increasing the 
expression of proteins from the BacRep virus (by increasing the MOI) causes a decrease in the 
number of non-genome containing virus particles (coded for by the BacCap virus). This has been 
speculated to be due to the effect of competition between the production of replication proteins 
and capsid proteins (Aucoin et al., 2006a). 
2.8. Use of alternate promoters in BEVS 
The vast majority of proteins produced in the BEVS system have been produced using 
baculovirus very-late polh or p10 promoters to drive foreign gene expression. While these 
promoters are some of the strongest known natural promoters, they are active only during the 
very-late phase of the baculovirus replication cycle in an insect cell, when the post-translational 
and secretory mechanisms of the cell are severely perturbed, and when high levels of cellular and 
baculovirus proteases are present in the system, as discussed earlier. The situation is further 
complicated by the fact that the cellular machinery may be overwhelmed by the large amount of 
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recombinant protein being produced under the control of the very-late promoters. Therefore, 
several groups have sought to investigate the use of promoters that are active earlier during the 
baculovirus infection cycle even though they would not be as strong as the polh and p10 
promoters. Conversely,  promoters stronger than the polh promoter have been produced through 
mutations within the promoter region (Rankin et al., 1998; Ooi et al, 1989) or by screening 
naturally occurring promoters from non-AcMNPV baculoviruses (Martínez-Solís et al, 2016).  
When expressing complex eukaryotic protein requiring post-translational modifications, 
the baculovirus ie1 promoter, though weaker, has been shown to allow as much or even more 
active protein to be produced, as compared to the polh promoter (Jarvis et al., 1996). Other 
promoters such as the basic protein promoter (Bonning et al., 1994; Chazenbalk and Rapoport, 
1995; Higgins et al., 2003) and the large gp64 promoter (Grabherr et al., 1997) have also been 
shown to also produce as much or greater amounts of complex proteins- proteins requiring 
secretion or trafficking to the cell surface, and multi-subunit proteins (Higgins et al., 2003). In 
nature, these promoters drive the production of the baculovirus p6.9 Basic DNA binding protein 
and the surface expressed baculovirus GP64 glycoprotein, respectively. Further control over 
expression levels and times have been achieved through modified promoters such as: a 
Pcappolh, a hybrid of the vp39 capsid and polh promoters (Thiem and Miller, 1990); tandem ie1 
promoters (Kojima et al., 2001); synthetic early promoters (Blissard et al., 1992); constitutive 
insect promoters like the hsp70 promoter (Lu et al., 1996; Prikhod'ko et al., 1998); and truncated 
p10 and ie1 promoters (Urabe et al., 2002; Urabe et al., 2006). A further possibility for 
modulating expression levels comes from addition of enhancer elements such as the baculovirus 
homologous regions (Guarino et al., 1986). Addition of the hr3 region ahead of a late vp39 
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promoter has been shown to induce onset of transcription from this promoter 10 hours before the 
unmodified vp39 promoter (Ishiyama and Ikeda, 2010). 
Promoters having earlier activity have shown benefit for the production of a two 
component simian immunodeficiency virus (SIV) VLP consisting of Env and Gag proteins. 
Driving the expression of the membrane associated Env protein using a hybrid late/very-late 
promoter resulted in a greater expression of Env on the cell surface, as opposed to Env produced 
using a very-late promoter (Yamshchikov et al., 1995). In addition, early promoters have been 
used to introduce non-native glycosylation abilities, which allow insect cells to replicate 
glycosylation patterns found in higher eukaryotes (Jarvis and Finn, 1996). 
2.9. Influenza A VLP production  
2.9.1. Influenza A, and VLPs as influenza vaccines 
Influenza A viruses are enveloped RNA viruses belonging to the Orthomyxoviridae family of 
viruses that are a significant cause of morbidity and mortality in the modern world. Laboratory 
strains are usually spherical ranging from 80 – 120 nm in diameter (Lamb and Choppin, 1983). 
The genome of these viruses are divided into 8 negative sense, single stranded RNA fragments, 
five of which encode a single protein each while the other three code for two proteins each 
(Bouvier and Palese, 2011). Of these, the hemagglutinin (HA) gene encodes for the HA 
glycoprotein which is found on the surface of the influenza A virus in its trimeric form. This 
protein mediates the binding of the influenza virus to sialic acid residues on target cells, and 
assists in membrane fusion between virus and cell (Wiley and Skehel, 1987). The release of 
newly formed virus from cell surfaces requires influenza neuraminidase (NA) surface 
glycoprotein, which cleaves the sialic acids binding the cell to the virus HA protein trimer. The 
third important structural component of the influenza virus is the matrix M1 protein which binds 
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viral RNA and, along with HA and NA, make up the structural component of the virus. Other 
components such as the M2 protein and various non-structural proteins are necessary for virus 
infectivity and transmission of host cells. 
 The virus hemagglutinin (HA) protein is a single pass type I membrane protein that is 
often localized to the host apical membrane in epithelial cells. The first 17 amino acid residues 
correspond to a nuclear localization signal. Following this is a 511 aa extracellular domain, 
followed by a helical 21 aa transmembrane domain, which is followed by a 16 aa cytoplasmic 
tail domain (Winter et al., 1981). The M1 protein is a 252 aa protein that is arranged in a series 
of helical domains, with the N and C terminals facing towards the inside of the influenza virion 
(Shishkov et al., 1999). 
While vaccines are effective in preventing or reducing the severity of the disease, the 
high rate of mutation and genetic re-assortment in these viruses requires the production of new 
vaccines every flu season. The two most common types of influenza vaccines currently used 
contain either live attenuated influenza virus or inactivated virions, and both are currently 
produced using embryonated chicken eggs. This is, however, a time and resource intensive 
process and is unsuitable for the production of vaccines against recent H5N1 viruses, which kill 
the chicken eggs (Quan et al., 2007). In addition, an influenza pandemic may significantly affect 
the supply of eggs for vaccine production. Therefore, it would be advantageous to develop a cell 
culture based system for the rapid production of influenza vaccines that would allow for quick 
responses to changes in influenza subtypes circulating in the human population, and against 
pandemic influenza. In addition, cell based vaccine production methods ensure that vaccines 
against dangerous influenza subtypes can be generated without any concerns of releasing those 
genes into the environment (Latham and Galarza, 2001). Protein Sciences has been a leader in 
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this field with their insect cell produced Flublok® anti-influenza vaccine, which has been 
increasingly used for routine vaccination, especially for patients who have egg allergies.  
VLPs, which are incomplete and non-replicative virus-like particles, have been explored 
as potential vaccine candidates for several viruses (Pattenden et al., 2005). VLPs are 
professionally presented by antigen presenting cells (APCs) which in turn activate the adaptive 
immune system (Buonaguro et al., 2006; Kang et al., 2009; Sailaja et al., 2007). The advantage 
of VLPs over soluble immunogenic antigens lies in the potential of VLPs to present the antigen 
in a similar context to the antigen on an infective virus particle (Kang et al., 2009). VLPs 
containing influenza hemagglutinin (HA) have been able to induce much higher protective serum 
antibody responses against highly pathogenic H5N1 influenza in mice, when compared with 
antibody responses elicited by recombinant HA protein (Bright et al., 2007; Mahmood et al., 
2008). VLPs also cause the production of antibodies that have a broader cross reactivity with 
antigenically different strains of the subtype of virus on which the VLPs were based (Bright et 
al., 2007). However, heat treated influenza VLPs were found to induce a lower titer of intact 
influenza specific antigens, and provide almost no protection against influenza challenge, due to 
the denaturation of the HA surface protein (Quan et al., 2007), thereby establishing the 
importance of the HA antigen in VLP based vaccines. There is also some evidence indicating 
that influenzaVLPs can induce a cytotoxic T cell response in mice, which may play an important 
role In protection from heterotypic subtypes of the influenza virus(Hemann et al, 2013). 
The work presented in this thesis deals with VLPs formed from the co-expression of HA 
and M1.  
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Within influenza virus infected cells, the trafficking of HA occurs with its synthesis and 
localization within the endoplasmic reticulum. Following this, it is transported to the golgi 
apparatus, where it interacts with the M1 protein. After this, the HA is transported to lipid rafts 
on the cell surface (Takeda et al., 2003). Targeting of the HA protein to lipid rafts, and to the 
apical membrane of polarized epithelial cells is thought to be mediated by regions within the 
transmembrane domain and in the exoplasmic region of the HA protein (Barman et al., 2001; Lin 
et al., 1998). In addition, the cytoplasmic tail domain of HA proteins may also have some 
function in localization of HA to lipid rafts (Zhang et al., 2000). Expression of HA alone can 
lead to HA protein release from the cell (Chen et al., 2007), possibly in the form of VLPs. 
M1 trafficking to the membrane may occur by either binding to microfilaments in the 
cytoskeleton (Avalos et al., 1997), or by binding to viral HA and NA (neuraminidase) as they are 
trafficked through the exocytic network (Ali et al., 2000). M1 has an inherent capability to bind 
to plasma membranes, which is not due to the hydrophobic regions within the protein (Akhnoukh 
et al., 1996; Ali et al., 2000), but potentially due to electrostatic interactions (Ruigrok et al., 
2000). M1 by itself does not localize to any particular section of the cell membrane. However, 
when M1 proteins are coexpressed with HA and NA proteins, M1 interacts with the cytoplasmic 
tails of these proteins (Chen et al., 2007) and so, becomes localized to lipid rafts where these 
proteins are located (Ali et al., 2000; Scheiffele et al., 1997; Zhang et al., 2000). M1 can localize 
to the lipid rafts only in the presence of HA (Chen et al, 2007). In addition, the coexpression of 
M1 with HA or NA proteins increases the amount of M1 recruited to the cell membrane (Gómez-
Puertas et al., 2000).  
The M1 proteins can assemble into enveloped VLP in baculovirus or vaccinia virus 
expression systems (Gómez-Puertas et al., 2000; Latham and Galarza, 2001). However, the M1 
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protein alone cannot cause VLP formation in a plasmid based production system (Chen et al., 
2007), and the release of VLPs in the other systems could be due to helper effects from 
transmembrane or other proteins expressed from the other viral genes. This could be due to some 
sort of helper function given by other proteins in the baculovirus or vaccinia system. Like several 
enveloped viruses, baculovirus gp64 is also trafficked into lipid rafts on the cell surface (Haines 
et al., 2009), and this could have allowed M1 expression to cause budding of influenza VLPs.  
Since viral membranes are enriched in cholesterol and glycosphingolipids, virions 
probably bud from these lipid rafts where all components of the virus are assembled, mostly on 
the apical surface of epithelial cells (Nayak et al., 2009; Scheiffele et al., 1999; Zhang et al., 
2000). It is likely that the lipid rafts serve as a region where viral proteins are concentrated to 
levels sufficient to induce budding (Takeda et al., 2003). This requires the action of several viral 
and host factors and has been reviewed elsewhere (Nayak et al., 2009). Evidence points to virion 
morphology (spherical vs filamentous) being influenced by the polypeptide sequences of the 
membrane bound proteins, particularly the cytoplasmic tail domains of the HA and NA proteins 
(Jin et al., 1997), and the M1 protein (Chen et al., 2007), as well as by the action of the 
cytoskeletal network (Simpson-Holley et al., 2002). 
Comprehensive reviews of the influenza virus production process from cells are found 
elsewhere (Nayak et al., 2009) 
2.9.2. Influenza VLP production 
Influenza VLPs have been produced in mammalian cells such as the COS-1 cell line (Gómez-
Puertas et al., 1999; Gómez-Puertas et al., 2000; Mena et al., 1996) and HEK293 cells 
(Thompson et al., 2015; Venereo-Sanchez et al, 2016). However, BEVS has been increasingly 
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used to produce influenza VLPs. One of the factors that makes this system suitable for the 
production of influenza VLPs is the lack of sialyation in most insect cells (Altmann et al., 1999; 
Jarvis and Finn, 1995; Kulakosky et al., 1998) due to which HA glycoproteins on the surface of 
influenza VLPs will not bind to cells, and therefore, do not require the presence of viral NA to 
cleave VLPs off the cell surface, as in the case of mammalian cell lines (Gómez-Puertas et al., 
1999). In the BEVS, multi-subunit influenza VLPs were first produced using a baculovirus 
coexpressing four influenza proteins, the hemagglutinin (HA), neuraminidase (NA), matrix 
(M1), and M2 proteins, with at least three of these (the HA, NA and M1 proteins) being 
incorporated into the virus-like particles produced (Latham and Galarza, 2001). Further studies 
have shown that VLPs produced using baculovirus vectors co-expressing HA, NA and M1 
proteins have been able to produce protective immunity from influenza viruses (Bright et al., 
2007; Pushko et al., 2005; Pushko et al., 2007), including against the H5N1 influenza virus 
(Mahmood et al., 2008). This has also been shown with particles containing only the HA and M1 
proteins produced by co-infection of insect cells with baculovirus coding for the individual 
proteins (Quan et al., 2007). In addition, these particles were shown to be budded off the surface 
of the insect cells with size and morphology similar to wild type influenza virus produced from 
mammalian cell culture. Furthermore, the VLPs when administered result in protection against 
several strains of influenza virus (Quan et al., 2007). An extension to this work has been the 
incorporation of multiple HA serotypes into a single VLP, which led to the inhibition of 
replication of the two strains of virus under consideration (Quan et al., 2008). Work on influenza 
VLP production in the baculovirus insect cell system has led to the development of a series of 
pandemic and seasonal influenza vaccines from Novavax, which were in Phase 1 and Phase 2 
trials respectively, when this thesis was written (Novavax website, March, 2016). 
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Chapter 3 : Temporal Characterization of Protein Production Levels from 
Baculovirus Vectors Coding for GFP and RFP Genes under Non- 
Conventional Promoter Control 
 
 
 
 
 
This work was published in the journal Biotechnology and Bioengineering in the September 
2015 issue.  
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3.1 Abstract 
 
The ease of use and versatility of the Baculovirus Expression Vector System (BEVS) has made it 
one of the most widely used systems for recombinant protein production However, co-expression 
systems currently in use mainly make use of the very strong very late p10 and polyhedron (polh) 
promoters to drive expression of foreign genes, which does not provide much scope for tailoring 
expression ratios within the cell. This work demonstrates the use of different Autographa 
californica multicapsid nucleopolyhedrovirus (AcMNPV) promoters to control the timing and 
expression of two easily traceable fluorescent proteins, the enhanced green fluorescent protein 
(eGFP), and a red fluorescent protein (DsRed2) in a BEVS co-expression system. Our results 
show that gene expression levels can easily be controlled using this strategy, and also that 
modulating the expression level of one protein can influence the level of expression of the other 
protein within the system, thus confirming the concept of genes “competing” for limited cellular 
resources. Plots of “expression ratios” of the two model genes over time were obtained, and may 
be used in future work to tightly control timing and levels of foreign gene expression in an insect 
cell co-expression system. 
 
 
 
Keywords: co-expression, baculovirus expression vector system, BEVS, insect cell, reporter 
protein, infection 
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3.2 Introduction 
The baculovirus expression vector – insect cell system is not only versatile for expressing 
significant quantities of proteins requiring post-translational modifications quickly; it is gaining 
significant traction as a production platform for complex biologics.  Both the ability of the insect 
cells to receive multiple baculoviruses carrying different transgenes and/or the ability of the 
baculovirus vectors to carry multiple transgenes have made the system a darling of those 
studying and producing virus-like particles or products requiring the expression of „helper‟ 
proteins (Sokolenko et al., 2012). No matter the product requiring multiple proteins, it is unlikely 
that each protein needs to be expressed at the same level. Tailoring gene expression ratios is 
important in cases where the levels of proteins affect the composition of the final product (Tsao 
et al., 1996), or when the expression of certain proteins has a detrimental effect on the cells 
(Urabe et al., 2002). Furthermore, it can be argued that producing an excess of certain proteins is 
just a waste of cellular resources that could be otherwise channelled into useful product.  
 While there exists a number of studies describing polycistronic baculovirus vectors 
(Fitzgerald et al., 2006; Fitzgerald et al., 2007a; Kanai et al., 2013), controlled gene expression 
ratios have most predominantly been achieved by co-infection. While co-infection offers the 
flexibility of manipulating gene expression ratios by varying the multiplicity of infection (MOI) 
of individual baculovirus populations, the probabilistic nature of infection (Licari and Bailey, 
1992) means that not all cells will receive the same proportion of the transgenes in each cell. Co-
expression systems generally make use of the very strong very late p10 and polyhedron (polh) 
promoters to drive expression of foreign genes. However, this does not provide much scope for 
tailoring gene product ratios within the cell. Given what is already known about baculovirus 
promoters and associated genetic elements from studies on: the ie1 promoter (Jarvis et al., 1996); 
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the basic promoter (Bonning et al., 1994; Chazenbalk and Rapoport, 1995; Higgins et al., 2003); 
the gp64 promoter (Grabherr et al., 1997); the Pcappolh, a hybrid of the vp39 capsid and polh 
promoters (Thiem and Miller, 1990); tandem ie1 promoters (Kojima et al., 2001); synthetic early 
promoters (Blissard et al., 1992), truncated p10 and ie1 promoters (Urabe et al., 2002; Urabe et 
al., 2006) and constitutive insect promoters like the hsp70 promoter (Lu et al., 1996; Prikhod'ko 
et al., 1998); there is a dearth in the characterization of expression when these promoters are used 
in conjunction with the expression of a second gene under the control of a different promoter. At 
best, there are a few studies such as one by Urabe et al. (Urabe et al., 2002) for the production of 
AAV2 vectors, and the subsequent work on that system (Aucoin et al., 2006b; Aucoin et al., 
2007; Kohlbrenner et al., 2005; Meghrous et al., 2005). In addition two recent patents have been 
filed on the use of weaker baculovirus promoters to drive the expression of non-structural 
components for the production of virus-like particles (Hu and Lin, 2013; Oker-Blom and 
Summers, 1992), and there has been  some work on an early baculovirus detection system 
utilizing an early promoter (Dalal et al., 2005).  
Beyond tailoring expression levels, there is also the ability to control the temporal nature 
of the expression with these promoters. Most characterizations of the promoters, when used in 
conjunction with another promoter-gene element, simply look at the resulting production levels 
and do not acknowledge that the „sequence‟ of events may also play a role in the overall product 
formation. It is also possible that by taking advantage of sequential gene expression, there is an 
advantage over trying to express all of the different elements at once. While there is some 
evidence that suggests that there is no resource limitation when expressing multiple proteins at 
once (Berger et al., 2004), there is other evidence which suggests that competition may be a real 
effect.  It has been shown that the deletion of the very-late p10 gene causes improved production 
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from genes under the control of the very-late polh promoter (Chaabihi et al., 1993; Hitchman et 
al., 2010). Further evidence of competition comes from studies where co-expressing more than 
one chaperone protein actually caused a decrease in yield of the target protein of interest (Kato et 
al., 2005; Tate et al., 1999). 
This work aims to demonstrate the use of different promoters in a polycistronic 
baculovirus to control the timing and expression of two easily traceable fluorescent proteins, the 
enhanced Green Fluorescent Protein (eGFP herein referred to simply as GFP) and a red 
fluorescent protein (DsRed2 herein referred to simply as RFP). The RFP gene is placed under the 
control of the very-late polh promoter, while the GFP gene was placed under the control of early 
(ie1), late (basic, gp64 and vcath) and very-late (p10) promoters.  
 
3.3 Materials and Methods 
3.3.1 Cell culture and baculovirus production 
Spodoptera frugiperda clonal isolate 9 (Sf9) cells (GIBCO, Carlsbad, CA, USA) were 
maintained in capped glass Erlenmeyer flasks in Sf900III media (GIBCO, Carlsbad, CA, USA) 
at a temperature of 27 °C on an orbital shaker rotating at 130 rpm. Maintenance cell cultures 
were kept at a density between 0.5 and 4 × 10
6
 cells/ml.  
3.3.2 Baculovirus construct generation 
Five baculovirus constructs co-expressing GFP and RFP fluorescent proteins were generated for 
this work (Table 3-1). The GFP and RFP genes were isolated from plasmids pcDNA3-GFP and 
pCALNL-DsRed obtained from Addgene (Cambridge, MA, USA) using primers GFPF, GFPR, 
RFPF and RFPR (Table A-1) using a Phusion® High-Fidelity polymerase (Thermo Scientific, 
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Waltham, MA, USA). These genes were then cloned into baculovirus transfer vector pAcUW51 
(BD Pharmingen, San Diego, CA, USA) using overlap extension PCR as described in other 
works (Bryksin and Matsumura, 2010). The resulting plasmid contained the GFP gene under 
control of a baculovirus p10 promoter and the RFP gene under the control of a baculovirus 
polyhedrin promoter. The p10 promoter was then replaced by four other AcMNPV promoters 
(ie1, basic, gp64 and vcath), using overlap extension PCR to create the vectors for the five 
viruses used in this work. The viruses were generated from these vectors using the BD 
BaculoGold™ Transfection Kit (BD Pharmingen, San Diego, CA, USA). The primers used to 
isolate the promoters, and allow for the insertion of these promoters into p10-GFP-RFP are given 
in Table A-1. Two additional monocistronic viruses were created expressing either GFP or RFP. 
The genes were isolated as before using primers listed in Table A-1, and then inserted into the 
plasmid pFastBac1 (Life Technologies Inc, Burlington, ON, Canada)  using the EcoRI and 
BamHI sites in the MCS. The primers used for these constructs are also listed in Table A-1. 
Viruses were generated from these constructs using the Bac-to-Bac® Baculovirus Expression 
System (Life Technologies Inc, Burlington, ON, Canada).  
Table 3-1: Baculovirus constructs used in the experiments shown in this paper. All baculoviruses have been generated 
from pAcUW51. These constructs are referred to in the paper by the names given in (). 
Construct Name 
Description 
Promoter 1 Gene 1 Promoter 2 Gene 2 
p10-GFP-RFP (p10) p10 GFP Polh RFP 
ie1-GFP-RFP (ie1) ie1 GFP Polh RFP 
basic-GFP-RFP (basic) basic GFP Polh RFP 
gp64-GFP-RFP (gp64) gp64 GFP Polh RFP 
vcath-GFP-RFP (vcath) 
polh GFP 
polh RFP 
vcath 
polh 
polh 
GFP 
GFP 
RFP 
Polh RFP 
 
34 
 
3.3.3 Baculovirus Amplification 
Cultures were seeded at 0.5 × 10
6
 cells/ml, allowed to grow to ~3 × 10
6 
cells/ml to reach a mid-
exponential phase, diluted to 1×10
6
 cells/ml in fresh media and infected with various viruses. 
The cultures were allowed to proceed until the viability dropped to 70–80%, after which the 
culture medium was harvested and centrifuged at 1000 × g for 10 min in order to spin down cells 
and cell debris. The supernatant was removed and used as baculovirus stock for experiments. 
3.3.4 Baculovirus Quantification 
Virus samples were quantified by four different methods: end point dilution assay (Reed and 
Muench, 2938; King and Possee, 1992), real time PCR (George et al, 2012), flow cytometry 
(Shen et al, 2002), and a growth cessation assay (see Supplementary information for more detail) 
. The titres obtained from the end point dilution assay were used to determine the quantity of 
virus to add to the cultures. 
3.3.5 Co-expression experimental design 
35 ml cell cultures at a density of 1 × 10
6
 cells/ml were infected with P2 stocks of the various 
viruses at MOIs of 5 or 25, in triplicate. Sampling was conducted at 0, 4, 8, 12, 16, 24, 36, 48, 72 
and 96 hours, to capture both early and late events in the course of infection. Cell counts were 
conducted at each of these time points using a hemacytometer to determine cell density and 
viability. Samples were centrifuged at 300 × g for 7 minutes, after which the cell pellets were 
resuspended in a 2% solution of formaldehyde (Thermo Scientific, Rockford, IL, USA) in PBS 
and kept at 4ºC for one hour before analysis by flow cytometry. Controls included uninfected 
cultures, and cultures infected with monocistronic baculovirus vectors containing either GFP or 
RFP under the control of the polh promoter. 
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3.3.6 Flow cytometry analysis 
Flow cytometry was conducted on a BD FACS Calibur (BD Biosciences, San Jose, CA, USA). 
The results were analyzed using FlowJo (Tree Star, Ashland, OR, USA). The threshold was 
based on FSC and was set at a value of 52, and served to remove small low scatter events. Green 
fluorescence was detected by the FL1 detector (emission 530, bandpass 30nm) and red 
fluorescence by the FL3 detector (emission 670 nm, longpass). All samples were analysed using 
a high flow rate (60 + 3 µl/min). Compensation was conducted to remove signal overflow from 
GFP fluorescence into the FL3 channel and was set at 11.5% of the FL2 signal based on the level 
of fluorescence detected when cells were infected with a monocistronic vector containing the 
GFP gene. 
 
3.4 Results 
3.4.1 Virus stocks, progression of infection and effect on cells 
Infection of the cultures with an MOI of 5 resulted in a synchronous infection as seen by growth 
cessation (Figure 3-1). The rate of decrease of viability in different cultures between 24 and 96 
hours post infection (hpi) was different for the different constructs tested, with the constructs 
expressing the high levels of foreign protein overall showing higher rates of viability decrease 
than the ie1 and basic constructs which drove lower levels of foreign protein production and 
showed lower rates of viability decrease (Figure 3-1C) 
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Figure 3-1: Cell density and viability of infected cell cultures: Figures 3-1A and 3-1B show cell density during the course 
of an infection experiment for cultures infected at MOIs of 5 (Figure 3-1A) and 25 (Figure 3-1B), obtained from 
hemacytometer counts. 35 ml cultures were infected with the following baculoviruses in triplicate: p10, ie1, basic, gp64 
and vcath. Figure 3-1C shows the rate of viability decrease of the different constructs between 24 and 96 hours post 
infection. The points shown in the plots are the average of values for triplicate flasks and error bars represent 1 standard 
deviation above and below means. 
To probe this further, and to ensure that the vectors were not compromised by using the 
alternative promoters to drive GFP, we followed the progression of the virus infection (MOI of 5 
and 25) by monitoring the levels of baculovirus in the supernatant using real time PCR (Figure 3-
2). No significant differences were observed in the replication of different constructs at MOI 5 or 
25 (Figure 3-2A and 3-2B). In addition, no differences in replication-capable progeny were 
observed by the end-point dilution assay (Figure 3.2C). Taken together, these results are 
reassuring for two reasons: 1) the amount of virus taken up did indeed allow for synchronous 
infection in all cases based on the immediate cessation in cell growth; and, 2) ~ five times as 
much virus was taken up for a five-fold increase in MOI (Table 3-2). 
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Figure 3-2: Baculovirus counts in cell culture supernatants over time, as determined using real-time PCR to determine 
genome counts (Figures 3- 2A and 3-2B) and the end point dilution assay to determine replicative virus titer (Figure 3-
2C). The genome counts were performed for cultures infected at MOI 5 (Figure 3- 2A) and MOI 25 (Figure 3-2B). Inset 
figures show genome counts at early time points post infection. Figure 3-2C shows titers of replication competent 
baculovirus at 48 hours post infection for the various cultures infected at an MOI of 5. 
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Table 3-2: Average percent of vector taken up in co-expression experiments at MOIs of 5 and 25. Values were calculated 
by comparing vector genome titers in the supernatant at 0 and 4 hours post infection by real-time PCR (see 
supplementary information for details on methodology) 
Vector 
% Vector/Number of Vector Particles Taken Up By Cells 
MOI = 5 MOI = 5 MOI = 25 MOI = 25 
p10 25%* 1.76×10
6
 58% 2.13×10
7
 
ie1 62% 8.43×10
6
 55% 4.47×10
7
 
basic 54% 4.86×10
6
 62% 4.28×10
7
 
gp64 43% 4.95×10
6
 53% 3.39×10
7
 
vcath 47% 7.77×10
6
 54% 6.15×10
7
 
*note: this value was obtained from triplicate cultures. A value this low has not been reproduced since. 
3.4.2 GFP/RFP Production 
The main objective of this work was to observe the expression patterns resulting from infection 
with baculoviruses having foreign genes controlled by non-conventional promoters. While the 
cells seemed to be mostly in a single population for the first 36–48 hours of infection, the 
formation of a secondary population can be seen starting at 48, becoming more apparent at 72 
and increasing further at 96 hours post-infection (two examples of which are seen in Figure 3-3). 
The number of events in the higher fluorescence population was found to correlate well with the 
overall viability of the culture (supplementary information). In addition, when the cultures were 
imaged by an ImageStream
X
 Mark II imaging flow cytometer (Amnis Corporation, Seattle, WA, 
USA ), the lower fluorescence population was found to be mis-shapen cells that seemed to be 
dying or dead (data not shown). The fluorescence of the high fluorescence population was used 
for subsequent analysis. 
Figure 3-4 shows the relative overall levels of green and red fluorescence observed for 
MOI 5 and 25 infected cells over time. The start of GFP production varied depending on the 
promoter in front of the gene, with the earliest signals at an MOI of 5 emerging after 4 hours 
under ie1; 8-12 hours under basic, and gp64 control; 12-16 hours for p10; and 16-24 hours for 
vcath (Table 3-3). Increasing the MOI to 25 caused the GFP signals from the basic and gp64 
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constructs to emerge at 4 hours, while the time of emergence in the other constructs was not 
affected. Of the constructs, the highest levels of GFP, as well as the fastest increase in GFP 
expression level was seen when the gene was placed under the control of the basic promoter. The 
heavily delayed emergence of any fluorescence signal when using the vcath vector could be due 
to the very weak strength of the vcath promoter, and not necessarily an indication of the start of 
vcath expression. GFP expression in the GFP single construct emerged only at 16–24 hours post 
infection. 
 
Figure 3-3: Representative flow cytometer scatterplots showing population distributions in cultures infected with basic 
and gp64 constructs over time. The plots compare values of red (FL3) and green (FL1) fluorescence over time post 
infection. Arrows indicate movement of populations as infection progresses. 
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Table 3-3: Times of detectable fluorescent protein detection. 
Vector 
Time at which protein production is detected (hpi) 
GFP RFP (polh) 
MOI = 5 MOI = 25 MOI = 5 MOI = 25 
Polh GFP
*
 NA NA 16-24 NA 
p10 12-16 12-16 16-24 24-36 
ie1 4-8 4-8 16-24 16-24 
basic 8-12 4-8 36-48 24-36 
gp64 8-12 4-8 16-24 12-16 
vcath 16-24 16-24 16-24 12-16 
Polh RFP
* 
16-24 NA NA NA 
*note: monocistronic baculovirus vectors with either GFP or RFP under the control of the polh promoter. 
 
 
Figure 3-4: Expression of GFP and RFP From various baculovirus constructs: Relative expression levels of GFP in highly 
fluorescent living cells infected at MOI 5 and 25 (Figure 3-4A and 3-4B) and RFP (Figure 3-4C and 3-4D), with the p10, 
ie1, basic, gp64 and vcath, the polh-GFP and polh-RFP monocistronic vectors. The plotted values are obtained from 
triplicate flasks, and represent the geometric means of high fluorescence cell populations in cell cultures, and error bars 
represent 1 standard deviation above and below the mean 
The choice of the promoter in front of the GFP gene also influenced the appearance of the 
signal from RFP, which was under the control of the polh promoter. At MOI 5, most constructs, 
including the RFP single construct showed an RFP signal starting at 16-24 hours post-infection. 
41 
 
However, the signal in the low GFP expressing vcath construct appeared much earlier (12–16 
hours), while the high GFP expressing basic construct only showed an RFP signal at 36 hours 
post-infection, which could be due to the very high levels of GFP that were produced in this 
system early in the infection. Increasing the MOI to 25 had an almost universal effect of causing 
RFP signals to emerge earlier except for the p10 vector where RFP was detected later. The 
earlier emergence of signals with higher MOI was likely due to the increased number of viruses 
providing increased numbers of templates for protein production. Alternatively, the increased 
numbers of viruses may have caused increase early gene expression, thereby accelerating the 
progression of viral infection. The delay in RFP for the p10 construct may be the direct result of 
overexpression of the GFP gene.   
GFP production showed minimal increases after 48 hpi in most cases, while RFP 
production generally increased till 96 hpi. It should be noted that at 36 hours, for many of the 
systems tested, there is a decrease in the GFP fluorescence – a dip of sorts – that may be 
indicative of a dual regulation of protein production or may be related to the onset of RFP 
production. Differences in RFP production from the different vectors were evident with the low 
GFP producing systems producing much higher levels of RFP (Figure 3-5), except for the ie1 
construct. High levels of GFP production earlier in the infection cycle (basic construct) caused a 
significant reduction in the amount of RFP produced. Single constructs, with GFP or RFP under 
the control of the polh promoter, produced the highest levels of fluorescence in all cases.  
The fluorescence levels of highly fluorescent cells infected with the single constructs 
were used to obtain a correlation of GFP to RFP fluorescence units, which ultimately allowed for 
the creation of protein production ratio profiles from the different polycistronic constructs 
(Figure 3-6). The figure shows that GFP and RFP production ratios vary widely between 
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constructs. In general, GFP was always produced at a lower level than RFP, except in cells 
infected with the basic promoter, where GFP was present at a level greater than that of RFP till 
36 hours post infection, following which GFP was present at roughly half the level of RFP. The 
vcath and gp64 constructs produced far more RFP than GFP. 
 
Figure 3-5: Peak levels of GFP and RFP produced from different constructs: Maximum levels of green (Figure 3-5A) and 
red fluorescence (Figure 3-5B) in cell cultures infected at MOIs 5 and 25 with the p10, ie1, basic, gp64 and vcath vectors, 
and the monocistronic polh-GFP and polh-RFP constructs.  The plotted values are the averages of fluorescence means of 
cell populations, multiplied by the total number of events to give the “culture fluorescence” from triplicate flasks, and 
error bars represent 1 standard deviation above and below means. 
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Figure 3-6: Expression ratios of GFP and RFP from different constructs: GFP/RFP expression ratio profiles over the 
course of cell culture infection with the p10, ie1, basic, gp64 and vcath vectors at MOIs of 5 (Figure 3-6A) and 25 (Figure 
3-6B). Profiles were obtained by first converting the geometric means of GFP fluorescence values of highly fluorescent 
cells into RFP fluorescence values using the correlation obtained by comparing fluorescence values of the two 
monocistronic polh-GFP and polh-RFP constructs. The ratios of converted GFP and RFP values were then plotted. 
                                                                                                                                                                                                                                                                                                              
3.5 Discussion 
3.5.1 Vector Alteration: Changing Promoter Sequences and Effect on Vectors 
For over twenty years researchers have alluded to the benefits of offsetting expression levels 
through promoter control (Tate et al., 1999), yet nobody has gone ahead and done a study to 
show how this should be done. Our belief is also that promoters can help stage an appropriate 
sequence of events that can lead to the efficient production of complex multi-protein molecules 
such as VLPs. This is in part based on evidence from natural systems such as influenza virus 
replication, where the rates of synthesis of different proteins differ over the course of the 
infection, with the Matrix (M) protein being produced at the highest levels after the other genes 
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have reached their peak production (Meier-Ewert and Compans, 1974). This could be due to the 
fact that the M protein which forms the inner layer of the influenza particle shell is only needed 
at later times during the virus replication cycle. The baculovirus system has an even more 
complex temporally separated protein production scheme with various transcription initiators 
being produced first, followed by structural proteins, with the outer protective proteinacious 
coats being produced only at the end (Rohrmann, 2011).   
This work aims to demonstrate the utility of promoter control in a very simple two 
protein co-expression system where the proteins are not secreted and not believed to interact. 
The enhanced Green Fluorescent Protein (GFP) and DsRed2 Red Fluorescent Protein (RFP) 
were further chosen because of their green and red fluorescence emissions, which enabled easy 
and accurate tracking of their production levels in infected cell cultures. Five different 
coexpressing virus constructs were generated for this experiment. In each of these, the RFP gene 
was placed under the control of a polh promoter, which activates at high levels during the very 
late phase of infection, at about 27 hours post infection (Bonning et al., 1994). The promoter 
controlling expression of the GFP gene is varied between the five constructs: the p10 promoter, 
which activates during the very late phase of infection, at about 19 hours post-infection (Bonning 
et al., 1994) the basic promoter, which is active from about 13 hours post infection (Bonning et 
al., 1994; Hill-Perkins and Possee, 1990); the gp64 promoter, which activates in both the early 
phase (from 6 hpi) at low levels and during the late phase at much higher levels (from before 24 
hpi) (Garrity et al., 1997); and the vcath promoter, which activates during the late phase at 
around 22 hpi (Hodgson et al., 2007; Hom et al., 2002; Slack et al., 1995a). Our results agree 
with these findings for the most part, however, GFP was observed earlier when controlled with 
the p10 and basic promoters, likely due to the sensitivity of the detection used in this study. 
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It is known that MOI can play a role in overall gene expression levels as well as onset of 
protein expression and so, extreme care was taken to have „equivalent‟ MOIs for experiments 
comparing different baculovirus constructs at MOIs of 5 and 25. Although titers via the different 
methods differed as expected (Figure A-1), together the methods were a good indication of: the 
composition of the stocks; and the minimal interference to baculovirus replication that may have 
been caused by using promoters that also drive essential genes. Given the fluctuations in seeding 
(Figure 3-2) it is expected that an MOI of 5 actually ranged from 4.3 to 8.8 and an MOI of 25 
actually ranged from 27 to 50. 
The effects of „re-using‟ promoters that control the expression of native genes are not 
extensively documented. Virus replication is an important aspect of BEVS that could be affected 
by changing native expression patterns with the „re-use‟ of native promoters. To examine this, 
baculovirus concentration in the media were measured by real-time PCR over the course of 
infections (Figure 3-2A and 3-2B). A further experiment was also conducted analysing 
replicative baculovirus titres at 48 hours post infection (Figure 3.2C). Both methods revealed that 
baculovirus replication did not vary between constructs. It still remains to be seen if any of the 
constructs are more prone to the production of defective interfering particles upon repeated 
passaging.  
3.5.2 Effect of Promoters and MOI on the Detection of Green and Red Fluorescent Protein 
It was hoped and expected that GFP levels would vary given that its expression is being driven 
by different promoters. However, it was also found that the emergence of RFP also varied 
between constructs. For the most part, the times of RFP emergence was around 16 – 24 hours 
post infection, including for the single construct. However, the basic construct, which showed 
high levels of early GFP expression, showed an RFP signal very late post infection (36 hours). 
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The late emergence of the RFP signal is thought to be directly related to the amount of resources 
committed by the cell to producing GFP. The increase in MOI from 5 to 25 caused earlier 
emergence of RFP production, with production in the cultures infected with the basic, vcath and 
gp64 constructs showing signals up to 12 hours earlier. Of interest is the RFP fluorescence 
emanating from the vcath and gp64 virus infecting cultures, which can be seen at low levels as 
early as 12 hours post-infection. This further reinforces studies by others, including Hu et al. (Hu 
and Bentley, 2000), which shows that increasing MOI can significantly accelerate the 
progression of infection with an earlier activation of genes from the very late phase of infection. 
3.5.3 Effect of Promoter on GFP and RFP levels: Competing for Resources 
Although there was no evidence of interference in terms of baculovirus replication, the idea that 
we might be creating or alleviating „competitive‟ environments with the use of these different 
promoters remained. The vcath and gp64 viruses produced the least amount of GFP, and the 
highest levels of RFP, while the basic construct, which expressed GFP at very high levels early 
during infection, produced far lower amounts of RFP than the p10 construct. These conclusions 
are further supported by data from the single constructs producing only GFP or RFP, which show 
greater levels of gene expression than any of the dual constructs (Figure 3-6A and C). In 
addition, co-infecting the two single constructs (overall MOI of 10) decreased the production of 
fluorescence molecules compared to cells infected with only the single foreign gene vectors, or 
cells infected with the p10 construct. The ie1 construct was an exception to the above 
observations, as it drove low levels of both GFP and RFP. It is thought that this may be related to 
some type of interference with the production of early transcriptional factors. Otherwise, this 
could be because of some form of regulation of the polh promoter by the spatially close ie1 
promoter within the construct.  
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3.5.4 Effect of MOI on GFP and RFP levels: Competing for Resources 
Many examples of „production saturation‟ exist in literature. Excessive multiplicity of infections 
(MOI) have indeed lowered of the amount of recombinant protein produced in some systems as  
far back as a study done on the production of β-galactosidase where infection of a culture at an 
MOI of 50 resulted in a poorer performance compared with infections at MOIs of 0.05, 0.5 and 5 
(Bedard et al., 1994). In our system, it was thought that the increase in MOI from 5 to 25 would 
increase the competition phenomenon, especially for those constructs with promoters driving late 
gene expression. For most of the constructs, there was very little improvement in the levels of 
GFP and RFP observed when increasing the MOI; however, despite the minimal increase in 
protein production, the results showed that there is a form of competition that arises from the 
expression of a secondary foreign protein. This was seen from the differing levels of RFP 
produced, despite always being under the control of the polh promoter. In the cases where there 
was infection with the vcath and gp64 constructs, significant increases in RFP levels with 
infection at the higher MOIs were observed, giving rise to the notion that the cell has a total 
protein capacity that can be utilized in many different ways depending on the promoter 
combinations used to drive gene expression and protein production. 
3.5.5 Further Implications  
  This research also has implications for new high capacity multiprotein production 
systems such as the MultiBac system (Fitzgerald et al., 2006; Fitzgerald et al., 2007a), where 
nutrient limitations may be important when producing proteins at high levels. In these systems, 
multiple genes are expressed at very high levels under the control of very strong promoters, 
thereby competing for limited resources. The utility of these systems lies in their ability to 
express complex protein structures such as virus-like particles with several virus components, 
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and enzyme complexes to perform complex reactions. However, over-expression of some 
components could lead to sub-optimal protein ratios in the final product, and cause reduced 
expression of correctly assembled product containing appropriate ratios of component proteins. 
In addition, high expression of genes that are not needed in large quantities can lead to a “waste” 
of cellular resources that could be used for the production of other proteins. It is possible that in 
some cases, inappropriate protein ratios and wasted cell resources make it impossible to use this 
system for the production of complex proteins. This paper demonstrates the use of different 
promoters to control the timing and expression of genes within BEVS, which we believe is the 
next step in improving the system for the production of complex proteins. In addition to the large 
number of promoters available within the baculovirus genome, foreign protein production can be 
further modulated by the use of baculoviral and other regulatory elements such as homologous 
regions (HRs) (Guarino et al., 1986; Ishiyama and Ikeda, 2010), as well as non-baculoviral, and 
truncated (Urabe et al., 2002; Urabe et al., 2006), hybrid (Thiem and Miller, 1990) or tandem 
(Kojima et al., 2001) promoters that extend the duration of protein production, or change 
expression levels of native promoters. Artificial promoters (Blissard et al., 1992; Rankin et al., 
1988) may also be used for modulating expression levels.  
 
3.6 Conclusions 
A detailed profile of expression levels over the entirety of the infection period by different 
vectors has been created and lends itself to serving as a template for “designing” expression 
systems in which the timing and expression level of different proteins can help in the 
optimization of product formation. Furthermore, this work shows that the expression of a gene 
under the control of one promoter can influence the production of protein whose gene was 
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controlled by another. Only one construct did not adhere to this theory: the ie1 construct. The 
latter resulted in low levels of both GFP and RFP, a result attributed in part by the fact that the 
ie1 promoter is recognized by a different polymerase, namely DNA polymerase II. In addition, 
this work should serve to stimulate further research into the use of other baculovirus promoters, 
enhancer regions, and non-native promoters and other control elements within the baculovirus 
insect cell system, which can be characterized to enhance the ability to rationally design the 
„expression‟ system. 
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Chapter 4 : Tracking RNA Expression Levels from Baculovirus Vectors 
Encoding for GFP and RFP 
4.1 Introduction 
The work presented in Chapter 4 (George et al., 2015) showed that promoters can be used to 
achieve fine and predictable control of gene expression within the baculovirus insect cell system, 
and that genes within this system do, in fact compete with each other for resources. However, the 
process of protein production involves both transcription and translation, and the previous work 
only examined the protein levels of two fluorescent proteins (enhanced Green Fluorescent 
Protein, referred to as GFP, and red fluorescent DsRed2, referred to as RFP) co-expressed within 
cells in the baculovirus insect cell system. Therefore, there is no information on how closely 
translation is related to transcription, and if the effect of competition is present at the 
transcription or translation levels, or if each of these individual processes is a contributing factor. 
Therefore, in this study, we tracked the levels of intracellular GFP and RFP RNA over time, 
from samples that were isolated at the same time, and from the same cultures as those used for 
the previous work. This enabled us to directly compare RNA and protein expression levels over 
time. This was done by semi quantitative real time PCR (qPCR), in which levels of GFP and 
RFP RNA were compared to levels of a control to get a value in terms of “fold difference” over 
levels of control RNA. As described in the previous chapter, the different viruses used contain 
the RFP gene under the control of the very-late polh promoter while GFP control is varied 
between the early (ie1), late (basic, gp64 and vcath) and very-late (p10) promoters. These viruses 
are referred to as the ie1, basic, gp64, vcath and p10 viruses, and samples of cells infected with 
these viruses are called  ie1, basic, gp64, vcath and p10 samples. 
51 
 
One of the aims of the work was to track levels of GFP and RFP transcripts using the 
insect cell 28S rRNA levels as a control, to control for variability in amounts of RNA extracted 
from cell pellets. The use of 28S rRNA as a control has been investigated in the BEVS system, 
and has been shown to be superior to several other commonly used controls in terms of transcript 
level maintenance over an infection cycle (Xue et al., 2010). In addition, the relative abundance 
of this RNA makes is quite easy to detect, as opposed to other low abundance control transcripts 
such as TATA box binding protein (TBP) gene (Xue et al., 2010) and glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) (Soos et al., 2011). Despite these reports, no correlation of 
28S rRNA transcript levels with respect to cell density has been shown and experiments do not 
demonstrate the robustness of this approach at varying multiplicities of infection and culture 
densities. Therefore validation of 28S rRNA as a control was tested over a wide range of cell 
densities and during infection at several MOIs.  
 
4.2 Materials and Methods 
RNA transcript levels of the different genes of interest (DsRed2 and eGFP) and control gene 
levels (28S rRNA) were tracked during the baculovirus infection process to monitor transcription 
patterns under the control of various promoters. The samples used were obtained from the same 
cultures as those used in the previous work on tracking fluorescent protein levels in cells over 
time (Chapter 3).  
4.2.1 RNA extraction 
RNA extraction from cell samples was conducted by spinning down cell culture samples at 300 
× g for 7 minutes to separate the cells from the media. Cell pellets were then stored at -80°C for 
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further treatment. Cell pellets were then subjected to RNA isolation using TRIzol® reagent (Life 
Technologies Inc., Burlington, ON, Canada), according to the protocols recommended by the 
manufacturer. All samples were treated with 5 μg RNase-free glycogen to enhance RNA yield, 
especially from low cell density samples. Extracted RNA samples were stored at -80°C for 
reverse transcription. 
4.2.2 Reverse transcription 
Reverse transcription to synthesize cDNA from extracted RNA samples was conducted using the 
reverse primers 28SrRNA R, RT GFP-R and RT RFP-R in Table 4-1. The levels of control 28S 
rRNA was tracked by using a previously described primer (28SrRNA R) for reverse transcription 
(Xue et al., 2010, Table 4-1). Reverse transcription of the GFP and RFP transcripts were 
conducted using primers RT GFP-R and RT RFP-R specific to regions in these (Table 4-1). All 
primers used in this work are listed in Table 4-1. Reverse transcription was performed using a 
High-Capacity cDNA Reverse Transcription kit (Applied Biosystems, Burlington, ON, Canada) 
using a slightly modified manufacturers‟ protocols. Briefly, to avoid exceeding the cDNA 
conversion capacity of the kit, given the high abundance of template RNA, 2 μl of diluted 
extracted RNA was mixed with 2 μl of 10 × RT Buffer, 0.8 μl of 25 × dNTP mix, 0.8 μl of each 
of the reverse primers at a concentration of 25 μM, and 1.0 μl Multiscribe™ reverse transcriptase 
and then topped off with nuclease-free water, for a total reaction volume of 20 μl. The 28S rRNA 
samples were run separately with a 1/50 diluted RNA sample as template, as this was found to 
yield a very reliable result, while the GFP and RFP samples were run together in one tube with a 
1/10 dilution of sample, which is necessary due to the much lower abundance of GFP and RFP 
transcripts in relation to 28S rRNA. The samples were then placed in a VeritiTM 96 Well 
Thermal Cycler (Applied Biosystems, Burlington, ON, Canada) and run at 25°C for 10 minutes, 
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37°C for 120 minutes and 85°C for 5 minutes. These reactions were then stored at -20°C until 
analysis by qPCR. 
4.2.3 qPCR 
qPCR reactions were conducted on a StepOne Plus Real-Time PCR system (Applied 
Biosystems, Burlington, ON, Canada). The determination of transcript levels for each of the 
transcripts was conducted in separate reactions. 28S rRNA levels were determined using 
previously described forward primer 28S-F and reverse primer 28S-R (Xue et al., 2010), which 
amplify out a region in the Sf9 28S rRNA. GFP and RFP transcript levels were determined using 
primers RT GFP-F and RT GFP-R, and RT RFP-F and RT RFP-R (Table 4-1). Each reaction 
consisted of 2 μl cDNA sample mixed with 10 μl of 2 × Power SYBR® Green PCR Master Mix 
(Applied Biosystems, Burlington, ON, Canada), forward and reverse primers at a final 
concentration of 900 μM, and nuclease-free water to a final volume of 20 μl. All reaction 
components except the cDNA were prepared as a master mix and mixed together with cDNA in 
a MicroAmp Fast Optical 96-Well Reaction Plate (Applied Biosystems, Burlington, ON, 
Canada). The plate was then sealed with MicroAmp Optical Adhesive Film (Applied 
Biosystems, Burlington, ON, Canada) and run according to reaction conditions described in the 
literature (Xue et al., 2010). The initial denaturation was run at 95°C for 10 minutes, followed by 
45 cycles of denaturation at 95°C for 5 seconds, annealing at 55°C for 20 seconds and extension 
at 72°C for 20 seconds. Melt curve analysis, for distinguishing the different species of DNA 
amplified during the reaction, was conducted by holding samples at 55°C for 10 seconds and 
then increasing the temperature in 0.3°C increments of 15 seconds to 95°C, with fluorescence 
being measured during the ramping stage.  
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The amplification curves obtained from qPCR were then analyzed by assumption-free 
analysis (Ramakers et al., 2003) using the program LineReg PCR (Ruijter et al., 2009). This 
method allowed the PCR efficiency of each reaction and the average efficiency of all similar 
reactions on the plate to be determined. The average efficiency was used to compare cycle 
threshold (Ct) values of different reactions on the same plate, thereby allowing for determination 
of fold difference in cDNA abundance between samples. RFP and GFP transcript levels were 
normalized to the 28S rRNA levels, which was made possible by implementing a common 
fluorescence threshold for all reactions on the plate. This allowed us to account for differences in 
TRIzol® RNA extraction between samples as well. Briefly, the formula for the quantity of 
unknown transcript was: 
              … Equation (1) 
And:      
Where: 
XOU is the quantity (by mass) of either the GFP or RNA transcript cDNA present in the original 
cDNA sample; XO 28S is the quantity (by mass) of the 28S rRNA cDNA present in the cDNA 
sample; N is the number of moles of cDNA of any individual species present at the beginning of 
the reaction; F is the “initial fluorescence level” due to cDNA of any individual species at the 
beginning of the reaction; CT is the cycle threshold number for each individual reaction. 
Once the XOU values have been obtained for GFP and RFP (by setting XO 28S to the 
arbitrary value of 1), the number of copies of the two species of cDNA in the original sample (N) 
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can be compared by dividing each of the XOU values by the molecular weight of the amplified 
DNA fragment (38751.9 g/mol for GFP and 39218.3 g/mol for RFP). 
Table 4-1: List of primers used for tracking intracellular RNA levels 
Primer Name Sequence Description 
28SrRNA F 5′-CGA CGT TGC TTT TTG ATC CT-3′ Forward and reverse primers used 
in tracking 28S rRNA levels 28SrRNA R 5‟ - GCA ACG ACA AGC CAT CAG TA – 3‟ 
RT GFP-F 5‟ – CCT GAA GTT CAT CTG CAC CA – 3‟ Forward and reverse primers used 
in tracking eGFP RNA levels RT GFP-R 5‟ – GAA GAA GTC GTG CTG CTT CA – 3‟ 
RT RFP-F 5‟ – AAG CTG AAG GTG ACC AAG GG – 3‟ Forward and reverse primers used 
in tracking DsRed2 RNA levels RT RFP-R 5‟ –CCC TTG GTC ACC TTC AGC TT – 3‟ 
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4.3 Results 
4.3.1 Validation of the use of 28S rRNA as a control gene 
Eight random infected and uninfected cultures were sampled at different times, corresponding to 
a wide range of cell densities (~0.5 × 10
6
 cells/ml to 1.5 × 10
7
 cells/ml) with samples being 
infected by different viruses containing 2 different transgenes, grown at different volumes 
(ranging from 30 ml to 750 ml), and infected at MOIs ranging from ~0.2 to 5. 
 
4-1: qPCR conducted on infected and uninfected cell cultures to detect 28S rRNA transcript levels (Figure4-1 A).  Figure 
4-1 B shows the same points grouped by culture number 
 
Figure 4-1 shows the correlation between cycle threshold (Ct) values from the 
amplification of 28s rRNA cDNA, extracted and reverse transcribed from infected and 
uninfected cultures, and the cell densities of the cultures. As can be seen from the figure, the Ct 
values seem to vary exponentially with respect to the cell density, which is expected as Ct is 
related to the concentration of template in the reaction by the formula: 
                              …Equation (2) 
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where At is the copy number of the amplicon at the cycle threshold, Ao is the initial copy 
number, E is the efficiency of the reaction and Ct is the cycle threshold number. It is important to 
note that the fit of the points from infected cultures overlaps the points from the uninfected 
cultures, thereby indicating that 28S rRNA levels are density dependent and not a function of the 
infection of cells. 
Figure 4-1B shows the correlation between cycle threshold (Ct) values and cell densities 
of different cultures at different densities. As can be seen, all cultures follow the same general 
trend. 
4.3.2 GFP and RFP tracking 
Sf9 cells infected with GFP and RFP expressing baculovirus constructs were tracked using qPCR 
from time points 16 hours post infection (hpi). As can be seen in Figure 4-2, the levels of GFP 
and RFP are markedly different between constructs. Before 24 hours, the basic baculovirus 
infected cell samples seem to have much higher levels of GFP than other constructs. Past this 
time point, higher levels of GFP transcripts are seen to be produced from the p10 promoter. RFP 
RNA levels increase after 16 hpi in all constructs, but to different levels. In addition, the peak 
RFP RNA levels seems to be between 36 – 48 hours for most constructs except in the basic and 
p10 samples, where peak levels are only reached at 72 hpi. Interestingly, the RFP transcript 
levels when driven by the ie1 promoter seem to be increasing even after 72 hours post infection. 
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4-2: GFP (4-2 A) and RFP (4-2 B) RNA levels in cells infected with different baculovirus constructs, normalized with 
respect to cellular 28S rRNA levels. Figures 4-2 C and 4-2 D show corresponding GFP and RFP protein expression levels. 
 
Figure 4-3 shows the ratio of normalized GFP and RFP transcripts over time in each of 
the cell cultures infected with the different viruses. The level of GFP is generally lower than that 
of RFP at all time points except in basic samples at 16 hpi, where the ratio is close to 1. It is 
likely that ratios greater than 1 will be seen if basic samples are tracked before 16 hpi. The other 
constructs have GFP/RFP ratios of near 0.1 only at 16 hpi (the first recorded time point), after 
which they reduce drastically.  
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4-3: GFP/RFP RNA (4-5 A) and protein (4-5 B) ratios in cells infected with different baculovirus constructs 
 
4.4 Discussion 
The first step of this work was to validate the use of 28S rRNA as a control for RNA tracking, 
under a variety of different conditions. It can be seen that a correlation between the level of 28S 
rRNA and cell density exists. At higher cell densities, however, there was a greater amount of 
variability. This could be due to several factors, with the most likely being that the reverse 
transcription reaction was overloaded with template RNA at these densities, due to which the 
conversion efficiencies vary widely. Future work may consider lowering the amount of RNA 
used when doing the reverse transcription reactions for high cell density samples. 
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As can be seen from Figure 4-2, the levels of RNA in samples show patterns similar to 
the levels of fluorescent protein detected in previous work presented in Chapter 3 (George et al., 
2015), which have been reproduced in Figure 4-2. For example, the early emergence of a GFP 
signal under the control of the basic promoter can be seen in both RNA (Figure 4-2 A) and 
protein production. RFP RNA levels (Figure 4-2 B) can also be generally related to fluorescence 
levels. The gp64 samples show the highest levels of RFP RNA and protein, while the basic 
samples show the least. One anomaly is the level of RFP RNA in the vcath construct infected 
cells, which were only higher than the p10 construct RFP RNA levels at one time point, while 
fluorescence data (George et al., 2015, Figure 4-2 C and D) shows that the RFP protein level 
from vcath samples was higher than in the p10 construct infected cells at almost all time points. 
This could indicate that the level of RNA in cells at earlier time points is especially influential in 
determining the level of protein being produced at subsequent time points. Alternatively, the 
“competition” effect which produces the difference in RFP protein expression levels could be 
present at both the transcription and translation levels, and could also explain the discrepancy in 
the RNA and protein data from the vcath and p10 samples.  
The case for the large influence of RNA produced at earlier time points on protein 
production is further supported by several lines of evidence. While RFP RNA levels in the p10 
samples increased to almost that of the gp64 sample levels at later times post- infection, protein 
expression does not show a correspondingly high level in p10 samples. This could be because the 
levels of RFP RNA started increasing earlier in the gp64 construct, than the p10 construct, and 
this drove early production of RFP protein in cells infected with the gp64 construct. The later 
start of RNA transcription in the p10 samples could have then had a much smaller impact on 
RFP protein production in cells. In addition, the basic samples, which showed highest early GFP 
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RNA and protein levels, showed the lowest levels of RFP protein and RNA. When compared to 
p10 samples, the levels of RFP RNA produced from the basic construct was much lower than 
that produced from the p10 construct. This is in spite of the fact that the levels of p10 GFP RNA 
were much higher than basic GFP RNA during later time points. Because the levels of GFP RNA 
were lower in the p10 construct compared to the basic construct during earlier time points, this 
could indicate that the levels of GFP RNA at early time points influenced the lower production 
of RFP RNA from the basic construct, which indicates that competition is especially influenced 
by the RNA production at early time points.  
The normalized GFP and RFP values were used to generate a plot of the ratio of GFP to 
RFP RNA over time, similar to that in Chapter 3 (George et al., 2015), which is reproduced in 
Figure 4-3 B. While the general shape of the RNA plot seems to be the same as that of the 
protein, it seems to be shifted to earlier times post infection relative to the protein expression 
ratios. This could be due t o the time required to produce protein from  RNA transcripts, as well 
as due to the time required for the produced polypeptide chain to mature into a fluorescent 
protein. This should be taken into account when designing systems for expressing proteins in 
predetermined ratios, where the amount of time needed to produce different proteins may vary, 
and so the protein expression profiles would be different at different times post infection.  
Interestingly, the ratios of GFP protein to GFP RNA are similar at most time points 
except for the two highest GFP expressing p10 and basic constructs, where the ratios are much 
larger (Figure 4-3). The ie1 construct shows the next highest values, followed by the low GFP 
producer vcath and gp64 constructs. This could indicate that there is an “amplification” effect 
during protein production, where an increase in transcription results in a much higher increase in 
translation. The differences in ratios were not as obvious for RFP production, with only the vcath 
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construct having a markedly higher ratio than the other constructs. Due to the ratios not changing 
significantly over time after the infection event, it is thought that the competition effect is mainly 
determined at the transcription step. 
The RNA tracking data for the dual protein expressing constructs suffers in that there is 
high variability in the data. This is due to the systemic variability that is present when samples 
are run through the real time PCR process. The cell culture experimental setup involved infecting 
and analyzing three insect cell flasks for each of the five baculovirus constructs used in this 
work, for a total of fifteen flasks. The samples from the first flask of each set of triplicates were 
regarded as one set, the second flask of each set of triplicates as the second set, and the third 
flask of each of the triplicates as the third set. The real time PCR setup used in this work 
involved running one set of samples (for example samples from 16 – 96 hours of the first flask 
from a set of triplicates) of each of the constructs, on one qPCR plate. Therefore, complete 
characterization of each of the fluorescent protein RNA quantities required three plates (one for 
each set of samples). While the differences between constructs on each of the plates were 
consistent, the absolute values of replicates (from triplicate flasks) varied from plate to plate. 
Due to this, the data has high apparent variability between replicates (Figure A-2), and this is a 
serious drawback to this study. 
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Chapter 5 : Formation of Dual Fluorescent Influenza Virus-Like Particles 
by Expression of Fluorescent Hemagglutinin and Matrix 1 Fusion Proteins 
in Insect Cells 
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5.1 Abstract 
 
Cell culture-produced Influenza virus-like particles (VLPs) have been investigated extensively 
for use as vaccine candidates, and are in the process of being commercialized. However, much 
work still needs to be done on improving the VLP production process. This work reports on the 
generation of Influenza hemagglutinin and matrix 1 proteins that have been fused with 
fluorescent proteins, which then assemble into dual fluorescent VLPs. These fusion proteins 
enable tracking and monitoring of different stages in the VLP production process, from protein 
synthesis and localization within the cell, to the incorporation of component proteins into active 
VLPs, which can be detected using flow cytometry. It is hoped that this will provide a useful tool 
to study the VLP protein production process in cell culture, and help identify and remove the 
significant bottlenecks associated with high titer Influenza VLP production.  
 
5.2 Keywords 
Influenza virus-like particle 
Hemagglutinin 
Matrix 1 
Fluorescent tagged proteins 
Dual fluorescent virus-like particle 
Baculovirus expression vector insect cell system BEVS 
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5.3 Introduction 
Influenza A viruses are a significant cause of morbidity and mortality in the modern world. 
While vaccines have been shown to be effective in preventing or reducing the severity of the 
disease, the high rate of mutation and genetic re-assortment in these viruses requires the 
production of new vaccines every flu season. The two most common types of vaccines currently 
used contain either live attenuated Influenza virus or inactivated virions, and both are currently 
produced using embryonated chicken eggs. This is, however, a time and resource intensive 
process and is unsuitable for the production of vaccines against recent H5N1 viruses, which kill 
chicken eggs (Quan et al., 2007). In addition, an influenza pandemic may significantly affect the 
supply of eggs for vaccine production. Therefore, there has been a movement afoot in the past 
decade or so to move the production away from eggs and into cell culture. Today, Influenza 
vaccines based on the full virus are also made in MDCK cells, and more recently, seasonal flu 
vaccines based solely on the HA protein, are being made in insect cells by the Protein Sciences 
Corporation. The latter, and other vaccines based on virus-like particles (VLPs), i.e. incomplete 
and non-replicative virus particles, have the advantage of minimizing concerns related to the 
release of genes associated with virulent strains into the environment (Latham and Galarza, 
2001). Significant process challenges still remain in the large scale cell culture-based production 
of VLPs for use as vaccines (Palomares and Ramírez, 2009). These challenges stem from the fact 
that VLPs are complex particles comprised of one or more proteins that have to be correctly 
assembled to form intact VLPs. 
Influenza viruses are enveloped RNA viruses belonging to the Orthomyxoviridae family 
of viruses. Cell culture-propagated Influenza viruses are usually spherical between 80 and 120 
nm in diameter (Lamb and Choppin, 1983). The Hemagglutinin (HA) glycoprotein, which exits 
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as a homotrimer, is embedded in the virus lipid coat. The portion of HA that protrudes to the 
environment gives rise, in part, to the antigenicity of the particle. HA mediates the binding of the 
Influenza virus to sialic acid residues on target cells, as well as membrane fusion between virus 
and cell (Wiley and Skehel, 1987). Another important component of the virus particle is the 
matrix M1 protein, which binds viral RNA and, along with HA and neuraminidase (NA), make 
up the structural component of the virus. In the insect cell system, Influenza VLPs have been 
produced with four proteins (HA, NA, and M1 and matrix 2 (M2)) (Latham and Galarza, 2001), 
three proteins (HA, NA, and M1) (Bright et al., 2007; Pushko et al., 2005; Pushko et al., 2007; 
Thompson et al., 2015), and only the HA and M1 proteins (Quan et al. 2007). The production of 
these proteins within insect cells result in the formation of particles resembling wild type 
Influenza virions, which range in size between 80 – 120 nm (Quan et al., 2007). Work on 
Influenza VLP production in the baculovirus insect cell system has led to the development of a 
series of pandemic and seasonal Influenza vaccines from Novavax, which are in Phase 1 and 
Phase 2 trials respectively (Novavax website, October, 2015). However, while the VLP 
production process in insect cells has been examined (Krammer et al., 2010; Thompson et al., 
2015), there is still much work to be done on improving efficiency of the system. 
A major impediment to improving the process is the difficulty in tracking the Influenza 
virus-like particles. Fluorescently tagged parvovirus B19 VLPs (Gilbert et al., 2004; Gilbert et 
al., 2005) and HIV (Gutiérrez-Granados et al., 2013) have been produced, and such a strategy 
has immense potential for characterizing and evaluating the entire manufacturing process. In this 
work, we aimed to implement such a strategy to create a particle that could aid in process 
development. More specifically, we report herein the creation of fluorescently tagged Influenza 
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virus HA and M1 proteins that form dual fluorescent functional VLPs, i.e. VLPs that maintain 
hemagglutination activity. 
 
5.4 Materials and methods 
5.4.1 Baculovirus Vector Construction 
A baculovirus construct co-expressing Influenza hemagglutinin bound to enhanced green 
fluorescent protein (HA-GFP) and Influenza M1 attached to DsRed2 red fluorescent protein 
(M1-RFP) was generated for this work (Figure 5-1). The sequences for the eGFP and DsRed2 
genes, henceforth referred to as GFP and RFP respectively, were determined from plasmids 
pcDNA3-EGFP, which was a gift from Doug Golenbock (Addgene plasmid # 13031) and 
pCALNL-DsRed, which was a gift from Connie Cepko (Addgene plasmid # 13769 (Matsuda and 
Cepko, 2006)), and obtained from Addgene (Cambridge, MA, USA). The sequences for the HA 
and M1 genes from Influenza A virus (strain A/Puerto Rico/8/1934 H1N1) were determined 
from GenBank (National Center for Biotechnology Information, U.S. National Library of 
Medicine, Bethesda MD, USA). The sites for insertion of fluorescent genes into the Influenza 
genes were based on previous studies and were determined to be after the signal peptide at amino 
acids 1 – 17 for GFP into the Influenza HA gene (Li et al., 2005), and at the 3‟ end of the M1 
gene, for the RFP gene linked to the M1 C terminus (Shishkov et al., 1999). The fluorescent 
genes were separated from the Influenza coding sequences using the flexible linker VDADS 
(Linhult et al., 2003). The expression cassette consisting of the HA-GFP gene in the opposite 
sense, under the control of the p10 promoter from the plasmid pAcUW51 (BD Pharmingen, San 
Diego, CA, USA), and the polh promoter from the same plasmid upstream of the M1-RFP gene, 
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were synthesized and placed in a pMK vector (Life Technologies, Burlington, ON, Canada). The 
region of interest was then extracted, and 15 bp fragments were added to the ends of the 
sequence of interest by PCR using Phusion® High-Fidelity polymerase (Thermo Scientific, 
Waltham, MA, USA) using the primers: 5‟ – 
GGTAATGGTAGCGACCGGCGCTCAGCTGGAATT TCA GAT GCA TAT TCT GCA CTG 
CAA AG – 3‟ and 5'- CTA GCG CTT AAT AAA TGT ACT AAT AAC CGG ATC CCT ACA 
GGA ACA GGT GGT GGC GGC -3'. The underlined regions allow for integration of the 
extracted DNA fragment into a linearized baculovirus transfer vector. The plasmid pAcUW51 
was linearized using the enzymes FastDigest
TM
 BamH1 and EcoR1 (Thermo Scientific, 
Waltham, MA, USA). The expression cassette containing the Influenza genes and the linearized 
plasmid were ligated together using the In-Fusion PCR Cloning Kit (Clontech Laboratories Inc, 
Mountain View, CA, USA). The resulting plasmid contained the HA-GFP gene under control of 
a baculovirus p10 promoter and the M1-RFP gene under the control of a baculovirus polyhedron 
promoter (Figure 5-1). The baculovirus was generated from this vector using the BD 
BaculoGold™ Transfection Kit (BD Pharmingen, San Diego, CA, USA). 
 
5-1: Position and orientation of gene sequences within pAcUW51 transfer vector. The eGFP coding region was inserted in 
between the N terminal influenza HA signal peptide, and the rest of the HA coding sequence. The DsRed2 coding 
sequence was added to the 3’ end of the M1 gene 
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5.4.2 Cell Culture and Virus Production 
Spodoptera frugiperda clonal isolate 9 (Sf9) cells (GIBCO, Carlsbad, CA) were maintained in 
capped glass Erlenmeyer flasks in Sf900III media (GIBCO) at a temperature of 27⁰C on an 
orbital shaker rotating at 130 rpm. Maintenance cell cultures were kept at a density between 0.5 
and 4×10
6
 cells/mL. 
Baculovirus cultures were amplified by infecting Sf9 cells at a density of 1×10
6
 cells/mL 
and allowing the infection to proceed until the viability dropped to 70–80%, after which cultures 
were harvested and centrifuged at 1000×g for 10 min in order to spin down cells and cell debris. 
The supernatant was removed and used as baculovirus stock for experiments. Baculovirus stocks 
were quantified by flow cytometry (Shen et al., 2002) and the end point dilution assay (King and 
Possee, 1992; Reed and Muench, 1938). 
5.4.3 Native Polyacrylamide Gel Electrophoresis (PAGE) 
Influenza protein detection was conducted by native PAGE using standard protocols. Briefly, 
samples were run on a 12% gel made with 29:1 polyacrylamide/bisacrylamide. Samples mixed 
with 5 × loading buffer (50% glycerol, 0.5% bromophenol blue, 0.5M Tris-HCl, pH 6.8), and the 
gel was run in running buffer (25 mM Tris, 192 mM glycine, pH 8.3) for 70 minutes at 200V. 
Gels were visualized using a blue-light transilluminator (Pearl Biotech, San Francisco, CA, 
USA) and a Smartview 310 gel imaging system fitted with a Canon PowerShot G16 camera 
(Discovery Scientific, Kelowna, BC, Canada). Cell lysate samples were prepared by 
resuspending pelleted cells in RIPA buffer (150 mM sodium chloride, 1% Triton X-100, 0.5% 
sodium deoxycholate, 0.1% SDS (sodium dodecyl sulphate), 50 mM Tris, pH 8.0) supplemented 
with 1% n-dodecyl β-D-maltoside (DDM, Fisher Scientific, Toronto, ON, Canada), shaking 
samples on an orbital shaker at 4⁰C for 30 minutes, followed by centrifugation at 12,000 rpm for 
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10 minutes at 4⁰C. The supernatant was then separated and used for experiments. Samples of 
cells infected with viruses producing only GFP or  RFP were treated with NP-40 buffer (150 mM 
sodium chloride, 1.0% NP-40, 50 mM Tris, pH 8.0), which lyses the cell and efficiently releases 
free GFP and RFP from cells. Infected cell culture supernatant was also concentrated 10× by 
ultrafiltration using an Amicon Ultra -15 10K centrifugal filter device (Merck Millipore, 
Carrigtwohill, Cork, Ireland). These were also treated with 1% DDM and used for experiments. 
5.4.4 Ultracentrifugation 
The purification of Influenza particles from culture supernatant was conducted by 
ultracentrifugation using an iodixanol gradient (Hutchinson and Fodor, 2014). Briefly, a 14 × 89 
mm polyallomer centrifuge tube (Beckman Coulter, Mississauga, ON, Canada) was filled with 
12 mL of culture supernatant, following which the tubes were spun in an Beckman Coulter SW 
41Ti rotor (Beckman Coulter, Mississauga, ON, Canada) at 26,000 rpm (115,915 g) for 90 
minutes. Following this, the supernatant was aspirated out, and the pellet was resuspended in 500 
µL of NTC buffer (1 M NaCl, 0.2 M Tris-HCl pH 7.4, 50 mM CaCl2). A density gradient was 
then prepared in a 14 × 89 mm polyallomer centrifuge tube with different densities of iodixanol 
OptiPrep™ Density Gradient Medium (Sigma Aldrich, St. Louis, MO, USA). These were 10, 15, 
20, 25, 30, 35 and 40% iodixanol solutions prepared in NTC buffer, and 1.5 mL of each of these 
solutions was layered one at a time using a pipette. The resuspended virus pellet was then 
layered on top of the 10% gradient, and the tubes loaded into the SW 41Ti rotor and centrifuged 
for 35,000 rpm (209,000 g) for 150 minutes. Fractions were then collected by puncturing the side 
of the tube and analyzed by flow cytometry and transmission electron microscopy (TEM). 
5.4.5 Electron Microscopy 
Electron microscopy was conducted using a Philips CM10 transmission electron microscope 
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(TEM). Sample preparation was conducted by placing 5µl of undiluted sample onto parafilm and 
placing a 200 mesh carbon formvar coated copper grid (Ted Pella Inc, Redding, CA, USA) 
upside down onto the sample drop for 15 minutes. The grid was then placed into a drop of 2% 
formaldehyde in HEPES buffer for 10 minutes, following which the sample was placed into a 
drop of 3% aqueous phosphotungstic acid (PTA) stain pH balanced to pH 7.3 using an NaOH 
solution. After 45 seconds, the sample was removed from the drop, and PTA was wicked off 
with an absorbent wipe so as to leave only a thin film of stain on the grid. Sample grids were 
dried overnight prior to TEM imaging. Fully replicative Influenza A virus (H1N1 Puerto 
Rico/8/1934) produced in culture was a kind gift from the National Research Council of Canada 
(Montreal, QC, Canada) and was used as a control to compare with produced Influenza VLPs. 
5.4.6 Confocal Microscopy 
Confocal microscopy samples were prepared by first seeding 1×10
6
 cells onto sterile glass cover 
slips (22 × 22 mm – No 1.5) placed inside a 35 mm tissue culture dish or in a 6-well plate. The 
cells were allowed to attach overnight and then infected with virus. The infection was allowed to 
progress for varying lengths of time. The sample preparation protocol involved aspirating media 
from the plate, and rinsing the coverslip 5 – 7 times with 1×PBS followed by aspiration of the 
spent PBS. The cells were then fixed with 4% formaldehyde in PBS (pH 7.4) for 15 minutes at 
room temperature, following which the sample was washed with PBS 5 – 7 times. A drop of 
ProLong® Gold Antifade Mountant (Life Technologies Inc., Burlington, ON, Canada) was 
placed on a 76.2 × 25.4 × 1 mm microscope slide, and the cover slip was placed upside down 
onto the drop of mountant. The mountant was then allowed to cure for 24 hours in the dark, 
following which the coverslip was sealed using paraffin wax and a cotton swab. The samples 
were then stored in the dark at room temperature for the short term till imaging. Confocal 
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microscopy was conducted using a Zeiss LSM 510 confocal microscope (Zeiss Canada, Toronto, 
ON, Canada).  
5.4.7 Imaging Flow Cytometry Analysis (Cells) 
Imaging flow cytometry was conducted on unfixed cells in suspension using an ImageStream
X
 
Mark II (Amnis, Seattle, WA) imaging flow cytometer with 488 nm, 642 nm, and 785 nm lasers. 
Acquired flow cytometry files were analyzed, and images processed and exported using IDEAS 
software (Amnis, Seattle, WA). 
5.4.8 Hemagglutination Assay 
The presence of Influenza VLPs in samples was determined by the hemagglutination assay 
(Hirst, 1942), using well established protocols. Briefly, 50 µL of PBS was added to the wells of a 
round bottom 96-well plate, following which 50 µL of sample was added to the first well. Serial 
dilutions of sample were then conducted by mixing and transferring 50 µL of diluted sample 
sequentially to produce a row of wells with sequentially two-fold diluted samples. 50 µL of 0.5% 
chicken red blood cell suspension (Rockland Immunochemicals Inc. Limerick, PA, USA) in PBS 
was then added to each well, and the suspension allowed to sit at room temperature for an hour, 
following which results were read. Hemagglutination activity was noted by the lack of a red 
blood cell pellet at the bottom of wells. The highest dilution of samples which showed complete 
hemagglutination activity was noted and the reciprocal of the dilution factor was regarded as the 
number of Hemagglutination Units (HAU)/50 µL. This was then multiplied by 20 to derive the 
HAU/mL of sample. 
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5.4.9 Flow Cytometry Analysis (VLPs) 
Flow cytometry was conducted on a BD FACS Calibur (BD Biosciences, San Jose, CA). The 
results were analyzed using the FlowJo software (Tree Star, Ashland, OR). Green fluorescence 
was detected by the FL1 detector (emission 530nm, bandpass 30 nm) and red fluorescence by the 
FL3 detector (emission 670 nm, longpass). Compensation was conducted to remove signal 
overflow from GFP fluorescence into the FL3 channel and was set at 11.5% of the FL2 signal 
based on the level of fluorescence detected when cells were infected with a monocistronic vector 
containing the GFP gene. Particle counts were obtained by running diluted samples through the 
cytometer and comparing particle counts with Flow-Set
TM
 fluorospheres (Beckman Coulter, 
Mervue, Galway, Ireland) of a known concentration. The baculovirus population was removed 
from VLP scatterplots by defining gates on forward scatter vs side scatter scatterplots of 
ultracentrifuged supernatants of cell cultures infected with baculovirus producing non-fused GFP 
and RFP (George et al., 2015), as shown in Figure 5-5. The points falling outside of this 
“baculovirus region” were counted as dual fluorescing VLPs. 
 
5.5 Results and Discussion 
5.5.1 HA and M1 Fluorescent Fusions 
The Influenza HA and M1 genes used in this work were synthesized using the sequence of the 
Influenza A PR/8/34 H1N1 virus strain. The virus hemagglutinin (HA) protein is a single pass 
type I membrane protein that is often localized to the host apical membrane in epithelial cells. 
The first 17 amino acid residues correspond to a signal peptide, following which is a 511 aa 
extracellular domain, followed by a helical 21 aa transmembrane domain and finally a 16 aa 
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cytoplasmic tail domain (Winter et al., 1981). An enhanced green fluorescent protein (eGFP, 
henceforth referred to as GFP) polypeptide was inserted after the HA signal peptide which 
extends from amino acids 1 - 16, as this has been shown to be amenable to accepting insertions 
(Li et al., 2005). The location of the signal peptide was determined from the UniProt database 
(accession number: P03437). Flexible linker regions were added to the N and C termini GFP 
peptide to allow the separate domains to fold independently. The fused protein is referred to in 
this work as HA-GFP. 
The M1 protein is a 252 aa protein that is arranged in a series of helical domains, with the 
N and C terminals facing towards the inside of the Influenza virion (Shishkov et al., 1999). In 
our work, a red fluorescent protein (DsRed2, henceforth referred to as RFP) polypeptide was 
added to the C terminus of the protein with flexible linker regions in between. This fusion 
protein is referred to as M1-RFP. 
The production of fluorescent influenza proteins within Sf9 insect cells allowed for the 
easy visualization of influenza protein localization within the cell. 
5.5.2 Protein Localization 
Confocal microscopy was used to determine the localization of fluorescent Influenza HA and M1 
proteins within Sf9 cells infected with the baculovirus expressing both virus proteins (Figure 5-2 
A, B and C). It was found that HA-GFP localized mainly to the outer cell membrane, whereas 
the M1-RFP localized at the nucleus as well as parts of the membrane. This is different from 
when fluorescent proteins (eGFP, DsRed2) are expressed in insect cells (Sf9 or Hi5), where there 
is no distinct localization of the proteins and the entire cell either fluoresces red or green, even 
when the two proteins are co-expressed (George and Aucoin, 2015).The localization of HA-GFP 
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and M1-RFP was confirmed by using an imaging flow cytometer, where cells infected in 
suspension were passed through the cytometer (Figure 5-2 G-I), as opposed to confocal 
microscopy where the imaged cells were adhered to a glass slide, which indicates that the protein 
localization is independent of whether the cells are adhered to a surface, or in suspension. The 
localization of HA to the membrane was expected as the HA protein is an integral membrane 
bound protein which associates with lipid rafts (Scheiffele et al., 1997), which was confirmed by 
immunofluorescence staining (Wu et al., 2010).  
 
5-2: Confocal microscopy images of Sf9 cells infected with baculoviruses expressing HA-GFP (A) and M1-RFP (B) 
proteins. Panels D and E show the unfused GFP and RFP present throughout the Sf9 cells, without any specific 
localization. Imaging flow cytometry was conducted on cells in suspension, and used to show the presence of HA-GFP (G) 
and M1-RFP (H) in infected cells. Panels C and F are confocal overlay images of red and green fluorescence in the cells 
expressing Influenza fusion proteins, and unfused fluorescent proteins. Panel I is an imaging flow cytometry overlay of 
infected cells producing fluorescent Influenza fusion proteins. Figures 5-2 A, B and C were taken at the same plane in the 
cell sample, as were Figures 5-2 D, E and F. Similarly, Figures 5-2G, H and I were also taken at the same plane. 
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The membrane bound nature of the M1 protein has been well reported before, and could 
be due to either direct interaction of M1 with the membrane (Ruigrok et al., 2000), or through 
interactions with the cytoplasmic domain of membrane bound HA protein (Ali et al., 2000; 
Scheiffele et al., 1997; Zhang et al., 2000). The localization of M1 around the nucleus may be 
either due to the presence of a nuclear localization signal near the N terminal of the protein (Hui 
et al., 2003), or due to trafficking through the endoplasmic reticulum surrounding the nucleus 
after M1-RFP protein synthesis. The preferential localization of expressed M1 protein to the 
nucleus has also previously been observed in CV1 cells has been observed before, with a nuclear 
localization signal between amino acids 101 to 105 suspected as being the main driver of this 
behavior (Ye et al., 1995). This also suggests that the M1-RFP behaves similarly to unmodified 
M1 protein with respect to nuclear localization inside cells. 
Detergent-solubilized virus-infected cell lysate, and ultrafiltration-concentrated cell 
culture supernatant, were run on a non-denaturing native PAGE gel (Figure 5-3) to observe the 
modified Influenza proteins produced in Sf9 cells. The use of a non-denaturing gel allowed for 
the use of the innate fluorescence of the modified proteins to monitor their migration through the 
gel. The HA-GFP and M1-RFP fusion proteins migrated differently when compared with 
unfused GFP and RFP. The HA-GFP band migrates faster than the free GFP band, an effect 
which could be due to some effect of tertiary structure of the HA-GFP or its surface charge. As 
this is a native PAGE gel, the migration distance is not indicative of relative protein size, which 
hinders the use of conventional protein ladders. The fusion protein lanes also showed additional 
bands resulting from protein not being able to migrate as far into the gel. Furthermore, these 
additional bands showed both green and red fluorescence, which could further point to a tight 
association between the two molecules where proteins stay associated even after cell lysis and 
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membrane solubilization. Similar banding patterns were also seen from cell culture supernatant 
samples (Figure 5-3, lane 4).The relative abundance of protein in each of the three bands in Lane 
3 of the native PAGE gel is not indicative of the abundance of associated vs unassociated HA 
and M1 inside the cell, as there was a significant amount of protein that could not be dissociated 
from the membrane even after treatment with DDM, determined by the intense color associated 
with the membrane pellet after detergent treatment. Most of this un-dissociated protein is 
suspected to be membrane bound HA and associated M1. 
5.5.3 PAGE gel Visualization of intracellular and supernatant fluorescent proteins 
 
5-3: Native PAGE gel showing green and red fluorescence from cell lysate of cells producing GFP (Lane 1), RFP (Lane 2), 
HA-GFP and M1-RFP (Lane 3); and 10× ultrafiltration concentrated supernatant from cultures producing fused HA-
GFP and M1-RFP (Lane 4). 
Further evidence of a tight association of M1-RFP and HA-GFP to the cell membrane came from 
cell lysis studies using either: a solution containing NP-40; or a solution containing Triton X-100 
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and DDM. Using NP-40, which is a relatively mild detergent, cells were lysed and the lysate was 
recovered through centrifugation. The majority of the fluorescence remained in the pellet 
fraction, indicating NP-40 was not able to release the fluorescent proteins effectively. Using the 
solution containing Triton X-100 and DDM, which are significantly more effective for releasing 
membrane bound proteins, a significant increase in fluorescence in the supernatant resulted 
following centrifugation. This is in marked contrast to when unfused GFP and RFP are expressed 
in cells, where the fluorescent proteins are easily solubilized by cell lysis with the mild NP-40 
detergent, and the membrane pellet is completely decolorized. 
Given that fluorescent proteins were also observed in the cell culture supernatant, it is 
plausible that some or all of this supernatant protein was from influenza VLPs containing 
fluorescent proteins which had been released into the supernatant. To examine the presence of 
VLPs in culture supernatant, further purification and concentration of the supernatant through an 
iodixanol gradient ultracentrifugation was performed. 
5.5.4 Extracellular Fusion Proteins and VLP formation 
The presence of Influenza VLPs in infected cell supernatant was confirmed by TEM (Figure 5-
4). These particles were identified by the presence of characteristic HA spike projections on their 
surface, as is present in the wild-type Influenza virus produced in cell culture (Figure 5-4A). 
Interestingly, the presence of a large GFP on the exterior of the VLP, as well as the RFP inside 
the VLP does not seem to affect particle morphology significantly. 
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5-4: Electron micrograph of wild type H1N1 PR/8/34 Influenza virus (A), and Sf9 produced VLPs (B, C, D and E). 
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5.5.5 Flow Cytometry 
 
5-5: Flow cytometry scatterplot of ultracentrifuged supernatants produced from Sf9 cells. Panel A: Schematic of the 
processing steps used to obtain ultracentrifuge purified samples. Panels B and C: Forward scatter vs Sidescatter 
scatterplots between Influenza VLP producing constructs and non VLP producing constructs. B) Cultures infected with 
baculovirus producing unfused GFP and RFP.C) Culture infected with HA-GFP and M1-RFP producing baculovirus. 
Panels D and E: Scatterplot of green vs red fluorescence of events from the ungated region in Panels B and C, 
respectively. 
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Due to the fluorescent nature of the VLP component proteins, it was thought that these VLPs 
could be detected through the use of flow cytometry. Although flow cytometry is not designed to 
analyze viruses, it has been found to be useful in characterizing fluorescent and fluorescently 
labeled phage and viruses (Marie et al., 1999; Shen et al., 2002; Sokolenko et al., 2012). Given 
that we routinely quantify baculovirus by flow cytometry (Shen et al., 2002), we first ran 
samples of infected cell culture supernatant through an iodixanol density gradient 
ultracentrifugation step to isolate different fractions corresponding to different densities of liquid, 
with the rationale being that influenza VLPs would be present at the fraction density which 
corresponds to VLP density.  These fractions were then run through a flow cytometer to examine 
if both green and red fluorescing particles could be detected and quantified. Based on forward 
and side-scatter, two distinct populations were observed for cultures producing GFP and RFP 
(Figure 5-5) and cultures producing HA-GFP and M1-RFP (Figure 5-5C). When gating out the 
particles observed in Figure 5-5B, and capturing only the events outside that gated area, there 
was a significant number of particles that were observed having high green and red fluorescence 
from cultures producing HA-GFP and M1-RFP (Figure 5-5E). Furthermore, although a few 
events from the cultures producing GFP and RFP (Figure 5-5B) fell outside of the gated area, 
these events did not have the same fluorescence profile (Figure 5-5D) as those from cultures 
producing HA-GFP and M1-RFP (Figure 5-5E).  
The presence of fluorescent polypeptides attached to the Influenza proteins adds an 
increased layer of complexity in the assembly of the fusion proteins, and their incorporation into 
VLPs. In particular, the RFP used in this work (DsRed2) is an obligate tetramer (Bevis and 
Glick, 2002) that fluoresces in the red spectrum when assembled, though the dimeric form may 
also be fluorescent (Baird et al., 2000; Sacchetti et al., 2002). The intense DsRed2 signal seen in 
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our experiments is an indication of complete and extensive maturation of the (DsRed2) protein 
within the system. The ability to detect red fluorescent particles by flow cytometry indicates that 
the tetramers remain assembled even within the virus-like particle. The free association of 
tetramers within the confined space of a virus-like particle may be facilitated by the flexible 
linker region separating the M1 from the RFP within the fusion protein. It is even possible that 
the collection of M1-RFP and its incorporation into VLPs is facilitated by the oligomerization of 
DsRed2. 
Taken together, the detection of dual fluorescent events in iodixanol gradient 
ultracentrifugation fractions were indicators of VLP formation. The use of flow cytometry 
further  allowed the quantification of events by comparing the particle counts in samples to a 
solution of  calibration beads with known concentrations. Briefly, calibration bead solutions 
were run through the cytometer, and the time required to capture 10,000 events was noted. This 
was then compared to the time required to count 10,000 events from the ultracentrifugation 
fractions, and based on the concentration of the bead standard, the concentration of particles in 
the ultracentrifugation fractions could be determined. Therefore, this method could be developed 
further and used to monitor Influenza VLP production, and also accurately determine losses from 
downstream purification steps. 
5.5.6 Hemagglutination Assay 
Hemagglutination assays were conducted on ultracentrifuge purified culture supernatant to 
examine if the different ultracentrifugation fractions could cause hemagglutination, a test which 
has traditionally been used for the detection of influenza virus or VLPs in samples. The 
83 
 
hemagglutination activity followed the particle counts obtained from the flow cytometer of the 
various ultracentrifugation fractions (Figure 5-6). 
 
5-6: Hemagglutination activity and particle counts of ultracentrifuge purified fractions of Sf9 culture supernatant. 
Reported particle counts have been modified to account for the concentration of particles from ultracentrifugation. 
Hemagglutination counts were obtained from 5× concentrated samples. 
Hemagglutination activity was concentrated in the least dense ultracentrifugation 
fractions and was completely absent in the three densest fractions. The maximum flow cytometry 
counts of red and green fluorescent particles occurred in the second least dense fraction, and 
dropped down to negligible levels in the last three fractions. The discrepancy between the 
hemagglutination results and the flow cytometry counts, especially in the lightest fraction, could 
be due to a secondary population of particles that are either HA-only-containing VLPs which 
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would have been gated out during the flow cytometry analysis, or HA present on the surface of 
baculoviruses (Prabakaran et al., 2011; Yang et al., 2007). Even though the peak 
hemagglutination activity seen in Figure 5-6 was 160 HA units/mL (5× concentrated samples), 
an assay conducted on samples concentrated by ultrafiltration showed activity levels of ~320HA 
units/ml in a 10× concentrated supernatant samples, indicating that some hemagglutination 
activity was lost during the ultracentrifugation purification process. Hemagglutination activities 
obtained from supernatants were comparable to previous values (335 HA units/ml in iodixanol 
purified samples, and 32.3 HA units/ml in sucrose cushion purified samples, both expressed as 
HA units in non-concentrated samples) obtained from VLP production in Sf9 cells
 
(Thompson et 
al., 2015). However, the VLP counts of ~4×10
6
 VLPs/mL in non-concentrated supernatant 
obtained from flow cytometry in this work is significantly lower than titers of ~10
9
 VLP/mL 
reported by Thompson et al. (Thompson et al., 2015). This could be due to several factors; 
however, one of the reasons may be because flow cytometry only captures red and green 
fluorescent VLPs, while electron microscopy-based methods may be capturing VLP particles 
that would not show up as dual fluorescent. 
 
5.6 Conclusions 
In our work, we have produced modified Influenza virus-like particles using only two Influenza 
proteins: the hemagglutinin (HA) protein embedded in the outer VLP membrane, and the matrix 
(M1) protein, which is enclosed by the membrane. These proteins were modified with 
fluorescent proteins to enable easy tracking of the resulting VLPs during their production: from 
individual protein synthesis within the cell, to tracking VLPs in supernatant. It is hoped that this 
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will provide a useful tool to simplify the process of examining Influenza VLP production in 
insect cells, as well as in other cell types. 
Preliminary analysis of the VLP production process from these experiments indicates that 
only a fraction of the produced protein is excreted to the supernatant in the form of VLPs. 
Therefore, much work needs to be done to improve the assembly of protein into functional VLP 
product. This could involve placing both genes under the control of powerful early promoters to 
drive rapid protein export during the early stages of infection when the cell protein export 
mechanism is less compromised.  
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Chapter 6 : Controlling Expression of Influenza Proteins in Sf9 and High 
Five Cells Using Alternative Baculovirus Promoters to Manipulate VLP 
Composition 
 
 
 
 
 
This manuscript is to be submitted shortly to a scientific journal. 
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6.1 Abstract 
The increasing use of the Baculovirus Expression Vector System (BEVS) for protein production 
has given great incentive to improve its utility.  In particular, the development of tools to provide 
greater control over the intracellular protein production process could be of use in producing 
complex biologics such as influenza VLPs. In this work we report the use of various promoter 
combinations to control expression of fluorescent influenza proteins in a baculovirus-insect cell 
coexpression system. The green fluorescent hemagglutinin (HA-GFP) and red fluorescent matrix 
1 (M1-RFP) were produced at different levels in Sf9 and High Five
TM
 cell lines using 
baculovirus vectors containing the two genes under the control of three promoter combinations. 
The level of expression of these proteins was shown to vary widely between constructs, as well 
as between cell lines. In addition, the level of expression of the HA-GFP and M1-RFP was 
shown to affect the composition of VLP particles produced in culture supernatant.  
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6.2 Introduction 
The baculovirus insect cell system has been used extensively to produce a wide variety of protein 
products, especially complex multiprotein products such as virus-like particles (Sokolenko et al, 
2012). However, the systematic study of protein production within the insect cell system is a 
more recent field of interest, and to date there have only been a few studies examining the effect 
of using alternative promoters to control the level or timing of expression of individual proteins 
and improve the yield of the final multiprotein product. In insect cells, alternative protein 
promoters have been used to increase yields of influenza VLPs (Quan et al., 2007), simian 
immunodeficiency VLPs (Kang and Compans, 2003; Yamshchikov et al., 1995), human 
immunodeficiency VLPs (Sailaja et al., 2007), and ebola VLPs (Sun et al., 2009; Ye et al., 
2006). Most of these studies use the hybrid late/very late Pcap/polh to drive the expression of 
one or more VLP components, which allows for earlier expression of component proteins. 
Yamschikov et al (1995) directly compared the use of the Pcap/polh promoter to the very late 
polh promoter for improving the production of SIV envelope protein and discovered that the 
hybrid promoter increased the expression of SIV envelope protein and consequently SIV VLPs, 
when compared to the use of the purely “very late” polh promoter. 
Recently, a systematic examination of the production of two fluorescent proteins 
following infection of Sf9 cells with a polycistronic virus was conducted to better assess the 
ability to control expression by manipulating baculovirus promoter sequences (George et al., 
2015). The study revealed that protein expression levels and timing could be reliably controlled 
using different promoters, and that it was possible to set up expression schemes where a defined 
ratio of foreign proteins could be obtained. It was also found that multiple protein production 
within the same cell resulted in non-trivial competition effects, where the expression level of one 
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protein influenced the expression of other proteins. However, George et al. (2015) examined a 
simple co-expression system involving non-interacting fluorescent proteins, which, when 
produced in insect cells, did not localize to any particular region of the cell. For the concepts 
explored in that work to be of general use, the demonstration of promoter control and the 
interplay between protein expression levels at different points in time requires a more complex 
system. To this end, this work studies the production of influenza VLPs from the co-expression 
of influenza hemagglutinin (HA) and Matrix 1 (M1) fluorescent fusions in insect cells via 
infection with polycistronic baculovirus vectors. 
Several studies have successfully produced influenza VLPs using two, three or four of the 
influenza structural proteins (hemagglutinin (HA), neuraminidase (NA), and matrix 1 and 2 (M1 
and M2)), and have evaluated their efficacy as vaccines in animal models (Bright et al., 2007; 
Galarza et al., 2005; Kang et al., 2009; Pushko et al., 2005; Quan et al., 2007; Wen et al., 2009). 
Novavax have influenza VLP candidate vaccines that are in various stages of clinical trials. 
Despite the number of studies and advances in the area, there have been comparatively few 
studies on process considerations while producing the virus-like particles in insect cell culture 
(Krammer et al., 2010; Thompson et al., 2015). 
The production of influenza vaccines in insect cell culture has become an accepted 
alternative to production in embryonated chicken eggs, with Protein Sciences Corporation 
producing Flublok, which is composed of recombinant hemagglutinin antigens. Flublok is the 
only egg-free seasonal influenza vaccine available on the market. The insect cell system has also 
been used to produce several other vaccines including Cervarix® (GSK), with several other 
candidates undergoing clinical trials (Cox, 2012), and this provides significant impetus to 
continue research to improve the system. 
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The work presented here is a natural extension of the study on promoter control (George 
et al., 2015) and production of fluorescent influenza-like particles (Chapter 5). Using the genes 
for HA-GFP and M1-RFP (Chapter 5), two new polycistronic baculovirus vectors were created 
to have the HA-GFP downstream of either a basic or vcath promoter, and the M1-RFP 
downstream of the polh promoter. Together with the original construct (p10 HA-GFP, polhM1-
RFP; (Chapter 5)), these three viruses, herein referred to as the basic, vcath, and p10 viruses 
respectively, were used to infect two different cell lines – Sf9 and High FiveTM. We show that 
similar to our previous study, protein production can be modulated in insect cells in a 
reproducible and predictable manner based on the choice of promoter sequence upstream of the 
gene of interest (despite different sizes and localizations); and competition effects observed with 
the simple fluorescent protein system are also apparent in this fluorescent influenza protein 
system (high levels of expression of one protein will influence the expression of a second protein 
being produced). We also show that the levels of individual protein production affect the 
composition of the final influenza VLP particles that buds out of the cell. Infecting the two cell 
lines with the same baculoviruses revealed that in general, while High Five
TM
 cell line produced 
far more protein than the Sf9 cell line, Sf9 cells produced more VLPs. 
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6.3 Materials and Methods 
6.3.1 Baculovirus Vector Construction 
Three baculovirus vectors co-expressing influenza hemagglutinin bound to enhanced green 
fluorescent protein (HA-GFP) and influenza M1 attached to DsRed2 red fluorescent protein 
(M1-RFP) were used in this work. The construction of a plasmid containing the HA-GFP gene 
under control of a baculovirus p10 promoter and the M1-RFP gene under the control of a 
baculovirus polh promoter has been described earlier (Chapter 5). Two new constructs, prepared 
for this work, replaced the p10 promoter with Autographa californica multiple 
nucleopolyhedrovirus (AcMNPV) basic and vcath promoters (named basic and vcath constructs) 
using overlap extension PCR (Bryksin and Matsumura, 2010) to produce a total of three 
constructs (Figure 6-1). The primers used to extract the promoters and to replace the p10 
promoter are found in Table 6-1. Baculovirus vectors were generated from these constructed 
plasmid vectors using the BD BaculoGold™ Transfection Kit (BD Pharmingen, San Diego, CA, 
USA). 
 
6-1: Schematic of expression cassette in pAcUW51 coding for the HA-GFP and M1-RFP fusion proteins 
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6-1: Primers for replacing p10 promoter (the underlined regions correspond to areas around the p10 promoter on the 
pAcUW51 vector where the new promoters integrated) 
Promoter  Direction Sequence 
Basic 
 
Forward 5‟-CAACAAGGGGGACTATGAAATTATGCATTTGAGGATGCCGTTTTGCGACGATGCAG- 3‟ 
Reverse 
5‟– CTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATTCGTTTAAATTGTGTAATTTA 
TGTAGCTGTAATT – 3‟ 
Vcath 
 
Forward 
5‟ –GGACTATGAAATTATGCATTTGAGGATGAATTTATCTTAATTTTAAGTTGAATTCCAGCT 
– 3‟ 
Reverse 5‟ – GGTAGCGACCGGCGCTCAGCTGGAATTCAACTTAAAATTAAGATAAATTCATCCTC –3‟ 
6.3.2 Cell Culture and Virus Production 
Spodoptera frugiperda clonal isolate 9 (Sf9) cells (GIBCO, Carlsbad, CA) were maintained in 
capped glass Erlenmeyer flasks in Sf900III media (GIBCO) at a temperature of 27⁰C on an 
orbital shaker rotating at 130 rpm. High Five
TM
 cells (Thermo Fisher Scientific, Burlington, ON, 
Canada) were maintained in a similar fashion in Express Five
®
 Serum Free media (Thermo 
Fisher Scientific, Burlington, ON, Canada) supplemented with 18 mM of glutamine. 
Maintenance cell cultures were kept at a density between 0.5 and 4×10
6
 cells/mL. 
Baculovirus stocks were generated as described previously (Chapter 5). Briefly, 
baculoviruses were amplified in Sf9 cells by infecting cultures with a low MOI (estimated to be 
0.1) and recovering the supernatant when culture viability was between 70 – 80%. All virus used 
in this work was P2 virus. Titers were quantified by the end point dilution assay (King and 
Possee, 1992; Reed and Muench, 1938).  All VLP production experiments were conducted by 
infecting cell cultures at 1×10
6
 cells/mL with various viruses at an MOI of 5.  
6.3.3 Confocal Microscopy 
Confocal microscopy samples were prepared by seeding 1×10
6
 cells onto sterile glass cover slips 
(22 × 22 mm – No 1.5) placed inside a 35 mm tissue culture dish. The cells were allowed to 
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attach overnight and were then infected with virus for 48 hours. The coverslip was then rinsed 5 
times with 1×PBS (pH 7.4) and then fixed with 4% formaldehyde in PBS (pH 7.4)  for 15 
minutes at room temperature, following which, the sample was rinsed again 5 times with PBS. 
The coverslip was then placed upside down on a drop of ProLong® Gold Antifade Mountant 
(Life Technologies Inc., Burlington, ON, Canada) on a 1 mm thick microscope slide, and the 
mountant was allowed to cure for 24 hours in the dark. Confocal microscopy was conducted on 
the cured sample using a Zeiss LSM 510 confocal microscope (Zeiss Canada, Toronto, ON, 
Canada).  
6.3.4 Ultracentrifugation 
The purification of influenza particles from culture supernatant was conducted by 
ultracentrifugation using an iodixanol gradient (Hutchinson and Fodor, 2014). Briefly, VLPs and 
baculoviruses were pelleted from 12 mL supernatant samples by ultracentrifugation at 26,000 
rpm (115,915 g) for 90 minutes using a Beckman Coulter SW 41Ti rotor (Beckman Coulter, 
Mississauga, ON, Canada).  The pellets were then resuspended in 500 uL of NTC buffer (1 M 
NaCl, 0.2 M Tris-HCl pH 7.4, 50 mM CaCl2).  An iodixanol density gradient was constructed 
with 10, 15, 20, 25, 30, 35 and 40% solutions of iodixanol OptiPrep™ Density Gradient Medium 
(Sigma Aldrich, St. Louis, MO, USA), and the resuspended virus pellet was layered on top of the 
10% solution. These tubes were then centrifuged at 35,000 rpm (209,000 g) for 150 minutes in 
the same SW 41Ti rotor after which the different iodixanol gradient fractions were collected and 
analyzed using flow cytometry and transmission electron microscopy for the presence of virus 
like particles. 
94 
 
6.3.5 Transmission Electron Microscopy (TEM) 
Electron microscopy was conducted on concentrated supernatant samples to detect the presence 
of influenza VLPs. Sample grids were prepared by placing a 200 mesh carbon formvar coated 
copper grid (Ted Pella Inc, Redding, CA, USA) onto a sample droplet for 15 minutes. The grid 
was then placed in 2% formaldehyde dissolved in PBS to fix the sample, after which it was 
stained in a drop of 3% aqueous phosphotungstic acid (PTA) stain pH balanced to pH 7.3 for 45 
seconds. After this, excess stain was wicked off and samples allowed to dry overnight. The grids 
were imaged using a Philips CM10 transmission electron microscope. 
6.3.6 Hemagglutination Assay 
The presence of influenza VLPs in samples was determined by the hemagglutination assay, using 
a well-established protocol (Eisfeld et al., 2014). Briefly, serial dilutions of concentrated virus 
sample were added to chicken blood cells in round bottom 96 well plates and the suspension 
allowed to sit undisturbed at room temperature for an hour. The highest dilution of samples that 
showed complete hemagglutination activity was noted and the reciprocal of the dilution factor 
was regarded as the number of Hemagglutination Units (HAU)/50 ul. This was then multiplied 
by 20 to derive the HAU/ 1ml of sample. 
6.3.7 Flow Cytometry Analysis of cells and purified culture supernatant 
Cell fluorescence was obtained by fixing cells in formaldehyde solution and then running them 
through a BD FACS Calibur (BDBiosciences, San Jose, CA) flow cytometer equipped with a 
488 nm laser. Green fluorescence was detected by 530 mm filter with a bandpass of 30nm, and 
red fluorescence was detected by a 670 nm longpass filter. Compensation was used to remove 
the GFP signal from the red fluorescence channel, and determined using cells infected with 
monocistronic vectors encoding for GFP. 
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Fluorescent influenza virus-like particles were detected by flow cytometry as detailed 
previously (Chapter 5), and using the same filters used for detecting cell fluorescence. Briefly, 
the regions on a scatterplot of forward scatter (particle size) and side scatter (particle complexity) 
corresponding to particles was determined using a control culture infected with a construct that 
did not produce VLPs. This region was then excluded out of scatterplots of VLP containing 
supernatant concentrates, and the green and red fluorescence of the resulting populations. 
Particle counts were obtained by running ultracentrifugation purified supernatant samples and 
comparing these to known particle counts from a calibrated control (Flow-Set
TM
fluorospheres, 
Beckman Coulter, Mervue, Galway, Ireland). 
 
6.4 Results 
6.4.1 Tracking Fluorescent Proteins in Cells 
Flow cytometry was used to monitor fluorescent viral protein production in infected Sf9 and 
High Five
TM
 cells (Figure 6-2). The two cell types were infected with the basic, vcath and 
p10bicistronic baculovirus vectors. 
In general, High Five
TM
 cells expressed higher amounts of HA-GFP and M1-RFP, except 
in the case of the basic construct, where the Sf9 and High Five
TM
 cells produced the same 
amount of HA-GFP. The results also show that higher production of one protein generally 
corresponded to a lower level of production of the other protein, which is consistent with 
previous findings in a simple two reporter protein system (George et al., 2015). This can be seen 
especially well in the vcath and p10 constructs where the vcath construct produced significantly 
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lower levels of HA-GFP, but much higher levels of M1-RFP than the p10 construct, even though 
the M1-RFP gene was under the control of the polh promoter in both constructs (Figure 6-2). 
 
6-2: Protein expression from insect cell and culture viability over time: A) Viability of cells over the course of infection. B) 
Green (eGFP), and red (DsRed2) fluorescence values of Sf9 and High FiveTM cells infected with the basic, vcath and p10 
baculovirus constructs. Both Sf9 and High FiveTM cells were infected at the: same density (1×106 cells/ml) and with the 
same numbers of virus. Error bars are small and represent the standard deviation of duplicate flasks. 
Green and red fluorescence observed by flow cytometry was used to generate normalized 
expression ratios of green and red fluorescence in Sf9 and High Five
TM
 cells over time after 
infection with the different baculovirus constructs (Figure 6-3). Data normalization was 
conducted by dividing fluorescence at each time point by the maximum green or red 
fluorescence in that dataset, following which the ratio of the normalized data was plotted. While 
not indicative of true protein expression ratios, the figure illustrates that while the basic and p10 
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constructs produce large amounts of HA-GFP earlier in the infection cycle compared to M1-
RFP, in the vcath construct HA-GFP is expressed at much lower levels than M1-RFP at all times 
post infection, and in both cell types. In addition, while similar expression ratios are seen from 
both High Five
TM
 and Sf9 cells from the p10 and vcath constructs, the basic construct drives 
higher relative expression of HA-GFP as compared to M1-RFP in the Sf9 cells, as compared to 
the High Five
TM
 cells. 
 
6-3: Ratio of green and red fluorescence post-infection for different promoter combinations in Sf9 and High FiveTM cells 
The observations made by flow cytometry were verified by confocal microscopy (Figure 
6-4), where the images show clearly the relative differences between the different constructs. 
The localization of HA-GFP to the cell membrane can be seen as a result of infection by all 
constructs, particularly in the Sf9 cells. M1-RFP protein, however, is present at both the cell 
membrane and the nucleus. Overlay images of green and red fluorescence in Sf9 cells indicate a 
high degree of co-localization of HA-GFP and M1-RFP particularly at the cell membrane. A 
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further observation is the presence of very clear localization of proteins at polar opposite ends in 
some cells (Figure 6-4, white arrows). This type of polarization could be seen in Sf9 cells 
infected by all three different vectors. Protein localization is less obvious in High Five
TM
 cells, 
which could be due to the vastly greater amount of protein being produced in these cells. The 
large amount of protein being produced can be seen using flow cytometry (Figure 6-2). This was 
also observed by simple visual inspection of the shake flasks. Flasks containing infected High 
Five
TM
 cells showed far more intense red coloration than flasks with infected Sf9 cells. The 
relative lack of localization of M1-RFP was also seen in some of the Sf9 cells infected with the 
vcath construct, and may also be due to the presence of large amounts of M1-RFP protein.  
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6-4: Confocal microscopy images of Sf9 and High FiveTM cells infected with baculoviruses expressing HA-GFP and M1-
RFP proteins at 48 hours post infection 
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6.4.2 Extracellular analysis: the ones that made it out 
Transmission electron microscopy (TEM) was used to image concentrated supernatant samples 
from infected insect cells infected by each of the constructs, and showed the presence of VLPs in 
all cases (Figure 6-5).  
 
6-5: Electron micrograph pictures of influenza VLPs present in supernatant of Sf9 and High FiveTM cells infected with the 
basic, vcath and p10 constructs. The bottom panel shows aggregates present in the concentrated supernatant of p10 
infected High FiveTM cells 
Using flow cytometry, fractions from the iodixanol gradient were examined for particles 
exhibiting red and green fluorescence (Figure 6-6). The relative red and green fluorescence of 
the sample differed based on the construct, and generally correlated to the amount of protein 
produced in the cells when infected with each construct. For instance, iodixanol fractions 
recovered from cultures infected with the vcath constructs contained particles with low levels of 
green fluorescence, but high levels of red fluorescence which corresponds to what is seen in the 
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cells in culture. The p10 construct, which produces high levels of HA-GFP, but lower levels of 
M1-RFP compared to the vcath construct also showed a corresponding change in the relative 
fluorescence of the particles in purified culture supernatant. The same relationship was seen in 
the supernatant of the basic construct. VLPs produced from the High Five
TM
 cells had higher red 
fluorescence than those from Sf9 cells. VLPs produced from cultures infected with the p10 and 
basic vectors showed higher levels of green fluorescence when produced in Sf9 cells compared 
to High Five
TM
 cells. 
 
6-6: Flow cytometry scatterplots of ultracentrifuge purified supernatant samples produced from Sf9 and High FiveTM 
cells infected with the basic, p10 and vcath constructs. 
The ability to detect particles using flow cytometry also allowed for quantification of 
particle titers in ultracentrifugation purified sample fractions using a flow cytometry bead 
standard of known concentrations (Figure 6-7). The hemagglutination assay was also used as a 
102 
 
titration method to determine concentrations of particles showing hemagglutination activity. 
Comparison of the two methods showed that most of the particles and hemagglutination activity 
was concentrated in the three lightest ultracentrifugation samples.  
 
6-7: Hemagglutination activity and flow cytometry particle counts of ultracentrifuge-purified fractions of Sf9 and High 
FiveTM insect cell culture supernatant infected with the basic, vcath and p10 constructs 
The highest levels of hemagglutinin activity were present in the supernatants of p10 and 
basic infected Sf9 cells, with the p10 infected High Five
TM
 cells showing relatively lower 
activity. However, all three supernatants showed similar titers of fluorescent particles when 
examined by flow cytometry. The basic construct does not show hemagglutination activity in 
High Five
TM
 supernatant. Only very low numbers of fluorescent particles were produced by the 
vcath construct in Sf9 cells. Low VLP titers were also seen with High Five
TM
 cells infected with 
basic and vcath constructs. Based on our flow cytometry results, we estimate the volumetric 
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productivity of the p10 baculovirus infected Sf9 cultures to be nearly 8 × 10
5
 VLP particles per 
mL of culture volume, while the High Five
TM
 cultures only produced only about 2.3 × 10
5
 
particles/mL when infected with the same baculovirus.  The basic baculovirus infected Sf9 cells 
produced particles at a titer of nearly 4.3 × 10
5
 VLPs per mL of culture volume. 
 
6.5 Discussion 
The control of production of multiple proteins within the baculovirus-insect cell system has been 
shown to be a non-trivial process, where the levels of expression of one gene can affect the 
expression of other genes in a simple two fluorescent protein production system (George et al, 
2015). This work examines this effect in a more complex and industrially relevant system 
producing two fluorescently tagged influenza proteins in the insect cell system which then 
assembles into VLPs.  
Examination of influenza protein production in cells by flow cytometry revealed that this 
effect can indeed be seen in this work as well, where the high HA-GFP producing p10 construct 
expresses M1-RFP to a much lower level than the low HA-GFP producing vcath construct. The 
basic construct, which is supposed to drive high level expression at the late phase of infection, 
only seems to drive a moderate level of HA-GFP expression, but also has a low level of M1-RFP 
expression. In a previous work (George et al., 2015), which used almost identical constructs to 
drive expression of unfused GFP and RFP genes, the basic promoter did drive high level 
expression of the GFP gene, and produced low levels of RFP. It is a possibility that in our 
current constructs, the early expressed HA-GFP protein product is being rapidly recruited to the 
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membrane and then sent out of the cell, thereby reducing cell associated green fluorescence in 
the basic construct.  
6.5.1 HA-GFP and M1-RFP production in Sf9 and High  Five
TM
 cells 
The data from Figure 6-2 was used to generate expression ratios of the two fluorescent proteins 
produced from the different constructs in Sf9 and High Five
TM
 cells over time. This Figure 6-3 is 
analogous to the figure in a previous work (George et al, 2015) showing the ratios of unfused 
GFP and RFP produced in Sf9 cells over time. This shows that the protein expression ratios 
obtained in the simple GFP and RFP system are also applicable in the more complicated HA-
GFP and M1-RFP coexpression system.  This in turn gives evidence that the expression ratios 
seen in these two systems are applicable generally while considering protein coexpression in 
BEVS 
Examination of green and red fluorescence over time in Figures 6-2 showed that in 
general all baculovirus constructs produce higher levels of fluorescent proteins in High Five
TM
 
cells as compared to Sf9 cells. The one notable exception to this rule was the basic construct, 
where HA-GFP was produced at the same levels in both High Five
TM
 and Sf9 cells. This can be 
clearly seen in Figure 6-3, where the expression ratios of HA-GFP and M1-RFP are the same for 
Sf9 and High Five
TM
 cells, except in the case of expression driven by the basic construct.  
The analysis of influenza protein production in insect cells using this method is made 
more difficult by the fact that the proteins being produced are continually being trafficked to the 
viral membrane and exported out of the cell. The rate of export of proteins may vary based on 
the phase of baculovirus infection; therefore, interpretation of the flow cytometry data has to take 
this into account. For instance, the level of HA-GFP production from the basic construct in High 
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Five
TM
 cells could be influenced by the export of the protein from the cell. Alternatively, the 
level of expression seen from the basic promoter could be accurate and representative, and could 
be one reason for the well-known poor amplification of AcMNPV virus in High Five
TM
 cells 
(Krammer et al, 2010). However, as seen in Figure 6-2, levels of protein expression driven by the 
late vcath and very late p10 promoters are much higher in High Five
TM
 cells, as compared to Sf9 
cells. Taken together, these results indicate that late and very late phase protein production 
driven by baculovirus promoters such as vcath and p10 are very active in High Five
TM
 cells when 
compared to Sf9 cells, but the same may not be true of earlier promoters such as the baculovirus 
basic promoter. 
Confocal microscopy of infected insect cells showed that HA-GFP is generally localized 
to the cell membrane in all constructs, while M1-RFP localizes to either the cell membrane, or 
around the nucleus. However, in the vcath construct, the M1-RFP protein is spread out through 
the cell, which could be because of the much larger amount of M1-RFP protein produced by this 
construct.  Protein localization is not as obvious in High Five
TM
 cells, and could because of the 
large amount of influenza protein produced in these cells (Krammer et al., 2010). Baculovirus 
infection of insect cells can arrest the cell cycle in either the S or G2/M phase (Braunagel et al., 
1998; Ikeda and Kobayashi, 1999; Saito et al., 2002) and the localization of HA-GFP protein to 
polar ends of some Sf9 cells could be indicative of polarization of the cell membrane during one 
of these phases. 
6.5.2 Influenza VLPs are Exported into Culture Supernatant 
The works listed previously (Chapter 5) shows that influenza VLPs can bud out of insect cells 
and be exported to the supernatant. In our experiments, we detected influenza VLPs from all 
constructs by transmission electron microscopy (TEM). The formation of VLPs from Sf9 and 
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High Five
TM
 cells infected with the vcath vector is of note given that HA-GFP is expressed at 
very low levels and M1-RFP at very high levels. Therefore, it is not clear if the VLPs seen from 
infection with the vcath construct are the result of M1-RFP associating with HA-GFP, or by M1-
RFP budding out alone from the insect cells (Gómez-Puertas et al., 2000). 
6.5.3 Influenza VLP Composition and Titer is Influenced by Levels of Component Proteins 
in Cells  
A second aspect of this work was to attempt to control influenza VLP composition by varying 
levels of HA-GFP and M1-RFP produced in cells. Flow cytometry detection of influenza 
particles from the various constructs showed that the expression levels of protein within the cells 
is translated into differing VLP compositions of HA-GFP and M1-RFP. The vcath construct 
produced particles with very high red fluorescence, but low green fluorescence, and this, coupled 
with the lack of any detectable hemagglutination activity means that it is plausible that these 
particles only consist of M1 protein, which has been shown to be capable of mediating budding 
in the baculovirus insect cell system (Gómez-Puertas et al., 2000). However, the numbers of 
particles produced as a result of infection with the vcath construct, and detected by flow 
cytometry, was far less than in the case of the basic and p10 construct, which may be because of 
reduced budding efficiency in the absence or scarcity of HA protein.  
The basic and the p10 constructs infecting Sf9 cells produced similar numbers of VLP 
particles as seen by flow cytometry; and, hemagglutination assays conducted on 
ultracentrifugation fractions of baculovirus supernatant revealed that the purified basic and p10 
supernatants had almost identical hemagglutination activity. This, despite that p10 construct 
infected cells accumulated more protein intracellularly, and had a higher level of VLP 
fluorescence (per VLP) as detected by flow cytometry.  Taken together these facts indicate that 
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the lower level of HA-GFP expression in the basic construct does not seem to reduce particle 
formation to a great extent, and the early expression of the HA-GFP under the control of the 
basic promoter may speculatively allow for efficient HA-GFP protein export and VLP 
production at an earlier stage, even with lowered HA-GFP expression. It would be worthwhile to 
see if VLP titers could be improved by increasing the levels of expression of HA-GFP during the 
early stage of the infection process.  
6.5.4 Sf9 Cells are More Efficient VLP Producers than High Five Cells 
The p10 construct produced comparable levels of fluorescent particles and hemagglutination in 
High Five
TM
 and Sf9 supernatant, even though there was far more HA-GFP and  M1-RFP 
produced in High Five
TM
 cells. This result is supported by evidence from other works (Krammer 
et al., 2010) where it was found that High Five cells produce the same number of VLP particles 
as Sf9 cells in spite of producing far more protein intracellularly. Another result is that the basic 
construct infecting High Five
TM
 cells resulted in very few particles in the supernatant, even 
though both the Sf9 and High Five
TM
 cells produce similar quantities of both HA-GFP and M1-
RFP, which indicates that High Five
TM
 cells are not as good as Sf9 cells for the production of 
VLPs. 
Much of the recombinant protein produced in the cells, especially at the very late stage of 
the infection process, is not efficiently incorporated into VLPs, and the titers of VLPs are 
extremely low, only on the order of 10
6
 particles/ml. This is especially apparent in the High 
Five
TM
 cells, which in general produce far more protein from the late and very late p10 and vcath 
promoters, but do not produce more VLPs than Sf9 cells. The efficient export of HA-GFP from 
Sf9 cells infected with the basic construct provides some insight into improving this system, as 
even low levels of HA-GFP expression by the basic construct produce similar levels of VLPs as 
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when HA-GFP is produced at much higher levels at the very late phase by the p10 construct. 
Expressing all VLP component proteins at high levels during the early or late stage of the 
infection process may improve VLP production dramatically. This would also mimic the 
baculovirus budding process, where most of the major structural components of the budded 
baculovirus are produced at the late stage of infection, followed by budding in the late and very-
late phases (Matindoost et al., 2015).  
 
6.5 Conclusions 
While the manipulation of protein expression ratios to influence particle compositions has been 
explored in previous studies (Hu and Bentley, 2001), this study is the first to systematically vary 
expression levels of influenza HA and M1 proteins to examine their incorporation into VLPs. In 
addition, the use of tagged component proteins allowed the rapid detection of protein ratios in 
VLPs through the use of a direct technique like flow cytometry which examines the fluorescence 
of each individual particle, as opposed to an indirect technique such as measuring the ratios of 
component proteins in purified virus preparations by Western blotting. It was found that the 
levels of modified influenza HA-GFP and M1-RFP proteins could be controlled in insect cells 
through the use of different promoter combinations, and that this affected the composition of the 
final VLP product.  
The rational design of expression profiles of different VLP component proteins in a cell, 
with controlling gene expression levels, would allow for sophisticated control of VLP production 
within the cell. It is hoped that the concepts explored in this work will be extended to the study 
of other VLP systems with the end goal of improving VLP production in cell culture systems.    
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Chapter 7 : Effect of expression of copper-zinc superoxide dismutase in 
baculovirus-infected insect cells 
7.1 Introduction 
The infection of insect cells by baculovirus causes oxidative stress within the cell (Wang et al., 
2001b), which may be due to the production of reactive oxygen species such as peroxides (O2
2-
) 
and superoxides (O2
-
) from a variety of mechanisms. These cause significant damage to the cell 
through DNA damage, lipid peroxidation, and protein oxidation (Farinati et al., 1999; Wang et 
al., 2001a).  These reactive oxygen species can be deactivated by several antioxidant enzymes 
within the cell. In insect cell lines, these include superoxide dismutases, which convert highly 
reactive superoxide species into peroxides, and enzymes such as catalase and ascorbate 
peroxidase (Wang et al., 2001a).   
There are two types of superoxide dismutase (SOD) enzymes in Sf9 and High Five
TM
 
insect cells: copper-zinc SOD (Cu,Zn-SOD) in the cytoplasm and manganese SOD (Mn-SOD) in 
the mitochondria. Mn-SOD contributes to a larger portion of the SOD activity in High Five
TM
 
compared to in Sf9 cells (Wang et al., 2001a). The activity of Mn-SOD is not significantly 
affected by baculovirus infection (Wang et al., 2001b); however, Cu,Zn-SOD activity decreases 
in both Sf9 and High Five
TM
 cells following infection (Wang et al., 2001b). Low level expression 
of human Mn-SOD expression results in a 20% increase in viability at 72 and 96 hours post 
infection in insect High Five
TM
 cells, but provides no protection in Sf9 cells (Wang et al., 2004).  
Although an increase in viability has been attributed to the production of human Mn-
SOD in insect cells, it is not clear whether or not the control truly allowed for an appropriate 
comparison or isolation of the manipulated variable. In the study by Wang et al. (2004), control 
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cells were infected with a baculovirus expressing very high levels of a control protein, while the 
cells with increased viability were subjected to a baculovirus vector carrying the SOD gene under 
a weak early promoter. 
The lack of protective effect in Sf9 cells is not easily understood, but has been speculated 
to be due to the large amount of peroxide that is generated by SOD, which cannot be disposed of 
by the relatively small amount of catalase and ascorbate peroxide in Sf9 cells (Wang et al., 
2001a). The difference in effects on Sf9 and High Five
TM
 cells could also be because most of the 
superoxide defense in Sf9 cells comes from Cu,Zn-SOD and that it is down regulated upon 
baculovirus infection.  
Given that expression of superoxide dismutase could enhance overall recombinant 
protein production, we decided to follow-up on the study of Wang et al. (2004) but with an eye 
to using our alternative promoter polycistronic baculovirus system. In this work, we produced 
two constructs that co-express Cu,Zn-SOD under the control of either a weak gp64 or strong p10 
promoter, and DsRed2 red fluorescent protein (RFP) under the control of a very strong polh 
promoter. 
 
7.2 Materials and Methods 
7.2.1 Baculovirus Vector Construction 
Two vectors both expressing red fluorescent DsRed2, and copper-zinc superoxide dismutase 
(Cu,Zn-SOD) were constructed based on plasmid constructs described in from Chapter 3. 
Briefly, a modified human Cu,Zn-SOD sequence was isolated from plasmids provided by Dr. 
Elizabeth Meiering of the Department of Chemistry, at the University of Waterloo, using the 
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forward and reverse primers 5‟ – 
CAGCTGAGCGCCGGTCGCTACCATTACCAGATGGCCACAAAGGCTGTTGCT – 3‟ and 
5‟-  
CCGAGTTTGTCAGAAAGCAGACCAAACAGCGGTTATTGGGCGATCCCAATTACACC
AC – 3‟ . Underlined portions of the primer sequences correspond to regions on the pAcUW51 
plasmid downstream of the p10 promoter. This DNA fragment was then cloned into baculovirus 
transfer vector p10-GFP-RFP and gp64-GFP-RFP (George et al., 2015), which in turn was based 
on plasmid pAcUW51 (BD Pharmingen, San Diego, CA) using overlap extension PCR (Bryksin 
and Matsumura, 2010). The resulting plasmid contained the SOD gene under control of either a 
baculovirus p10 or gp64 promoter and the RFP gene under the control of a baculovirus polh 
promoter. Baculoviruses were generated from these vectors using the BD BaculoGold
TM
 
Transfection Kit (BD Pharmingen). The original p10-GFP-RFP and gp64-GFP-RFP 
baculoviruses expressing GFP either under a p10 or gp64 promoter, and RFP from a very late 
polh promoter were used as controls in this experiment (George et al., 2015).  
7.2.2 Cells and virus amplification 
Spodoptera frugiperda clonal isolate 9 (Sf9) cells (GIBCO, Carlsbad, CA, USA) were 
maintained in capped glass Erlenmeyer flasks in SF900III media (GIBCO, Carlsbad, CA, USA) 
at a temperature of 27 °C on an orbital shaker rotating at 130 rpm. Maintenance cell cultures 
were kept at a density between 0.5 and 4 ×10
6
 cells/ml.  
Baculovirus amplification was conducted by seeding cultures at 0.5×10
6
 cells/ml, 
allowing them to grow to ~3x10
6
cells/ml to reach a mid-exponential phase, diluting to 1×10
6
 
cells/ml in fresh media and infecting with various viruses. The cultures were allowed to proceed 
until the viability dropped to 70–80%, after which the culture medium was harvested and 
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centrifuged at 1000 × g for 10 min in order to spin down cells and cell debris. The supernatant 
was removed and used as baculovirus stock for experiments 
7.2.3 SOD activity measurement 
Cu,Zn-SOD activity was measured in the cell lysates using a pyrogallol assay in which  Cu,Zn-
SOD inhibits the autoxidation of pyrogallol (1,2,3-Benzenetriol) by superoxide radicals in 
solution, which can be measured as an inhibition in the rate of increase of absorbance at 420 or 
325 nm (Marklund and Marklund, 1974).  Bovine liver catalase is added to the reaction mixture 
and has no effect on the autoxidation of pyrogallol, but increases the reaction efficiency by 
halving the amount of oxygen consumed in the reaction through the evolution of molecular 
oxygen from hydrogen peroxide generated by Cu,Zn-SOD (Marklund and Marklund, 1974). 
Cell lysates from samples taken 48, 72, or 96 hpi were added to a 96-well plate on ice.  
Unless otherwise noted, 2.5 µg of cell lysate was added to each reaction.  Assay buffer (50 mM 
Tris, 1 mM diethylenetriaminepentaacetic acid, pH 8.2) was heated to 25°C on a hot plate and 
stirred at maximum speed with a magnetic stir bar to promote aeration of the solution for 1 h 
prior to the experiment.  A fresh solution of pyrogallol (8 mM pyrogallol in 10 mM HCl) was 
prepared in MilliQ water, kept at 4°C, and protected from light.  A mixture of 20 mL assay 
buffer, 200 µL of bovine liver catalase (Sigma-Aldrich, Oakville, ON, Canada) diluted to 100 
units/mL in KH2PO4 buffer and stored at -80°C until use, and 500 µL of fresh pyrogallol solution 
(Sigma-Aldrich, Oakville, ON, Canada) was rapidly mixed and 200 µL of the mixture was 
immediately added to each well of the plate containing cell lysate. Eight absorbance readings 
were immediately measured at 31 second intervals over 3.5 minutes using a Synergy 2 (Bio-Tek, 
Winooski, VT, USA) spectrophotometer at 420 or 325 nm.  Data was collected using a Synergy4 
multi-mode reader (Bio-Tek, Winooski, VT, USA).  Linear regression was performed in Excel to 
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determine the rate of autoxidation of pyrogallol in the presence of the various cell lysates and 
compared to the reference, which contained no cell lysate.  Rates were expressed per unit of total 
cellular protein 
7.3 Results and Discussion 
 
7-1: SOD activity of Sf9 cells infected with various baculoviruses in SF900 III media supplemented with 1.0 mM CuSO4 
and 0.1 mM ZnSO4.The Y axis represents percent inhibition of pyrogallol autooxidation per µg of cell lysate.  Error bars 
represent one standard deviation from the mean of duplicate values 
A pyrogallol assay (Marklund and Marklund, 1974) was used for the detection of SOD activity 
in cells infected with the various types of baculovirus. As can be seen in Figure 7-1, cells 
infected with the non SOD producing virus showed no SOD activity, while cells infected with 
baculovirus producing SOD under the weak gp64 promoter only showed SOD activity when 
much larger cell lysate protein amounts were loaded into the SOD activity assay (data not 
shown). As expected, producing SOD under the control of the very strong p10 promoter resulted 
in easily detectable SOD activity within infected cells. These results show that the native levels 
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of SOD activity within Sf9 cells is quite low, and also confirms that the expressed Cu-Zn SOD is 
active within infected cells. 
 
 
7-2:Cell density (A) and viability (B) of cultures infected with various baculoviruses, in media supplemented with 1.0 mM 
CuSO4 and 0.1 mM ZnSO4. 
A time course of cells infected by the virus at an MOI of 5 indicates that as expected, the 
cell densities and viabilities decrease over time, with no significant differences between the 
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different constructs (Figure 7-2). Therefore we conclude that Cu-Zn SOD expression at high or 
low levels does not prolong the lifespan of baculovirus infected Sf9 cells.  
It is possible that reduction of oxidative stress within insect cells through SOD expression 
would increase the productivity of the cell in terms of fluorescent protein production. Therefore, 
infected cells were subjected to flow cytometry, and their red and green fluorescence measured 
(Figure 7-3). As expected, significant green fluorescence was only observed in cells infected 
with GFP producing virus. The slight increase in green fluorescence from SOD expressing cells 
over time may be due to either signal leakage from the red fluorescent protein, or from some 
process that produces fluorescent entities  
The levels of RFP produced were similar in the case of constructs where either the GFP 
or SOD was under the control of the gp64 promoter. This indicates that there was no 
enhancement of fluorescent RFP when protective SOD species were present in cells. In addition, 
the “competition” effect was also seen in this system, as the level of production of DsRed2 was 
much less when the SOD gene was placed under the control of the very strong p10 promoter, 
which confirms results obtained earlier, with the dual fluorescent protein system shown in 
Chapter 5 (George et al, 2015). 
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7-3: Green (A) and red (B) fluorescence from the various constructs over time within Sf9 cells infected with various 
baculoviruses. 
The experiments conducted show that the expression of Cu-Zn SOD in Sf9 insect cells 
had no effect on improving cell viability, or cell productivity. In the future, the effect of Cu-
ZnSOD expression in High Five
TM
 cells should also be investigated. In addition, Mn-SOD 
constructs expressing both Mn-SOD and RFP should be produced, and the effect of their 
expression should be investigated in both Sf9 and High Five
TM
 cells. The study of Mn-SOD in 
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High Five
TM
 cells will complement the work by Wang et al (2004) and will determine if Mn-
SOD expression improves cell viability when high levels of protein are being produced. 
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Conclusions and Recommendations 
The work presented in this thesis aimed to expand the utility of the baculovirus vector expression 
system for the simultaneous production of multiple proteins. This work was started with the goal 
of demonstrating tight control over the timing and expression levels of multiple genes within 
insect cell, and to examine any effects like “competition” between genes for cellular resources.  
This was realized in the first study where two simple fluorescent proteins eGFP and  
DsRed2 were expressed under the control of various promoter combinations. The expression 
levels of these two genes could be finely controlled using these promoter combinations, such that 
we determined the expression ratios of these proteins over time, with different promoter 
combinations. The study showed that coexpressed genes do in fact compete with each other for 
resources, and so the expected expression level from a promoter depends on the expression 
levels of other heterologous and baculovirus genes being expressed. This lays the basis for a 
theoretical template which other researchers can use to tailor expression systems that can 
produce proteins at different levels at different times during the baculovirus infection cycle. The 
genome of the many baculoviruses found in nature provides a rich source of promoters, as well 
as modified versions of these, that are active at various times and at different levels during the 
baculovirus infection cycle in insect cells. This study examined only the use of baculovirus 
promoters, but future research could examine the effects of other genetic elements to improve 
control over this system.  In addition, this study only examined expression from two gene 
systems and future studies could expand this concept to larger systems with three or more genes.  
This could especially be relevant for systems which require widely disparate levels of gene 
expression, such as when low levels of foreign chaperones or proteases are needed to efficiently 
produce or mature a protein of interest. 
119 
 
This second study was meant to address a question raised by the first study: namely, is 
the “competition” effect that is seen present at the transcription or translation stages. Real Time 
qPCR tracking of eGFP and DsRed2 transcripts revealed that the competition effect seemed to be 
present at the transcription stage, even though this may not be the only source of the competition 
effect. However, the data obtained was not of high quality. 
The third and fourth studies were conducted to extend the work done with eGFP and 
DsRed2 to a more complex and commercially relevant system: the production of influenza virus-
like particles. This system involved the production of influenza hemagglutinin and matrix 1 
proteins, that require significant post-translational modification, export to the cell membrane and 
assembly into VLPs, all features which were lacking from the eGFP – DsRed2 system. The 
influenza proteins were modified by genetically fusing them to fluorescent proteins to enable 
easy and direct visualization of influenza protein production in insect cells. This also allowed for 
examination of fluorescent VLP production into culture supernatant. These modified virus genes 
were then placed under the control of different promoter combinations and it was again shown 
that the levels of proteins could be reliably controlled by promoter control, and that competition 
effects could be observed in this more complex system. In addition, manipulating intracellular 
influenza protein levels affected the ratio of these proteins in VLPs in culture supernatant. These 
effects were shown to be present in Sf9 and High Five
TM
 cell lines. Unexpectedly, while High 
Five
TM 
cells produced far more intracellular protein than Sf9 cells, VLP production was not 
higher than from Sf9 cells. This work leads to several avenues of improvement. One of the major 
limitations of this VLP production system is the very low numbers of VLPs formed and exported 
into culture supernatant. This could be due to several factors such as lack of assembly of 
influenza proteins into VLPs in insect cells, or lack of VLP release from the cell surface. This 
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could be a subject of future research. It is also apparent that much of the influenza protein 
produced in both Sf9 and High Five
TM
 cells are not exported as VLPs and future studies on the 
bottlenecks in the VLP production process have the potential to greatly improve influenza VLP 
production from insect cells. The fluorescent influenza proteins produced in this work could also 
be used to examine influenza protein production in other cell types, and the approach of adding 
fluorescent tags to virus proteins could be adapted to other VLP forming virus systems. 
The last study presented in this work involved expressing Cu,Zn-superoxide dismutase to 
extend the lifespan of infected insect cells, by reducing oxidative stress through the destruction 
of superoxide species. It was thought that extending the lifespan of the cells could increase the 
production of DsRed2, which was coexpressed with SOD. No protective effect of SOD was 
found in Sf9 cells, and no increases in DsRed2 production were observed. Future research could 
examine the effect of coexpressing catalase with SOD, which would break down the peroxide 
species produced by SOD and further reduce oxidative stress in infected insect cells. In addition, 
while Cu,Zn-SOD was not protective in Sf9 cells, it‟s expression may be protective in other 
insect cells such as High Five
TM
 cells.   
Taken together, it is hoped that this work demonstrates the potential for the 
implementation of “designed” coexpression systems in BEVS, where the timing and levels of 
individual proteins can be pre-determined based on works similar to that presented in Chapter 3. 
These proteins can be components of a complex protein product, as demonstrated with the 
production of influenza VLPs, or chaperones, or other helper proteins to improve the production 
process, as in the case of the coexpression of SOD to improve cell viability. 
 
121 
 
References 
Ailor, E., & Betenbaugh, M. J. (1998) Overexpression of a cytosolic chaperone to improve 
solubility and secretion of a recombinant IgG protein in insect cells. Biotechnology 
Bioengineering. 58, 196-203.  
Ailor, E., & Betenbaugh, M. J. (1999) Modifying secretion and post-translational processing in 
insect cells. Current Opinion in Biotechnology. 10, 142-145.  
Akhnoukh, R., Kretzmer, G., & Schugerl, K. (1996) On-line monitoring and control of the 
cultivation of Spodoptera frugiperda Sf9 insect cells and B-galactosidase production by 
Autographica californica virus vector. Enzyme Microbial Technology. 18, 220-228.  
Ali, A., Avalos, R. T., Ponimaskin, E., & Nayak, D. P. (2000) Influenza virus assembly: Effect 
of influenza virus glycoproteins on the membrane association of M1 protein. Journal of 
Virology. 74, 8709-8719.  
Altmann, F., Staudacher, E., Wilson, I. B., & Marz, L. (1999) Insect cells as hosts for the 
expression of recombinant glycoproteins. Glycoconjugate Journal. 16, 109-123.  
Aucoin, M. G., Perrier, M., & Kamen, A. A. (2006) Production of adeno-associated viral vectors 
in insect cells using triple infection: Optimization of baculovirus concentration ratios. 
Biotechnology Bioengineering. 95, 1081-1092.  
Aucoin, M. G., Perrier, M., & Kamen, A. A. (2007) Improving AAV vector yield in insect cells 
by modulating the temperature after infection. Biotechnology Bioengineering. 97(6), 1501-
1509. 
Aumiller, J. J., Hollister, J. R., & Jarvis, D. L. (2003) A transgenic insect cell line engineered to 
produce CMP-sialic acid and sialylated glycoproteins. Glycobiology. 13, 497-507.  
Avalos, R. T., Yu, Z., & Nayak, D. P. (1997) Association of influenza virus NP and M1 proteins 
with cellular cytoskeletal elements in influenza virus-infected cells. Journal of Virology. 71, 
2947-2958.  
Ayres, M. D., Howard, S. C., Kuzio, J., Lopez-Ferber, M., & Possee, R. D. (1994) The complete 
DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology. 202, 586-
605.  
Baird, G. S., Zacharias, D. A., & Tsien, R. Y. (2000) Biochemistry, mutagenesis, and 
oligomerization of DsRed, a red fluorescent protein from coral. Proceedings of the National 
Academy of Sciences of the United States of America. 97, 11984-11989.  
Barman, S., Ali, A., Hui, E. K., Adhikary, L., & Nayak, D. P. (2001) Transport of viral proteins 
to the apical membranes and interaction of matrix protein with glycoproteins in the assembly 
of influenza viruses. Virus Research. 77, 61-69.  
122 
 
Bedard, C., Kamen, A., Tom, R., & Massie, B. (1994) Maximization of recombinant protein 
yield in the insect cell/baculovirus system by one-time addition of nutrients to high-density 
batch cultures. Cytotechnology. 15, 129-138.  
Berger, I., Fitzgerald, D. J., & Richmond, T. J. (2004) Baculovirus expression system for 
heterologous multiprotein complexes. Nature Biotechnology. 22, 1583-1587.  
Betenbaugh, M., Yu, M., Kuehl, K., White, J., Pennock, D., Spik, K., & Schmaljohn, C. (1995) 
Nucleocapsid- and virus-like particles assemble in cells infected with recombinant 
baculoviruses or vaccinia viruses expressing the M and the S segments of hantaan virus. 
Virus Research. 38, 111-124.  
Bevis, B. J., & Glick, B. S. (2002) Rapidly maturing variants of the discosoma red fluorescent 
protein (DsRed). Nature Biotechnology. 20, 83-87.  
Blissard, G. W., & Rohrmann, G. F. (1991) Baculovirus gp64 gene expression: Analysis of 
sequences modulating early transcription and transactivation by IE1. Journal of Virology. 
65, 5820-5827.  
Blissard, G. W., & Wenz, J. R. (1992) Baculovirus gp64 envelope glycoprotein is sufficient to 
mediate pH-dependent membrane fusion. Journal of Virology. 66, 6829-6835.  
Blissard, G. W., Kogan, P. H., Wei, R., & Rohrmann, G. F. (1992) A synthetic early promoter 
from a baculovirus: Roles of the TATA box and conserved start site CAGT sequence in 
basal levels of transcription. Virology. 190, 783-793.  
Bonning, B. C., Roelvink, P. W., Vlak, J. M., Possee, R. D., & Hammock, B. D. (1994) Superior 
expression of juvenile hormone esterase and beta-galactosidase from the basic protein 
promoter of Autographa californica nuclear polyhedrosis virus compared to the p10 protein 
and polyhedrin promoters. The Journal of General Virology. 75 ( Pt 7), 1551-1556.  
Bouvier, N. M., & Palese, P. (2008). The Biology of Influenza Viruses. Vaccine. 26(Suppl 4), 
D49–D53. 
Braunagel, S. C., Parr, R., Belyavskyi, M., & Summers, M. D. (1998) Autographa californica 
nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase. Virology. 244, 
195-211.  
Bright, R. A., Carter, D. M., Daniluk, S., Toapanta, F. R., Ahmad, A., Gavrilov, V., Massare, M., 
Pushko, P., Mytle, N., Rowe, T., Smith, G., & Ross, T. M. (2007) Influenza virus-like 
particles elicit broader immune responses than whole virion inactivated influenza virus or 
recombinant hemagglutinin. Vaccine. 25, 3871-3878.  
Bryksin, A. V., & Matsumura, I. (2010) Overlap extension PCR cloning: A simple and reliable 
way to create recombinant plasmids. BioTechniques. 48, 463-465.  
Bump, N., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., 
Ghayur, T., Li, P., et, al. (1995) Inhibition of ICE family proteases by baculovirus 
antiapoptotic protein p35. Science. 269, 1885-1888.  
123 
 
Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L. X., Kamin-Lewis, R., 
Abdelwahab, S., Lewis, G. K., & Buonaguro, F. M. (2006) Baculovirus-derived human 
immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex 
vivo T-cell responses. Journal of Virology. 80, 9134-9143.  
Bustin, S. A. (2000) Absolute quantification of mRNA using real-time reverse transcription 
polymerase chain reaction assays. Journal of Molecular Endocrinology. 25, 169-193.  
Carstens, E. B., Tjia, S. T., & Doerfler, W. (1979) Infection of Spodoptera frugiperda cells with 
Autographa californica nuclear polyhedrosis virus I. Synthesis of intracellular proteins after 
virus infection. Virology. 99, 386-398.  
Carstens, E. B. (1982) Mapping the mutation site of an Autographa californica nuclear 
polyhedrosis virus polyhedron morphology mutant. Journal of Virology. 43, 809-818.  
Carstens, E. B. (1987) Identification and nucleotide sequence of the regions of Autographa 
californica nuclear polyhedrosis virus genome carrying insertion elements derived from 
Spodoptera frugiperda. Virology. 161, 8-17.  
Chaabihi, H., Ogliastro, M. H., Martin, M., Giraud, C., Devauchelle, G., & Cerutti, M. (1993) 
Competition between baculovirus polyhedrin and p10 gene expression during infection of 
insect cells. Journal of Virology. 67, 2664-2671.  
Chang, M. J., & Blissard, G. W. (1997) Baculovirus gp64 gene expression: Negative regulation 
by a minicistron. Journal of Virology. 71, 7448-7460.  
Chazenbalk, G. D., & Rapoport, B. (1995) Expression of the extracellular domain of the 
thyrotropin receptor in the baculovirus system using a promoter active earlier than the 
polyhedrin promoter. Journal of Biological Chemistry. 270, 1543-1549.  
Chen, B. J., Leser, G. P., Morita, E., & Lamb, R. A. (2007) Influenza virus hemagglutinin and 
neuraminidase, but not the matrix protein, are required for assembly and budding of 
plasmid-derived virus-like particles. Journal of Virology. 81, 7111-7123.  
Cheng, X., Hillman, C. C., Zhang, C., & Cheng, X. (2013) Reduction of polyhedrin mRNA and 
protein expression levels in Sf9 and Hi5 cell lines, but not in Sf21 cells, infected with 
Autographa californica multiple nucleopolyhedrovirus fp25k mutants. Journal of General 
Virology. 94, 166-176.  
Chisholm, G. E., & Henner, D. J. (1988) Multiple early transcripts and splicing of the 
Autographa californica nuclear polyhedrosis virus IE-1 gene. Journal of Virology. 62, 3193-
3200.  
Clem, R. J. (1997) Regulation of programmed cell death by baculovirus. In: Miller, L.K. (Ed.), 
The Baculoviruses. Plenum, pp. 237-266. 
Crawford, S. E., Labbe, M., Cohen, J., Burroughs, M. H., Zhou, Y., & Estes, M. K. (1994) 
Characterization of virus-like particles produced by the expression of rotavirus capsid 
proteins in insect cells. Journal of Virology. 68, 5945-5952.  
124 
 
Dalal, N. G., Bentley, W. E., & Cha, H. J. (2005) Facile monitoring of baculovirus infection for 
foreign protein expression under very late polyedrin promoter using green fluorescent 
protein reporter under early-to-late promoter. Biochemical Engineering Journal. 24, 27-30.  
Davidson, D. J., & Castellino, F. J. (1991) Asparagine-linked oligosaccharide processing in 
lepidopteran insect cells. Temporal dependence of the nature of the oligosaccharides 
assembled on asparagine-289 of recombinant human plasminogen produced in baculovirus 
vector infected Spodoptera frugiperda (IPLB-SF-21AE) cells. Biochemistry. 30, 6167-6174.  
Davidson, D. J., Fraser, M. J., & Castellino, F. J. (1990) Oligosaccharide processing in the 
expression of human plasminogen cDNA by lepidopteran insect (Spodoptera frugiperda) 
cells. Biochemistry. 29, 5584-5590.  
Eisfeld, A. J., Neumann, G., & Kawaoka, Y. (2014) Influenza A virus isolation, culture and 
identification. Nature Protocols. 9, 2663-2681.  
Farinati, F., Cardin, R., Degan, P., De Maria, N., Floyd, R. A., Van Thiel, D. H., & Naccarato, R. 
(1999) Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic 
HCV infection. Free Radical Biology and Medicine. 27, 1284-1291. 
Fitzgerald, D. J., Berger, P., Schaffitzel, C., Yamada, K., Richmond, T. J., & Berger, I. (2006) 
Protein complex expression by using multigene baculoviral vectors. Nature Methods. 3, 
1021-1032.  
Fitzgerald, D. J., Schaffitzel, C., Berger, P., Wellinger, R., Bieniossek, C., Richmond, T., & 
Berger, I. (2007) Multiprotein expression strategy for structural biology of eukaryotic 
complexes. Structure. 15, 275-279.  
French, T. J., & Roy, P. (1990) Synthesis of bluetongue virus (BTV) corelike particles by a 
recombinant baculovirus expressing the two major structural core proteins of BTV. Journal 
of Virology. 64, 1530-1536.  
Friesen, P. D. (1997) Regulation of baculovirus early gene expression. In: Miller, L.K. (Ed.), The 
Baculoviruses; The Viruses. Plenum Press, New York, pp. 141-170. 
Fuchs, L. Y., Woods, M. S., & Weaver, R. F. (1983) Viral transcription during Autographa 
californica nuclear polyhedrosis virus infection: A novel RNA polymerase induced in 
infected Spodoptera frugiperda cells. Journal of Virology. 48, 641-646.  
Funk, C. J., Braunagel, S. C., & Rohrmann, G. F. (1997) Baculovirus structure. In: Miller, L.K. 
(Ed.), The Baculoviruses. Plenum, pp. 7. 
Funk, C. J., & Consigli, R. A. (1993) Phosphate cycling on the basic protein of Plodia 
interpunctella granulosis virus. Virology. 193, 396-402.  
Galarza, J. M., Latham, T., & Cupo, A. (2005) Virus-like particle (VLP) vaccine conferred 
complete protection against a lethal influenza virus challenge. Viral Immunology. 18, 244-
251.  
125 
 
Garrity, D. B., Chang, M., & Blissard, G. W. (1997) Late promoter selection in the Baculovirus 
gp64 envelope fusion Protein Gene. Virology. 231, 167-181.  
George, S., & Aucoin, M. G. (2015) Characterization of alternative promoters to stagger and 
control protein expression in the baculovirus-insect cell system: From intracellular reporter 
proteins to fluorescent influenza virus-like particles. BMC Proceedings. 9, P49-P49.  
George, S., & Aucoin, M. G. (Under Review)  
Formation of dual fluorescent influenza virus-like particles by expression of fluorescent 
influenza hemagglutinin and matrix 1 Fusion Proteins in insect cells. Journal of 
Biotechnology. 
George, S., Jauhar, A. M., Mackenzie, J., Kieβlich, S., & Aucoin, M. G. (2015) Temporal 
characterization of protein production levels from baculovirus vectors coding for GFP and 
RFP genes under non-conventional promoter control. Biotechnology and Bioengineering. 
112, 1822-1831.  
George, S., Sokolenko, S., & Aucoin, M. G. (2012) Rapid and cost-effective baculovirus sample 
preparation method as a viable alternative to conventional preparation for quantitative real-
time PCR. Journal of Virological Methods. 182, 27-36.  
Gilbert, L., Toivola, J., Lehtomäki, E., Donaldson, L., Käpylä, P., Vuento, M., & Oker-Blom, C. 
(2004) Assembly of fluorescent chimeric virus-like particles of canine parvovirus in insect 
cells. Biochemical and Biophysical Research Communications. 313, 878-887.  
Gilbert, L., Toivola, J., White, D., Ihalainen, T., Smith, W., Lindholm, L., Vuento, M., & Oker-
Blom, C. (2005) Molecular and structural characterization of fluorescent human parvovirus 
B19 virus-like particles. Biochemical and Biophysical Research Communications. 331, 527-
535.  
Giri, L., Feiss, M. G., Bonning, B. C., & Murhammer, D. W. (2012) Production of baculovirus 
defective interfering particles during serial passage is delayed by removing transposon target 
sites in fp25k. Journal of General Virology. 93, 389-399.  
Gómez-Puertas, P., Albo, C., Pérez-Pastrana, E., Vivo, A., & Portela, A. (2000) Influenza virus 
matrix protein is the major driving force in virus budding. Journal of Virology. 74, 11538-
11547.  
Gómez-Puertas, P., Mena, I., Castillo, M., Vivo, A., Pérez-Pastrana, E., & Portela, A. (1999) 
Efficient formation of influenza virus-like particles: Dependence on the expression levels of 
viral proteins. Journal of General Virology. 80, 1635-1645.  
Gotoh, T., Miyazaki, Y., Chiba, K., & Kikuchi, K. (2002) Significant increase in recombinant 
protein production of a virus-infected Sf9 insect cell culture of low MOI under low 
dissolved oxygen conditions. Journal of Bioscience and Bioengineering. 94, 426-433.  
Gotoh, T., Miyazaki, Y., Sato, W., Kikuchi, K., & Bentley, W. E. (2001) Proteolytic activity and 
recombinant protein production in virus-infected Sf9 insect cell cultures supplemented with 
126 
 
carboxyl and cysteine protease inhibitors. Journal of Bioscience and Bioengineering. 92, 
248-255.  
Grabherr, R., Ernst, W., Doblhoff-Dier, O., Sara, M., & Katinger, H. (1997) Expression of 
foreign proteins on the surface of Autographa californica nuclear polyhedrosis virus. 
BioTechniques. 22, 730-735.  
Grula, M. A., Buller, P. L., & Weaver, R. F. (1981) Alpha-amanitin-resistant viral RNA 
synthesis in nuclei isolated from nuclear polyhedrosis virus-infected Heliothis zea larvae and 
Spodoptera frugiperda cells. Journal of Virology. 38, 916-921.  
Guarino, L. A., Gonzalez, M. A., & Summers, M. D. (1986) Complete sequence and enhancer 
function of the homologous DNA regions of Autographa californica nuclear polyhedrosis 
virus. Journal of Virology. 60, 224-229.  
Guarino, L. A., Xu, B., Jin, J., & Dong, W. (1998) A virus-encoded RNA polymerase purified 
from baculovirus-infected cells. Journal of Virology. 72, 7985-7991.  
Gutiérrez-Granados, S., Cervera, L., Gódia, F., & Segura, M. (2013) Characterization and 
quantitation of fluorescent gag virus-like particles. BMC Proceedings. 7, 1-3. 
Habib, S., & Hasnain, S. E. (2000) Differential activity of two non-hr origins during replication 
of the baculovirus Autographa californica nuclear polyhedrosis virus genome. Journal of 
Virology. 74, 5182-5189.  
Haines, F. J., Griffiths, C. M., Possee, R. D., Hawes, C. R., & King, L. A. (2009) Involvement of 
lipid rafts and cellular actin in AcMNPV GP64 distribution and virus budding. Virologica 
Sinica. 24, 333-349.  
Harrison, R. L., Jarvis, D. L., & Summers, M. D. (1996) The role of the AcMNPV25K Gene, 
“FP25,” in Baculovirus polh and p10 Expression. Virology. 226, 34-46.  
Hawtin, R. E., Arnold, K., Ayres, M. D., de A. Zanotto, P. M., Howard, S. C., Gooday, G. W., 
Chappell, L. H., Kitts, P. A., King, L. A., & Possee, R. D. (1995) Identification and 
preliminary characterization of a chitinase gene in the Autographa californica nuclear 
polyhedrosis virus genome. Virology. 212, 673-685.  
Hemann, E. A., Kang, S., & Legge, K. L. (2013) Protective CD8 T Cell–Mediated immunity 
against influenza A virus infection following influenza Virus–like particle vaccination. The 
Journal of Immunology. 191, 2486-2494. 
Hershberger, P. A., LaCount, D. J., & Friesen, P. D. (1994) The apoptotic suppressor P35 is 
required early during baculovirus replication and is targeted to the cytosol of infected cells. 
Journal of Virology. 68, 3467-3477.  
Higgins, M. K., Demir, M., & Tate, C. G. (2003) Calnexin co-expression and the use of weaker 
promoters increase the expression of correctly assembled shaker potassium channel in insect 
cells. Biochimicaet Biophysica Acta (BBA) - Biomembranes. 1610, 124-132.  
127 
 
Hill-Perkins, M. S., & Possee, R. D. (1990) A baculovirus expression vector derived from the 
basic protein promoter of Autographa californica nuclear polyhedrosis virus. The Journal of 
General Virology. 71 ( Pt 4), 971-976.  
Hitchman, R. B., Possee, R. D., Crombie, A. T., Chambers, A., Ho, K., Siaterli, E., Lissina, O., 
Sternard, H., Novy, R., Loomis, K., Bird, L. E., Owens, R. J., & King, L. A. (2010). Genetic 
modification of a baculovirus vector for increased expression in insect cells. Cell Biology 
and Toxicology. 26, 57-68.  
Hitchman, R. B., Siaterli, E. A., Nixon, C. P., & King, L. A. (2007) Quantitative real-time PCR 
for rapid and accurate titration of recombinant baculovirus particles. Biotechnology and 
Bioengineering. 99, 810-814. 
Hodgson, J. J., Arif, B. M., & Krell, P. J. (2007) Reprogramming the chiA expression profile of 
Autographa californica multiple nucleopolyhedrovirus. Journal of General Virology. 88, 
2479-2487.  
Hom, L. G., Ohkawa, T., Trudeau, D., & Volkman, L. E. (2002) Autographa californica M 
nucleopolyhedrovirus ProV-CATH is activated during infected cell death. Virology. 296, 
212-218.  
Hsu, T., & Betenbaugh, M. J. (1997) Coexpression of molecular chaperone BiP improves 
immunoglobulin solubility and IgG secretion from Trichoplusia ni insect cells. 
Biotechnology Progress. 13, 96-104.  
Hu, Y., & Lin, S. (2013) Method for preparing virus-like particle and recombinant baculovirus 
used therein.  US Patent US 20130252311 A1. 
Hu, Y., & Bentley, W. E. (2000) A kinetic and statistical-thermodynamic model for baculovirus 
infection and virus-like particle assembly in suspended insect cells. Chemical Engineering 
Science. 55, 3991-4008.  
Hui, E. K., Barman, S., Yang, T. Y., & Nayak, D. P. (2003) Basic residues of the helix six 
domain of influenza virus M1 involved in nuclear translocation of M1 can be replaced by 
PTAP and YPDL late assembly domain motifs. Journal of Virology. 77, 7078-7092.  
Hutchinson, E., & Fodor, E. (2014) Purification of influenza virions by haemadsorption and 
ultracentrifugation. Protocol Exchange.  
Ikeda, M., & Kobayashi, M. (1999) Cell-cycle perturbation in Sf9 cells infected with Autographa 
californica nucleopolyhedrovirus. Virology. 258, 176-188.  
Ikonomou, L., Schneider, Y. J., & Agathos, S. N. (2003) Insect cell culture for industrial 
production of recombinant proteins. Applied Microbiology and Biotechnology. 62, 1-20.  
Ishiyama, S., & Ikeda, M. (2010) High-level expression and improved folding of proteins by 
using the vp39 late promoter enhanced with homologous DNA regions. Biotechnology 
Letters. 32, 599-614.  
128 
 
Jarvis, D. L., Bohlmeyer, D. A., & Garcia, A. (1992) Enhancement of polyhedrin nuclear 
localization during baculovirus infection. Journal of Virology. 66, 6903-6911.  
Jarvis, D. L., & Summers, M. D. (1989) Glycosylation and secretion of human tissue 
plasminogen activator in recombinant baculovirus-infected insect cells. Molecular and 
Cellular Biology. 9, 214-223.  
Jarvis, D. L., Weinkauf, C., & Guarino, L. A. (1996) Immediate-early baculovirus vectors for 
foreign gene expression in transformed or infected insect cells. Protein Expression and 
Purification. 8, 191-203.  
Jarvis, D. L. (1997) Baculovirus expression vectors. In: Miller, L.K. (Ed.), The Baculoviruses. 
Plenum Press, New York, pp. 389-431 
Jarvis, D. L., & Finn, E. E. (1995) Biochemical analysis of the N-glycosylation pathway in 
baculovirus-infected lepidopteran insect cells. Virology. 212, 500-511.  
Jarvis, D. L., & Finn, E. E. (1996) Modifying the insect cell N-glycosylation pathway with 
immediate early baculovirus expression vectors. Nature Biotechnology. 14, 1288-1292.  
Jin, H., Leser, G. P., Zhang, J., & Lamb, R. A. (1997) Influenza virus hemagglutinin and 
neuraminidase cytoplasmic tails control particle shape. The EMBO Journal. 16, 1236-1247.  
Kanai, Y., Athmaram, T. N., Stewart, M., & Roy, P. (2013) Multiple large foreign protein 
expression by a single recombinant baculovirus: A system for production of multivalent 
vaccines. Protein Expression and Purification. 91, 77-84.  
Kang, S., & Compans, R. W. (2003) Enhancement of mucosal immunization with virus-like 
particles of simian immunodeficiency virus. Journal of Virology. 77, 3615-3623.  
Kang, S., Yoo, D., Lipatov, A. S., Song, J., Davis, C. T., Quan, F., Chen, L., Donis, R. O., & 
Compans, R. W. (2009) Induction of long-term protective immune responses by influenza 
H5N1 virus-like particles. PLoS ONE. 4, e4667 EP.  
Karp, G. (1996) Utilization of genetic information: From transcription to translation. In: Karp, G. 
(Ed.), Cell and Molecular Biology: Concepts and Experiments. John Wiley & Sons, Inc., 
Canada, pp. 450-505 
Kato, T., Murata, T., Usui, T., & Park, E. Y. (2005) Improvement of the production of GFPuv-
β1,3-N-acetylglucosaminyltransferase 2 fusion protein using a molecular chaperone-assisted 
insect-cell-based expression system. Biotechnology Bioengineering. 89, 424-433.  
Kelly, B. J., King, L. A., & Possee, R. D. (2007) Introduction to baculovirus molecular biology. 
In: Murhammer, D.W. (Ed.), Methods in Molecular Biology. The Humana Press Inc, 
Totowa, NJ, USA, pp. 25-34. 
King, L. A., & Possee, R. D. (1992) The Baculovirus Expression System - A laboratory guide. 
Chapman & Hall, London. 
129 
 
Kogan, P. H., & Blissard, G. W. (1994) A baculovirus gp64 early promoter is activated by host 
transcription factor binding to CACGTG and GATA elements. Journal of Virology. 68, 813-
822.  
Kogan, P. H., Chen, X., & Blissard, G. W. (1995) Overlapping TATA-dependent and TATA-
independent early promoter activities in the baculovirus gp64 envelope fusion protein gene. 
Journal of Virology. 69, 1452-1461.  
Kohlbrenner, E., Aslanidi, G., Nash, K., Shklyaev, S., Campbell-Thompson, M., Byrne, B. J., 
Snyder, R. O., Muzyczka, N., Warrington, K. H.,Jr, & Zolotukhin, S. (2005) Successful 
production of pseudotyped rAAV vectors using a modified baculovirus expression system. 
Molecular Therapy : The Journal of the American Society of Gene Therapy. 12, 1217-1225.  
Kojima, K., Hayakawa, T., Asano, S., & Bando, H. (2001) Tandem repetition of baculovirus ie1 
promoter  results in upregulation of transcription. Archives of Virology. 146, 1407-1414.  
Kool, M., van den Berg, P. M. M. M., Tramper, J., Goldbach, R. W., & Vlak, J. M. (1993) 
Location of two putative origins of DNA replication of Autographa californica nuclear 
polyhedrosis virus. Virology. 192, 94-101.  
Kool, M., Voncken, J. W., Van Lier, F. L. J., Tramper, J., & Vlak, J. M. (1991) Detection and 
analysis of Autographa californica nuclear polyhedrosis virus mutants with defective 
interfering properties. Virology. 183, 739-746.  
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) Baculovirus as versatile vectors for protein 
expression in insect and mammalian cells. Nature Biotechnology. 23, 567-575.  
Krammer, F., Schinko, T., Palmberger, D., Tauer, C., Messner, P., & Grabherr, R. (2010) 
Trichoplusiani cells (High Five®) are highly efficient for the production of influenza A 
virus-like particles: A comparison of two insect cell lines as production platforms for 
influenza vaccines. Molecular Biotechnology. 45, 226-234.  
Krappa, R., Behn-Krappa, A., Jahnel, F., Doerfler, W., & Knebel-Mörsdorf, D. (1992) 
Differential factor binding at the promoter of early baculovirus gene PE38 during viral 
infection: GATA motif is recognized by an insect protein. Journal of Virology. 66, 3494-
3503.  
Kulakosky, P. C., Shuler, M. L., & Wood, H. A. (1998) N-glycosylation of a baculovirus-
expressed recombinant glycoprotein in three insect cell lines. In Vitro Cellular & 
Developmental Biology- Animal. 34, 101-108.  
Lamb, R. A., & Choppin, P. W. (1983) The gene structure and replication of influenza virus. 
Annual Review of Biochemistry. 52, 467-506.  
Latham, T., & Galarza, J. M. (2001) Formation of wild-type and chimeric influenza virus-like 
particles following simultaneous expression of only four structural proteins. Journal of 
Virology. 75, 6154-6165.  
130 
 
Lawrie, A. M., King, L. A., & Ogden, J. E. (1995) High level synthesis and secretion of human 
urokinase using a late gene promoter of the Autographa californica nuclear polyhedrosis 
virus. Journal of Biotechnology. 39, 1-8.  
Lee, H. Y., & Krell, P. J. (1992) Generation and analysis of defective genomes of Autographa 
californica nuclear polyhedrosis virus. Journal of Virology. 66, 4339-4347.  
Li, Z., Mueller, S. N., Ye, L., Bu, Z., Yang, C., Ahmed, R., & Steinhauer, D. A. (2005) Chimeric 
influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis 
protective antigen: Protein characterization, incorporation into infectious influenza viruses, 
and antigenicity. Journal of Virology. 79, 10003-10012.  
Licari, P., & Bailey, J. E. (1992) Modeling the population of baculovirus-infected insect cells: 
Optimizing infection strategies for enhanced recombinant protein yields. Biotechnology 
Bioengineering 39, 432-441.  
Lin, S., Naim, H. Y., Chapin Rodriguez, A., & Roth, M. G. (1998) Mutations in the middle of 
the transmembrane domain reverse the polarity of transport of the influenza virus 
hemagglutinin in MDCK epithelial cells. The Journal of Cell Biology. 142, 51-57.  
Linhult, M., Gülich, S., Gräslund, T., Nygren, P., & Hober, S. (2003) Evaluation of different 
linker regions for multimerization and coupling chemistry for immobilization of a 
proteinaceous affinity ligand. Protein Engineering. 16, 1147-1152.  
Lu, A., & Miller, L. K. (1997) Regulation of baculovirus late and very late gene expression. In: 
Miller, L.K. (Ed.), The Baculoviruses; The Viruses. Plenum Press, New York, pp. 193-216. 
Lu, A., Seshagiri, S., & Miller, L. K. (1996) Signal sequence and promoter effects on the 
efficacy of toxin-expressing baculoviruses as biopesticides. Biological Control. 7, 320-332.  
Mahmood, K., Bright, R. A., Mytle, N., Carter, D. M., Crevar, C. J., Achenbach, J. E., Heaton, P. 
M., Tumpey, T. M., & Ross, T. M. (2008) H5N1 VLP vaccine induced protection in ferrets 
against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine. 26, 5393-
5399.  
Marie, D., Brussaard, C. P. D., Thyrhaug, R., Bratbak, G., & Vaulot, D. (1999) Enumeration of 
marine viruses in culture and natural samples by flow cytometry. Applied and 
Environmental Microbiology. 65, 45-52.  
Marklund, S., & Marklund, G. (1974) Involvement of the superoxide anion radical in the 
autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European 
Journal of Biochemistry. 47, 469-474. 
Matindoost, L., Nielsen, L., & Reid, S. (2015) Intracellular trafficking of baculovirus particles: A 
quantitative study of the HearNPV/HzAM1 cell and AcMNPV/Sf9 cell systems. Viruses. 7, 
2288.  
Martínez-Solís, M., Gómez-Sebastián, S., Escribano, J.M., Jakubowska, A.K. & Herrero, S. 
(2016) A novel baculovirus-derived promoter with high activity in the Baculovirus 
Expression System. PeerJ Preprints 4:e2024v1. 
131 
 
Matsuda, T., & Cepko, C. L. (2006) Controlled expression of transgenes introduced by in vivo 
electroporation. Proceedings of the National Academy of Sciences of the United States of 
America. 104, 1027-1032. 
Meghrous, J., Aucoin, M. G., Jacob, D., Chahal, P. S., Arcand, N., & Kamen, A. A. (2005) 
Production of recombinant adeno-associated viral vectors using a Baculovirus/Insect cell 
suspension culture system: From shake flasks to a 20-L bioreactor. Biotechnology Progress 
21, 154-160.  
Meier-Ewert, H., & Compans, R. W. (1974) Time course of synthesis and assembly of influenza 
virus proteins. Journal of Virology. 14, 1083-1091.  
Mena, I., Vivo, A., Pérez, E., & Portela, A. (1996) Rescue of a synthetic chloramphenicol 
acetyltransferase RNA into influenza virus-like particles obtained from recombinant 
plasmids. Journal of Virology. 70, 5016-5024.  
Mistretta, T., & Guarino, L. A. (2005) Transcriptional activity of baculovirus very late factor 1. 
Journal of Virology. 79, 1958-1960.  
Monsma, S. A., & Scott, M. (1997) BacVector-3000: An engineered baculovirus for foreign 
protein expression, lacking viral chitinase and cathepsin protease activities. Innovations, 16-
19.  
Morris, T. D., & Miller, L. K. (1994) Mutational analysis of a baculovirus major late promoter. 
Gene. 140, 147-153.  
Murges, D., Kremer, A., & Knebel-Mörsdorf, D. (1997) Baculovirus transactivator IE1 is 
functional in mammalian cells. Journal of General Virology. 78, 1507-1510.  
Nayak, D. P., Balogun, R. A., Yamada, H., Zhou, Z. H., & Barman, S. (2009) Influenza virus 
morphogenesis and budding. Virus Research. 143, 147-161.  
Nissen, M. S., & Friesen, P. D. (1989) Molecular analysis of the transcriptional regulatory region 
of an early baculovirus gene. Journal of Virology. 63, 493-503.  
Noad, R., Stewart, M., Boyce, M., Celma, C., Willison, K., & Roy, P. (2009) Multigene 
expression of protein complexes by iterative modification of genomic bacmid DNA. BMC 
Molecular Biology. 10, 1-13.  
Nobiron, I., O'Reilly, D. R., & Olszewski, J. A. (2003) Autographa californica 
nucleopolyhedrovirus infection of Spodoptera frugiperda cells: A global analysis of host 
gene regulation during infection, using a differential display approach. The Journal of 
General Virology. 84, 3029-3039.  
Ogonah, O. W., Freedman, R. B., Jenkins, N., Patel, K., & Rooney, B. C. (1996) Isolation and 
characterization of an insect cell line able to perform complex N-linked glycosylation on 
recombinant proteins. Nature Biotechnology. 14,197-202.  
Ohkawa, T., Volkman, L. E., & Welch, M. D. (2010) Actin-based motility drives baculovirus 
transit to the nucleus and cell surface. The Journal of Cell Biology. 190, 187-195.  
132 
 
Okano, K., Vanarsdall, A. L., & Rohrmann, G. F. (2007) A baculovirus alkaline nuclease 
knockout construct produces fragmented DNA and aberrant capsids. Virology. 359, 46-54.  
Oker-Blom, C. E. G., & Summers, M. D. (1992) Multiple promoter baculovirus expression 
system and defective particle production European Patent EP 0549721 B1. 
Ooi, B. G., Rankin, C., & Miller, L. K. (1989) Downstream sequences augment transcription 
from the essential initiation site of a baculovirus polyhedrin gene. Journal of Molecular 
Biology. 210, 721-736.  
Palomares, L. A., Joosten, C. E., Hughes, P. R., Granados, R. R., & Shuler, M. L. (2003) Novel 
insect cell line capable of complex N-glycosylation and sialylation of recombinant proteins. 
Biotechnology Progress. 19, 185-192.  
Palomares, L. A., & Ramírez, O. T. (2009) Challenges for the production of virus-like particles 
in insect cells: The case of rotavirus-like particles. Biochemical Engineering Journal. 45, 
158-167.  
Pattenden, L. K., Middelberg, A. P. J., Niebert, M., & Lipin, D. I. (2005) Towards the 
preparative and large-scale precision manufacture of virus-like particles. Trends in 
Biotechnology. 23, 523-529.  
Pijlman, G. P., van den Born, E., Martens, D. E., & Vlak, J. M. (2001) Autographa californica 
baculoviruses with large genomic deletions are rapidly generated in infected insect cells. 
Virology. 283, 132-138.  
Pijlman, G. P., van Schijndel, J. E., & Vlak, J. M. (2003) Spontaneous excision of BAC vector 
sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells. 
Journal of General Virology. 84, 2669-2678.  
Prabakaran, M., Meng, T., He, F., YunRui, T., Qiang, J., Lin, R. T. P., & Kwang, J. (2011) 
Subcutaneous immunization with baculovirus surface-displayed hemagglutinin of pandemic 
H1N1 influenza A virus induces protective immunity in mice. Clinical and Vaccine 
Immunology : CVI. 18, 1582-1585.  
Prikhod'ko, G. G., Popham, H. J. R., Felcetto, T. J., Ostlind, D. A., Warren, V. A., Smith, M. M., 
Garsky, V. M., Warmke, J. W., Cohen, C. J., & Miller, L. K. (1998) Effects of simultaneous 
expression of two sodium channel toxin genes on the properties of baculoviruses as 
biopesticides. Biological Control. 12, 66-78.  
Pullen, S. S., & Friesen, P. D. (1995a) The CAGT motif functions as an initiator element during 
early transcription of the baculovirus transregulator ie-1. Journal of Virology. 69, 3575-
3583.  
Pullen, S. S., & Friesen, P. D. (1995b) Early transcription of the ie-1 transregulator gene of 
Autographa californica nuclear polyhedrosis virus is regulated by DNA sequences within its 
5' noncoding leader region. Journal of Virology. 69, 156-165.  
133 
 
Pushko, P., Tumpey, T. M., Bu, F., Knell, J. A. R.,Robin, & Smith, G. (2005) Influenza virus-
like particles comprised of the HA, NA, and M1 proteins of H2N2 influenza virus induce 
protective immune responses in BALB/c mice. Vaccine. 23, 5751-5759.  
Pushko, P., Tumpey, T. M., Van Hoeven, N., Belser, J. A., Robinson, R., Nathan, M., Smith, G., 
Wright, D. C., & Bright, R. A. (2007) Evaluation of influenza virus-like particles and 
novasome adjuvant as candidate vaccine for avian influenza. Vaccine. 25, 4283-4290.  
Quan, F. S., Steinhauer, D., Huang, C., Ross, T. M., Compans, R. W., & Kang, S. (2008) A 
bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. 
Vaccine. 26, 3352-3361.  
Quan, F., Huang, C., Compans, R. W., & Kang, S. (April 1, 2007) Virus-like particle vaccine 
induces protective immunity against homologous and heterologous strains of influenza 
virus. Journal of Virology. 81, 3514-3524.  
Ramakers, C., Ruijter, J. M., Deprez, R. H. L., & Moorman, A. F. M. (2003) Assumption-free 
analysis of quantitative real-time polymerase chain reaction (PCR) data. Neuroscience 
Letters. 339, 62-66.  
Rankin, C., Ooi, B. G., & Miller, L. K. (1988) Eight base pairs encompassing the transcriptional 
start point are the major determinant for baculovirus polyhedrin gene expression. Gene. 70, 
39-49.  
Reed, L. J., & Muench, H. (1938) A simple method of estimating fifty percent endpoints. The 
American Journal of Hygiene. 27, 493-497.  
Rodems, S. M., & Friesen, P. D. (1993) The hr5 transcriptional enhancer stimulates early 
expression from the Autographa californica nuclear polyhedrosis virus genome but is not 
required for virus replication. Journal of Virology. 67, 5776-5785.  
Rodems, S. M., & Friesen, P. D. (1995) Transcriptional enhancer activity of hr5 requires dual-
palindrome half sites that mediate binding of a dimeric form of the baculovirus 
transregulator IE1.Journal of Virology. 69, 5368-5375.  
Rohrmann, G. F. (2011) Baculovirus Molecular Biology: Second edition [internet]. National 
Center for Biotechnology Information (US), Bethesda (MD). 
Roldao, A., Vieira, H. L. A., Alves, P. M., R.Oliveira & Manuel J T Carrondo. (2006) 
Intracellular dynamics in rotavirus-like particles production: Evaluation of multigene and 
monocistornic infection strategies. Process Biochemistry. 41, 2188-2199.  
Ruigrok, R. W. H., Barge, A., Durrer, P., Brunner, J., Ma, K., & Whittaker, G. R. (2000) 
Membrane interaction of influenza virus M1 protein. Virology. 267, 289-298.  
Ruijter, J. M., Velden, S. V. D., & Ilgun, A. (2009) Lineregpcr. 11.5. 
Sacchetti, A., Subramaniam, V., Jovin, T. M., & Alberti, S. (2002) Oligomerization of DsRed is 
required for the generation of a functional red fluorescent chromophore. FEBS letters. 525, 
13-19.  
134 
 
Sailaja, G., Skountzou, I., Quan, F., Compans, R. W., & Kang, S. (2007) Human 
immunodeficiency virus-like particles activate multiple types of immune cells. Virology. 
362, 331-341.  
Saito, T., Dojima, T., Toriyama, M., & Park, E. Y. (2002) The effect of cell cycle on GFPuv 
gene expression in the baculovirus expression system. Journal of Biotechnology. 93, 121-
129.  
Scheiffele, P., Rietveld, A., Wilk, T., & Simons, K. (1999) Influenza viruses select ordered lipid 
domains during budding from the plasma membrane. Journal of Biological Chemistry. 274, 
2038-2044.  
Scheiffele, P., Roth, M. G., & Simons, K. (1997) Interaction of influenza virus haemagglutinin 
with sphingolipid-cholesterol membrane domains via its transmembrane domain. The 
EMBO Journal. 16, 5501-5508.  
Shanks, M., & Lomonossoff, G. P. (2000) Co-expression of the capsid proteins of cowpea 
mosaic virus in insect cells leads to the formation of virus-like particles. Journal of General 
Virology. 81, 3093-3097.  
Shen, C. F., Meghrous, J., & Kamen, A. (2002) Quantitation of baculovirus particles by flow 
cytometry. Journal of Virological Methods. 105, 321-330.  
Shishkov, A. V., Goldanskii, V. I., Baratova, L. A., Fedorova, N. V., Ksenofontov, A. L., 
Zhirnov, O. P., & Galkin, A. V. (1999) The in situ spatial arrangement of the influenza A 
virus matrix protein M1 assessed by tritium bombardment. Proceedings of the National 
Academy of Sciences. 96, 7827-7830.  
Simpson-Holley, M., Ellis, D., Fisher, D., Elton, D., McCauley, J., & Digard, P. (2002) A 
functional link between the actin cytoskeleton and lipid rafts during budding of filamentous 
influenza virions. Virology. 301, 212-225.  
Slack, J. M., Kuzio, J., & Faulkner, P. (1995a) Characterization of v-cath, a cathepsin L-like 
proteinase expressed by the baculovirus Autographa californica multiple nuclear 
polyhedrosis virus. Journal of General Virology. 76, 1091-1098.  
Slack, J. M., Kuzio, J., & Faulkner, P. (1995b) Characterization of v-cath, a cathepsin L-like 
proteinase expressed by the baculovirus Autographa californica multiple nuclear 
polyhedrosis virus. Journal of General Virology. 76, 1091-1098.  
Smith, G. E., Fraser, M. J., & Summers, M. D. (1983a) Molecular engineering of the Autographa 
californica nuclear polyhedrosis virus genome: Deletion mutations within the polyhedrin 
gene. Journal of Virology. 46, 584-593.  
Smith, G. E., Vlak, J. M., & Summers, M. D. (1983b) Physical analysis of Autographa 
californica nuclear polyhedrosis virus transcripts for polyhedrin and 10,000-molecular-
weight protein. Journal of Virology. 45, 215-225.  
135 
 
Sokolenko, S., George, S., Wagner, A., Tuladhar, A., Andrich, J. M. S., & Aucoin, M. G. (2012) 
Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: 
Benefits and drawbacks. Biotechnology Advances. 30, 766-781.  
Sokolenko, S., Nicastro, J., Slavcev, R., & Aucoin, M. G. (2012) Graphical analysis of flow 
cytometer data for characterizing controlled fluorescent protein display on λ phage. 
Cytometry Part A. 81A, 1031-1039. 
Song, M., Park, D., Kim, Y., Lee, K., Lu, Z., Ko, K., Choo, Y. K., Han, Y. S., Ahn, M., Oh, D., 
& Ko, K. (2010) Characterization of N-glycan structures and biofunction of anti-colorectal 
cancer monoclonal antibody CO17-1A produced in baculovirus-insect cell expression 
system. Journal of Bioscience and Bioengineering. 110, 135-140.  
Soos, A., George, S., Sokolenko, S., & Aucoin, M. G. (2011) Validation of GAPDH as a 
Housekeeping Gene for Baculovirus Infected Insect Cells", 60th Canadian Chemical 
Engineering Conference, October 24-27, 2010, Saskatoon, Saskatchewan, Canada. 
Sun, Y., Carrion Jr., R., Ye, L., Wen, Z., Ro, Y., Brasky, K., Ticer, A. E., Schwegler, E. E., 
Patterson, J. L., Compans, R. W., & Yang, C. (2009) Protection against lethal challenge by 
ebola virus-like particles produced in insect cells. Virology. 383, 12-21.  
Takeda, M., Leser, G. P., Russell, C. J., & Lamb, R. A. (2003) Influenza virus hemagglutinin 
concentrates in lipid raft microdomains for efficient viral fusion. Proceedings of the 
National Academy of Sciences of the United States of America. 100, 14610-14617.  
Tate, C. G., Whiteley, E., & Betenbaugh, M. J. (1999) Molecular chaperones stimulate the 
functional expression of the cocaine-sensitive serotonin transporter. Journal of Biological 
Chemistry. 274, 17551-17558.  
Thiem, S. M., & Miller, L. K. (1990) Differential gene expression mediated by late, very late and 
hybrid baculovirus promoters. Gene. 91, 87-94.  
Thompson, C. M., Petiot, E., Mullick, A., Aucoin, M. G., Henry, O., & Kamen, A. A. (2015) 
Critical assessment of influenza VLP production in Sf9 and HEK293 expression systems. 
BMC Biotechnology. 15, 31.  
Todd, J. W., Passarelli, A. L., Lu, A., & Miller, L. K. (1996) Factors regulating baculovirus late 
and very late gene expression in transient-expression assays. Journal of Virology. 70, 2307-
2317.  
Tsao, E. I., Mason, M. R., Cacciuttolo, M. A., Bowen, S. H., & Folena-Wasserman, G. (1996) 
Production of parvovirus B19 vaccine in insect cells co-infected with double baculoviruses. 
Biotechnology Bioengineering. 49, 130-138.  
Urabe, M., Ding, C. T., & Kotin, R. M. (2002) Insect cells as a factory to produce adeno-
associated virus type 2 vectors. Human Gene Therapy. 13, 1935-1943.  
Urabe, M., Nakakura, T., Xin, K. Q., Obara, Y., Mizukami, H., Kume, A., Kotin, R. M., & 
Ozawa, K. (2006) Scalable generation of high-titer recombinant adeno-associated virus type 
5 in insect cells. Journal of Virology. 80, 1874-1885.  
136 
 
Venereo-Sanchez, A., Gilbert, R., Simoneau, M., Caron, A., Chahal, P., Chen, W., Ansorge, S., 
Li, X., Henry, O., & Kamen, A. Hemagglutinin and neuraminidase containing virus-like 
particles produced in HEK-293 suspension culture: An effective influenza vaccine 
candidate. Vaccine. In Press. 
Vieira, H. L. A., Estêvão, C., Roldão, A., Peixoto, C. C., Sousa, M. F. Q., Cruz, P. E., Carrondo, 
M. J. T., & Alves, P. M. (2005) Triple layered rotavirus VLP production: Kinetics of vector 
replication, mRNA stability and recombinant protein production. Journal of Biotechnology. 
120, 72-82.  
Vijayachandran, L. S., Thimiri Govinda Raj, D.,B., Edelweiss, E., Gupta, K., Maier, J., Gordeliy, 
V., Fitzgerald, D. J., & Berger, I. (2012) Gene gymnastics: Synthetic biology for baculovirus 
expression vector system engineering. Bioengineered. 4, 279-287.  
Volkman, L. E., & Goldsmith, P. A. (1985) Mechanism of neutralization of budded Autographa 
californica nuclear polyhedrosis virus by a monoclonal antibody: Inhibition of entry by 
adsorptive endocytosis. Virology. 143, 185-195.  
Wang, Y., Oberley, L. W., & Murhammer, D. W. (2001a) Antioxidant defense systems of two 
lepidopteran insect cell lines. Free Radical Biology and Medicine. 30, 1254-1262.  
Wang, Y., Oberley, L. W., & Murhammer, D. W. (2001b) Evidence of oxidative stress following 
the viral infection of two lepidopteran insect cell lines. Free Radical Biology and Medicine. 
31, 1448-1455.  
Wang, Y., Oberley, L., Howe, D., Jarvis, D., Chauhan, G., & Murhammer, D. (2004) Effect of 
expression of manganese superoxide dismutase in baculovirus-infected insect cells. Applied 
Biochemistry and Biotechnology. 119, 181-193.  
Wen, Z., Ye, L., Gao, Y., Pan, L., Dong, K., Bu, Z., Compans, R. W., & Yang, C. (2009) 
Immunization by influenza virus-like particles protects aged mice against lethal influenza 
virus challenge. Antiviral Research. 84, 215-224.  
Wilde, M., Klausberger, M., Palmberger, D., Ernst, W., & Grabherr, R. (2014) Tnao38, high five 
and Sf9-evaluation of host-virus interactions in three different insect cell lines: Baculovirus 
production and recombinant protein expression. Biotechnology Letters. 36, 743-749.  
Wiley, D. C., & Skehel, J. J. (1987) The structure and function of the hemagglutinin membrane 
glycoprotein of influenza virus. Annual Review of Biochemistry. 56, 365-394.  
Winter, G., Fields, S., & Brownlee, G. G. (1981) Nucleotide sequence of the haemagglutinin 
gene of a human influenza virus H1 subtype. Nature. 292, 72-75. 
Wu, C., Yeh, Y., Yang, Y., Chou, C., Liu, M., Wu, H., Chan, J., & Hsiao, P. (2010) Mammalian 
expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS 
ONE. 5, e9784.   
Xue, J. L., Salem, T. Z., Turney, C. M., & Cheng, X. W. (2010) Strategy of the use of 28S rRNA 
as a housekeeping gene in real-time quantitative PCR analysis of gene transcription in insect 
cells infected by viruses. Journal of Virological Methods. 163, 210-215.  
137 
 
Yamshchikov, G. V., Ritter, G. D., Vey, M., & Compans, R. W. (1995) Assembly of SIV virus-
like particles containing envelope proteins using a baculovirus expression system. Virology. 
214, 50-58.  
Yang, D., Chung, Y., Lai, Y., Lai, C., Liu, H., & Hu, Y. (2007) Avian influenza virus 
hemagglutinin display on baculovirus envelope: Cytoplasmic domain affects virus properties 
and vaccine potential. Molecular Therapy : the Journal of the American Society of Gene 
Therapy. 15, 989-996.  
Yang, S., & Miller, L. K. (1999) Activation of baculovirus very late promoters by interaction 
with very late factor 1. Journal of Virology. 73, 3404-3409.  
Ye, L., Lin, J., Sun, Y., Bennouna, S., Lo, M., Wu, Q., Bu, Z., Pulendran, B., Compans, R. W., 
& Yang, C. (2006) Ebola virus-like particles produced in insect cells exhibit dendritic cell 
stimulating activity and induce neutralizing antibodies. Virology. 351, 260-270.  
Ye, Z., Robinson, D., & Wagner, R. R. (1995) Nucleus-targeting domain of the matrix protein 
(M1) of influenza virus. Journal of Virology. 69, 1964-1970.  
Zhang, J., Pekosz, A., & Lamb, R. A. (2000) Influenza virus assembly and lipid raft 
microdomains: A role for the cytoplasmic tails of the spike glycoproteins. Journal of 
Virology. 74, 4634-4644.  
zuPutlitz, J., Kubasek, W. L., Duchene, M., Marget, M., von Specht, B., & Domdey, H. (1990) 
Antibody production in baculovirus-infected insect cells. Nature Biotechnology. 8, 651-654. 
 
 
 
 
 
 
 
 
 
138 
 
Appendix 
Gene sequences used in this project 
Influenza A virus (A/Puerto Rico/8/1934(H1N1)) HA gene for hemagglutinin, 
ATGAAGGCAAACCTACTGGTCCTGTTATGTGCACTTGCAGCTGCAGATGCAGACACA
ATATGTATAGGCTACCATGCGAACAATTCAACCGACACTGTTGACACAGTACTCGAG
AAGAATGTGACAGTGACACACTCTGTTAACCTGCTCGAAGACAGCCACAACGGAAA
ACTATGTAGATTAAAAGGAATAGCCCCACTACAATTGGGGAAATGTAACATCGCCG
GATGGCTCTTGGGAAACCCAGAATGCGACCCACTGCTTCCAGTGAGATCATGGTCCT
ACATTGTAGAAACACCAAACTCTGAGAATGGAATATGTTATCCAGGAGATTTCATCG
ACTATGAGGAGCTGAGGGAGCAATTGAGCTCAGTGTCATCATTCGAAAGATTCGAA
ATATTTCCCAAAGAAAGCTCATGGCCCAACCACAACACAAACGGAGTAACGGCAGC
ATGCTCCCATGAGGGGAAAAGCAGTTTTTACAGAAATTTGCTATGGCTGACGGAGA
AGGAGGGCTCATACCCAAAGCTGAAAAATTCTTATGTGAACAAAAAAGGGAAAGAA
GTCCTTGTACTGTGGGGTATTCATCACCCGCCTAACAGTAAGGAACAACAGAATCTC
TATCAGAATGAAAATGCTTATGTCTCTGTAGTGACTTCAAATTATAACAGGAGATTT
ACCCCGGAAATAGCAGAAAGACCCAAAGTAAGAGATCAAGCTGGGAGGATGAACT
ATTACTGGACCTTGCTAAAACCCGGAGACACAATAATATTTGAGGCAAATGGAAAT
CTAATAGCACCAATGTATGCTTTCGCACTGAGTAGAGGCTTTGGGTCCGGCATCATC
ACCTCAAACGCATCAATGCATGAGTGTAACACGAAGTGTCAAACACCCCTGGGAGC
TATAAACAGCAGTCTCCCTTACCAGAATATACACCCAGTCACAATAGGAGAGTGCC
CAAAATACGTCAGGAGTGCCAAATTGAGGATGGTTACAGGACTAAGGAACATTCCG
TCCATTCAATCCAGAGGTCTATTTGGAGCCATTGCCGGTTTTATTGAAGGGGGATGG
ACTGGAATGATAGATGGATGGTATGGTTATCATCATCAGAATGAACAGGGATCAGG
CTATGCAGCGGATCAAAAAAGCACACAAAATGCCATTAACGGGATTACAAACAAGG
TGAACACTGTTATCGAGAAAATGAACATTCAATTCACAGCTGTGGGTAAAGAATTCA
ACAAATTAGAAAAAAGGATGGAAAATTTAAATAAAAAAGTTGATGATGGATTTCTG
GACATTTGGACATATAATGCAGAATTGTTAGTTCTACTGGAAAATGAAAGGACTCTG
GATTTCCATGACTCAAATGTGAAGAATCTGTATGAGAAAGTAAAAAGCCAATTAAA
GAATAATGCCAAAGAAATCGGAAATGGATGTTTTGAGTTCTACCACAAGTGTGACA
ATGAATGCATGGAAAGTGTAAGAAATGGGACTTATGATTATCCCAAATATTCAGAA
GAGTCAAAGTTGAACAGGGAAAAGGTAGATGGAGTGAAATTGGAATCAATGGGGA
TCTATCAGATTCTGGCGATCTACTCAACTGTCGCCAGTTCACTGGTGCTTTTGGTCTC
CCTGGGGGCAATCAGTTTCTGGATGTGTTCTAATGGATCTTTGCAGTGCAGAATATG
CATCTGA  
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Influenza A virus (A/Puerto Rico/8/1934(H1N1)) segment 7, coding for the M1 gene 
ATGAGTCTTCTAACCGAGGTCGAAACGTACGTACTCTCTATCATCCCGTCAGGCCCC
CTCAAAGCCGAGATCGCACAGAGACTTGAAGATGTCTTTGCAGGGAAGAACACCGA
TCTTGAGGTTCTCATGGAATGGCTAAAGACAAGACCAATCCTGTCACCTCTGACTAA
GGGGATTTTAGGATTTGTGTTCACGCTCACCGTGCCCAGTGAGCGAGGACTGCAGCG
TAGACGCTTTGTCCAAAATGCCCTTAATGGGAACGGGGATCCAAATAACATGGACA
AAGCAGTTAAACTGTATAGGAAGCTCAAGAGGGAGATAACATTCCATGGGGCCAAA
GAAATCTCACTCAGTTATTCTGCTGGTGCACTTGCCAGTTGTATGGGCCTCATATACA
ACAGGATGGGGGCTGTGACCACTGAAGTGGCATTTGGCCTGGTATGTGCAACCTGTG
AACAGATTGCTGACTCCCAGCATCGGTCTCATAGGCAAATGGTGACAACAACCAAT
CCACTAATCAGACATGAGAACAGAATGGTTTTAGCCAGCACTACAGCTAAGGCTAT
GGAGCAAATGGCTGGATCGAGTGAGCAAGCAGCAGAGGCCATGGAGGTTGCTAGTC
AGGCTAGACAAATGGTGCAAGCGATGAGAACCATTGGGACTCATCCTAGCTCCAGT
GCTGGTCTGAAAAATGATCTTCTTGAAAATTTGCAGGCCTATCAGAAACGAATGGGG
GTGCAGATGCAACGGTTCAAG 
eGFP from plasmid pcDNA3-GFP 
ATGGTGAGCAAGGGCGAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCT
GGACGGCGACGTAAACGGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGAT
GCCACCTACGGCAAGCTGACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTG
CCCTGGCCCACCCTCGTGACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTAC
CCCGACCACATGAAGCAGCACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTC
CAGGAGCGCACCATCTTCTTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGT
GAAGTTCGAGGGCGACACCCTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCA
AGGAGGACGGCAACATCCTGGGGCACAAGCTGGAGTACAACTACAACAGCCACAA
CGTCTATATCATGGCCGACAAGCAGAAGAACGGCATCAAGGTGAACTTCAAGATCC
GCCACAACATCGAGGACGGCAGCGTGCAGCTCGCCGACCACTACCAGCAGAACACC
CCCATCGGCGACGGCCCCGTGCTGCTGCCCGACAACCACTACCTGAGCACCCAGTCC
GCCCTGAGCAAAGACCCCAACGAGAAGCGCGATCACATGGTCCTGCTGGAGTTCGT
GACCGCCGCCGGGATCACTCTCGGCATGGACGAGCTGTACAAGTAA 
DsRed2  from plasmid pCALNLDsRed 
ATGGCCTCCTCCGAGAACGTCATCACCGAGTTCATGCGCTTCAAGGTGCGCATGGAG
GGCACCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTA
CGAGGGCCACAACACCGTGAAGCTGAAGGTGACCAAGGGCGGCCCCCTGCCCTTCG
CCTGGGACATCCTGTCCCCCCAGTTCCAGTACGGCTCCAAGGTGTACGTGAAGCACC
CCGCCGACATCCCCGACTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAG
CGCGTGATGAACTTCGAGGACGGCGGCGTGGCGACCGTGACCCAGGACTCCTCCCT
GCAGGACGGCTGCTTCATCTACAAGGTGAAGTTCATCGGCGTGAACTTCCCCTCCGA
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CGGCCCCGTGATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACCGAGCGCCTGT
ACCCCCGCGACGGCGTGCTGAAGGGCGAGACCCACAAGGCCCTGAAGCTGAAGGAC
GGCGGCCACTACCTGGTGGAGTTCAAGTCCATCTACATGGCCAAGAAGCCCGTGCA
GCTGCCCGGCTACTACTACGTGGACGCCAAGCTGGACATCACCTCCCACAACGAGG
ACTACACCATCGTGGAGCAGTACGAGCGCACCGAGGGCCGCCACCACCTGTTCCTG
TAG 
 
HA-GFP-RFP-M synthesized sequence 
CGCTCAGCTGGAATTTCAGATGCATATTCTGCACTGCAAAGATCCATTAGAACACAT
CCAGAAACTGATTGCCCCCAGGGAGACCAAAAGCACCAGTGAACTGGCGACAGTTG
AGTAGATCGCCAGAATCTGATAGATCCCCATTGATTCCAATTTCACTCCATCTACCTT
TTCCCTGTTCAACTTTGACTCTTCTGAATATTTGGGATAATCATAAGTCCCATTTCTT
ACACTTTCCATGCATTCATTGTCACACTTGTGGTAGAACTCAAAACATCCATTTCCGA
TTTCTTTGGCATTATTCTTTAATTGGCTTTTTACTTTCTCATACAGATTCTTCACATTT
GAGTCATGGAAATCCAGAGTCCTTTCATTTTCCAGTAGAACTAACAATTCTGCATTA
TATGTCCAAATGTCCAGAAATCCATCATCAACTTTTTTATTTAAATTTTCCATCCTTTT
TTCTAATTTGTTGAATTCTTTACCCACAGCTGTGAATTGAATGTTCATTTTCTCGATA
ACAGTGTTCACCTTGTTTGTAATCCCGTTAATGGCATTTTGTGTGCTTTTTTGATCCG
CTGCATAGCCTGATCCCTGTTCATTCTGATGATGATAACCATACCATCCATCTATCAT
TCCAGTCCATCCCCCTTCAATAAAACCGGCAATGGCTCCAAATAGACCTCTGGATTG
AATGGACGGAATGTTCCTTAGTCCTGTAACCATCCTCAATTTGGCACTCCTGACGTA
TTTTGGGCACTCTCCTATTGTGACTGGGTGTATATTCTGGTAAGGGAGACTGCTGTTT
ATAGCTCCCAGGGGTGTTTGACACTTCGTGTTACACTCATGCATTGATGCGTTTGAG
GTGATGATGCCGGACCCAAAGCCTCTACTCAGTGCGAAAGCATACATTGGTGCTATT
AGATTTCCATTTGCCTCAAATATTATTGTGTCTCCGGGTTTTAGCAAGGTCCAGTAAT
AGTTCATCCTCCCAGCTTGATCTCTTACTTTGGGTCTTTCTGCTATTTCCGGGGTAAA
TCTCCTGTTATAATTTGAAGTCACTACAGAGACATAAGCATTTTCATTCTGATAGAG
ATTCTGTTGTTCCTTACTGTTAGGCGGGTGATGAATACCCCACAGTACAAGGACTTC
TTTCCCTTTTTTGTTCACATAAGAATTTTTCAGCTTTGGGTATGAGCCCTCCTTCTCCG
TCAGCCATAGCAAATTTCTGTAAAAACTGCTTTTCCCCTCATGGGAGCATGCTGCCG
TTACTCCGTTTGTGTTGTGGTTGGGCCATGAGCTTTCTTTGGGAAATATTTCGAATCT
TTCGAATGATGACACTGAGCTCAATTGCTCCCTCAGCTCCTCATAGTCGATGAAATC
TCCTGGATAACATATTCCATTCTCAGAGTTTGGTGTTTCTACAATGTAGGACCATGAT
CTCACTGGAAGCAGTGGGTCGCATTCTGGGTTTCCCAAGAGCCATCCGGCGATGTTA
CATTTCCCCAATTGTAGTGGGGCTATTCCTTTTAATCTACATAGTTTTCCGTTGTGGC
TGTCTTCGAGCAGGTTAACAGAGTGTGTCACTGTCACATTCTTCTCGAGTACTGTGTC
AACAGTGTCGGTTGAATTGTTCGCATGGTAGCCTATACATATTGTGTC CGA ATC 
TGC ATC TAC 
CTTGTACAGCTCGTCCATGCCGAGAGTGATCCCGGCGGCGGTCACGAACTCCAGCA
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GGACCATGTGATCGCGCTTCTCGTTGGGGTCTTTGCTCAGGGCGGACTGGGTGCTCA
GGTAGTGGTTGTCGGGCAGCAGCACGGGGCCGTCGCCGATGGGGGTGTTCTGCTGG
TAGTGGTCGGCGAGCTGCACGCTGCCGTCCTCGATGTTGTGGCGGATCTTGAAGTTC
ACCTTGATGCCGTTCTTCTGCTTGTCGGCCATGATATAGACGTTGTGGCTGTTGTAGT
TGTACTCCAGCTTGTGCCCCAGGATGTTGCCGTCCTCCTTGAAGTCGATGCCCTTCAG
CTCGATGCGGTTCACCAGGGTGTCGCCCTCGAACTTCACCTCGGCGCGGGTCTTGTA
GTTGCCGTCGTCCTTGAAGAAGATGGTGCGCTCCTGGACGTAGCCTTCGGGCATGGC
GGACTTGAAGAAGTCGTGCTGCTTCATGTGGTCGGGGTAGCGGCTGAAGCACTGCA
CGCCGTAGGTCAGGGTGGTCACGAGGGTGGGCCAGGGCACGGGCAGCTTGCCGGTG
GTGCAGATGAACTTCAGGGTCAGCTTGCCGTAGGTGGCATCGCCCTCGCCCTCGCCG
GACACGCTGAACTTGTGGCCGTTTACGTCGCCGTCCAGCTCGACCAGGATGGGCACC
ACCCCGGTGAACAGCTCCTCGCCCTTGCTCAC CGA ATC TGC ATC TAC 
TGCATCTGCAGCTGCAAGTGCACATAACAGGACCAGTAGGTTTGCCTTCATCTGGTA
ATGGTAGCGACCGGCGCTCAGCTGGAATTCAGATCTGTGATTGTAAATAAAATGTAA
TTTACAGTATAGTATTTTAATTAATATACAAATGATTTGATAATAATTCTTATTTAAC
TATAATATATTGTGTTGGGTTGAATTAAAGGTCCCGGCATCCTCAAATGCATAATTT
CATAGTCCCCCTTGTTGTAAGTGATGCGTATTTCTGAATCTTTGTAAAATAGCACACA
AGACTCCAACGCGTTTGGCGTTTTATTTTCTTGCTCGACTCTAGAGGATCGATCCCCC
GGATCTGATCATGGAGATAATTAAAATGATAACCATCTCGCAAATAAATAAGTATTT
TACTGTTTTCGTAACAGTTTTGTAATAAAAAAACCTATAAATACGGATCCGGTTATT
AGTACATTTATTAAGCATGAGTCTTCTAACCGAGGTCGAAACGTACGTACTCTCTAT
CATCCCGTCAGGCCCCCTCAAAGCCGAGATCGCACAGAGACTTGAAGATGTCTTTGC
AGGGAAGAACACCGATCTTGAGGTTCTCATGGAATGGCTAAAGACAAGACCAATCC
TGTCACCTCTGACTAAGGGGATTTTAGGATTTGTGTTCACGCTCACCGTGCCCAGTG
AGCGAGGACTGCAGCGTAGACGCTTTGTCCAAAATGCCCTTAATGGGAACGGGGAT
CCAAATAACATGGACAAAGCAGTTAAACTGTATAGGAAGCTCAAGAGGGAGATAAC
ATTCCATGGGGCCAAAGAAATCTCACTCAGTTATTCTGCTGGTGCACTTGCCAGTTG
TATGGGCCTCATATACAACAGGATGGGGGCTGTGACCACTGAAGTGGCATTTGGCCT
GGTATGTGCAACCTGTGAACAGATTGCTGACTCCCAGCATCGGTCTCATAGGCAAAT
GGTGACAACAACCAATCCACTAATCAGACATGAGAACAGAATGGTTTTAGCCAGCA
CTACAGCTAAGGCTATGGAGCAAATGGCTGGATCGAGTGAGCAAGCAGCAGAGGCC
ATGGAGGTTGCTAGTCAGGCTAGACAAATGGTGCAAGCGATGAGAACCATTGGGAC
TCATCCTAGCTCCAGTGCTGGTCTGAAAAATGATCTTCTTGAAAATTTGCAGGCCTA
TCAGAAACGAATGGGGGTGCAGATGCAACGGTTCAAG GTAGATGCAGATTCG 
GCCTCCTCCGAGAACGTCATCACCGAGTTCATGCGCTTCAAGGTGCGCATGGAGGGC
ACCGTGAACGGCCACGAGTTCGAGATCGAGGGCGAGGGCGAGGGCCGCCCCTACGA
GGGCCACAACACCGTGAAGCTGAAGGTGACCAAGGGCGGCCCCCTGCCCTTCGCCT
GGGACATCCTGTCCCCCCAGTTCCAGTACGGCTCCAAGGTGTACGTGAAGCACCCCG
CCGACATCCCCGACTACAAGAAGCTGTCCTTCCCCGAGGGCTTCAAGTGGGAGCGC
GTGATGAACTTCGAGGACGGCGGCGTGGCGACCGTGACCCAGGACTCCTCCCTGCA
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GGACGGCTGCTTCATCTACAAGGTGAAGTTCATCGGCGTGAACTTCCCCTCCGACGG
CCCCGTGATGCAGAAGAAGACCATGGGCTGGGAGGCCTCCACCGAGCGCCTGTACC
CCCGCGACGGCGTGCTGAAGGGCGAGACCCACAAGGCCCTGAAGCTGAAGGACGG
CGGCCACTACCTGGTGGAGTTCAAGTCCATCTACATGGCCAAGAAGCCCGTGCAGCT
GCCCGGCTACTACTACGTGGACGCCAAGCTGGACATCACCTCCCACAACGAGGACT
ACACCATCGTGGAGCAGTACGAGCGCACCGAGGGCCGCCACCACCTGTTCCTGTAG
 GATCCGGTTATTAGT 
Color Legend: 
Hemagglutinin gene sequence 
Matrix 1 gene sequence 
eGFP sequence 
DsRed2 sequence 
polh promoter 
p10 promoter 
Linker regions 
Sequences overlapping baculovirus vector 
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Baculovirus Quantification Methods 
Virus sample preparation for real-time PCR 
Viral DNA template was prepared by subjecting samples of baculovirus-containing supernatant 
to freeze/thaw cycles and Triton X-100 treatments, as detailed previously (George et al., 2012). 
Briefly, 10% Triton X-100 (EMD Chemicals, Gibbstown, NJ, USA) was added to 200ul cell 
culture supernatant samples to a final concentration of 0.1% Triton X-100. The samples were 
incubated at 37 °C for 10 minutes, followed by two freeze/thaw cycles alternating between 
-80 °C and 37°C, 10 minutes at a time. Treated samples were then used for real-time PCR. 
Real-time PCR virus quantification 
All real-time PCRs were conducted with a StepOnePlus Real-Time PCR system (Applied 
Biosystems, Burlington, ON, Canada) and were prepared in MicroAmp Fast Optical 96-well 
Reaction Plates (Applied Biosystems, Burlington, ON, Canada). Each reaction consisted of 2 μl 
sample, 10 μl of 2× Power SYBR® Green PCR Master Mix (Applied Biosystems, Burlington, 
ON, Canada), 900 nM each of forward and reverse primers, and nuclease free water, for a final 
volume of 20 μl. Replicate samples were prepared in one well and then distributed among the 
required number of wells. The plate was then sealed with MicroAmp Optical Adhesive Film 
(Applied Biosystems, Burlington, ON, Canada) and centrifuged briefly at 1000 g in an 
Eppendorf 5804R centrifuge (Eppendorf Canada, Mississauga, ON, Canada) with an A2-DWP 
flat plate rotor (Eppendorf Canada, Mississauga, ON, Canada). The primers used for the 
reactions have been described in another work (Hitchman et al., 2007) and are targeted against a 
region in the gp64 gene (gp64F – 5- CGGCGTGAGTATGATTCTCAAA – 3‟ and gp64R – 5‟ – 
ATGAGCAGACACGCAGCTTTT – 3‟).The reaction was conducted according to conditions 
described previously (George et al., 2012). The initial denaturation was conducted at 95 °C for 
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10 min, followed by 45 cycles of denaturation at 95 °C for 30 s and annealing/extension at 60 °C 
for 30 s. Following PCR, a melt curve analysis was performed by heating the final mixture to 95 
°C for 15 s followed by annealing at 60 °C for 1 min. The temperature was then increased in 0.3 
°C increments to 95 °C for 15 s, with fluorescence being measured during the elevation stage. 
Each sample was run in triplicate on a single PCR plate to provide statistical validity and 
confidence in the data obtained. Data obtained from each reaction plate was analysed by 
StepOne™ Software v2.0. Plasmid standards were generated in our lab, and have been described 
previously (George et al., 2012). Plasmid standard dilutions were run alongside the samples, and 
a standard curve of threshold cycle (CT) vs standard concentration was generated. The threshold 
fluorescence level was automatically set by the instrument control software StepOne™ Software 
v2.0 (Applied Biosystems, Burlington, ON, Canada) to be significantly higher than the 
background noise. The CT values of the samples were then compared with the standard curve to 
determine the concentration of baculovirus DNA in samples. 
Baculovirus particle titer determination by flow cytometry 
Baculovirus particle counts were conducted using flow cytometry, as described previously 
(Shen, et al. 2002). Counts were carried out using a BD FACS Calibur flow cytometer (BD 
Biosciences, San Jose, CA, USA), and Flow-Set™ Fluorospheres (Beckman Coulter Inc., 
Fullerton, CA, USA) were used as an external standard to calibrate the instrument and allow for 
particle concentration determination. 
Viable baculovirus titer determination by end point dilution assay 
The end point dilution assay was conducted as per the Tissue Culture Infectious Dose 50 
(TCID50) assay (Reed and Muench, 1938) and analyzed using equations from King and Possee 
(King and Possee, 1992). Briefly, a 96 well plate was seeded with 2 x 10
4
 cells. Serial dilutions 
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of baculovirus in Sf900 III media were made ranging from 10
-4
 to 10
-10
and added to the plated 
cells (with each virus dilution being added to 12 wells). The plates were stored at 27⁰C for 7 
days, after which the plate was examined under a fluorescence microscope, and the wells scored 
as infected or non-infected based on fluorescence from baculovirus infected wells. The values 
obtained from the End Point Dilution Assay were used to determine the amounts of virus 
solution to be added to cell cultures (given the close agreement between methods and stocks). 
Viable baculovirus titer determination by growth cessation assay 
This assay was used to confirm the results obtained from the End Point Dilution Assay. Briefly, 
30 ml cell cultures at 1 x 10
6
 cells/ml were infected with 1000, 100, 10, 5 and 1 µl of virus stocks 
and the cultures were monitored over 5 days, to determine when cell growth cessation occurred. 
The amount of baculovirus that caused an immediate cessation of growth was taken to be 
equivalent to an MOI of 3, from which the titre of the virus stock could be determined. 
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Table A-1: Primers used in work performed in Chapter 3 (Integrated DNA Technologies, Coralville, IA, USA). The 
underlined regions correspond to sequences on the pAcUW51 plasmid where sequences are to be inserted 
Primer Name Primer Sequence Description 
GFPF 5‟ –CAGCTGAGCGCCGGTCGCTACCATTACCAGATGG 
TGAGCAAGGGCGAGGAGCTG – 3‟ 
Primers for amplifying 
out GFP gene and 
inserting it into  
plasmid pAcUW51 
GFPR 5‟ – CCGAGTTTGTCAGAAAGCAGACCAAACAGCGGT 
TACTTGTACAGCTCGTCCATGCCGAGAG – 3‟ 
RFPF 5‟ –CTATAAATACGGATCATGGCCTCCTCCGAGAACG 
TCATC – 3‟ 
Primers for amplifying 
out RFP gene and 
inserting it into  
plasmid pAcUW51 
RFPR 5'- GTACTAATAACCGGATCCTACAGGAACAGGTGGTG 
GCG – 3‟ 
ie1F 5‟ -  CAACAAGGGGGACTATGAAATTATGCATTTGAGG 
ATGCGCCATTAGGGCAGTATAAATTG – 3‟ 
Primers for amplifying 
out the ie1 promoter, 
and replacing the p10 
promoter in pAcUW51 
ie1R 5‟ –CTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATTC 
AGTCACTTGGTTGTTCACGATC – 3‟ 
basicF 5‟ – CAACAAGGGGGACTATGAAATTATGCATTTGAGG 
ATGCCGTTTTGCGACGATGCAG – 3‟ 
Primers for amplifying 
out the basic promoter, 
and replacing the p10 
promoter in pAcUW51 
basicR 5‟ – CTGGTAATGGTAGCGACCGGCGCTCAGCTGGAATT 
CGTTTAAATTGTGTAATTTATGTAGCTGTAATT – 3‟ 
gp64F 5‟ – CAACAAGGGGGACTATGAAATTATGCATTTGAGG 
ATGTGTGTCACGTAGGCCAGATAAC – 3‟ 
Primers for amplifying 
out the gp64 promoter, 
and replacing the p10 
promoter in pAcUW51 
gp64R 5‟ – GTAATGGTAGCGACCGGCGCTCAGCTGGAATTCC 
TTGCTTGTGTGTTCCTTATTGAAGCC -3' 
vcathF 5‟ –GGACTATGAAATTATGCATTTGAGGATGAATTTATC 
TTAATTTTAAGTTGAATTCCAGCT – 3` 
Primers for amplifying 
out the vcath promoter, 
and replacing the p10 
promoter in pAcUW51 
vcathR 5‟ – GGTAGCGACCGGCGCTCAGCTGGAATTCAACTTA 
AAATTAAGATAAATTCATCCTC – 3‟ 
GFPFB1F 5‟ - CGCGGATCCATGGTGAGCAAGGGCGAGGA - 3‟ Primers for amplifying 
out GFP gene and 
inserting it into  
plasmid pFastBac1 GFPFB1R 5‟ - GCCGAATTCTTACTTGTACAGCTCGTCCATGCCGAG - 3‟ 
RFPFB1F 5‟ - CGCGGATCCATGGCCTCCTCCGAGAACGTCA - 3‟ Primers for amplifying 
out RFP gene and 
inserting it into  
plasmid pFastBac1 RFPFB1R 5‟ - GCCGAATTCCTACAGGAACAGGTGGTGGCG - 3‟ 
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Supplementary 
Figures
 
Figure A-1: Comparison of virus titers obtained using four different methods to quantify the five viruses used in this 
experiment: Real Time PCR (Figure A-1 A), Flow Cytometry (Figure A-1 B), End Point Dilution Assay (Figure A-1 C), 
and growth cessation assay (Figure A-1 D) 
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Figure A-2 : eGFP (A-1 A) and DsRed2 (A-1 B) RNA levels in cells infected with different baculovirus constructs, 
normalized with respect to cellular 28SrRNA levels 
